KR20200108887A - Chemical liquid for forming a water-repellent protective film and a method for surface treatment of wafers - Google Patents
Chemical liquid for forming a water-repellent protective film and a method for surface treatment of wafers Download PDFInfo
- Publication number
- KR20200108887A KR20200108887A KR1020207023680A KR20207023680A KR20200108887A KR 20200108887 A KR20200108887 A KR 20200108887A KR 1020207023680 A KR1020207023680 A KR 1020207023680A KR 20207023680 A KR20207023680 A KR 20207023680A KR 20200108887 A KR20200108887 A KR 20200108887A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- protective film
- water
- wafer
- integer
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims abstract description 284
- 230000001681 protective effect Effects 0.000 title claims abstract description 145
- 239000005871 repellent Substances 0.000 title claims abstract description 116
- 239000007788 liquid Substances 0.000 title claims description 258
- 238000000034 method Methods 0.000 title claims description 104
- 238000004381 surface treatment Methods 0.000 title claims description 99
- 235000012431 wafers Nutrition 0.000 title description 168
- 239000000010 aprotic solvent Substances 0.000 claims abstract description 49
- 150000003377 silicon compounds Chemical class 0.000 claims abstract description 35
- -1 aminosilane compound Chemical class 0.000 claims abstract description 29
- 150000001875 compounds Chemical class 0.000 claims description 130
- 239000002994 raw material Substances 0.000 claims description 99
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 88
- 125000004432 carbon atom Chemical group C* 0.000 claims description 42
- 150000007513 acids Chemical class 0.000 claims description 40
- 125000000962 organic group Chemical group 0.000 claims description 31
- 238000002360 preparation method Methods 0.000 claims description 31
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 30
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 28
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 28
- 229910052731 fluorine Inorganic materials 0.000 claims description 28
- 239000011737 fluorine Substances 0.000 claims description 28
- 239000001257 hydrogen Substances 0.000 claims description 28
- 229910052739 hydrogen Inorganic materials 0.000 claims description 28
- 238000004140 cleaning Methods 0.000 claims description 25
- 238000001035 drying Methods 0.000 claims description 19
- 230000002940 repellent Effects 0.000 claims description 16
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims description 13
- 125000005843 halogen group Chemical group 0.000 claims description 9
- 229910052709 silver Inorganic materials 0.000 claims description 5
- 239000004332 silver Substances 0.000 claims description 4
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 14
- 230000000694 effects Effects 0.000 abstract description 38
- 239000000243 solution Substances 0.000 description 135
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 37
- 230000000052 comparative effect Effects 0.000 description 34
- 238000011156 evaluation Methods 0.000 description 24
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 23
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 21
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 21
- 229910052710 silicon Inorganic materials 0.000 description 21
- 239000010703 silicon Substances 0.000 description 21
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 20
- 150000002430 hydrocarbons Chemical group 0.000 description 20
- 239000002904 solvent Substances 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 19
- 238000010790 dilution Methods 0.000 description 16
- 239000012895 dilution Substances 0.000 description 16
- 239000002245 particle Substances 0.000 description 16
- 238000006467 substitution reaction Methods 0.000 description 14
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 150000005846 sugar alcohols Polymers 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 7
- 239000004065 semiconductor Substances 0.000 description 7
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical class [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 238000007654 immersion Methods 0.000 description 6
- 238000004528 spin coating Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 5
- 239000013064 chemical raw material Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000000428 dust Substances 0.000 description 4
- 230000001747 exhibiting effect Effects 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 238000003892 spreading Methods 0.000 description 4
- ZUHZGEOKBKGPSW-UHFFFAOYSA-N tetraglyme Chemical compound COCCOCCOCCOCCOC ZUHZGEOKBKGPSW-UHFFFAOYSA-N 0.000 description 4
- 238000009834 vaporization Methods 0.000 description 4
- 230000008016 vaporization Effects 0.000 description 4
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 3
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 229910004298 SiO 2 Inorganic materials 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 238000000149 argon plasma sintering Methods 0.000 description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000005530 etching Methods 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920002120 photoresistant polymer Polymers 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- QYGBYAQGBVHMDD-XQRVVYSFSA-N (z)-2-cyano-3-thiophen-2-ylprop-2-enoic acid Chemical compound OC(=O)C(\C#N)=C/C1=CC=CS1 QYGBYAQGBVHMDD-XQRVVYSFSA-N 0.000 description 2
- KVNYFPKFSJIPBJ-UHFFFAOYSA-N 1,2-diethylbenzene Chemical compound CCC1=CC=CC=C1CC KVNYFPKFSJIPBJ-UHFFFAOYSA-N 0.000 description 2
- AUHZEENZYGFFBQ-UHFFFAOYSA-N 1,3,5-trimethylbenzene Chemical compound CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 2
- XUKSWKGOQKREON-UHFFFAOYSA-N 1,4-diacetoxybutane Chemical compound CC(=O)OCCCCOC(C)=O XUKSWKGOQKREON-UHFFFAOYSA-N 0.000 description 2
- GDXHBFHOEYVPED-UHFFFAOYSA-N 1-(2-butoxyethoxy)butane Chemical compound CCCCOCCOCCCC GDXHBFHOEYVPED-UHFFFAOYSA-N 0.000 description 2
- VBVHNUMQFSVYGE-UHFFFAOYSA-N 1-[1-(1-methoxypropan-2-yloxy)propan-2-yloxy]propan-2-yl acetate Chemical compound COCC(C)OCC(C)OCC(C)OC(C)=O VBVHNUMQFSVYGE-UHFFFAOYSA-N 0.000 description 2
- HYLLZXPMJRMUHH-UHFFFAOYSA-N 1-[2-(2-methoxyethoxy)ethoxy]butane Chemical compound CCCCOCCOCCOC HYLLZXPMJRMUHH-UHFFFAOYSA-N 0.000 description 2
- KTSVVTQTKRGWGU-UHFFFAOYSA-N 1-[2-[2-(2-butoxyethoxy)ethoxy]ethoxy]butane Chemical compound CCCCOCCOCCOCCOCCCC KTSVVTQTKRGWGU-UHFFFAOYSA-N 0.000 description 2
- OHRSSDYDJRJIMN-UHFFFAOYSA-N 1-[2-[2-(2-butoxypropoxy)propoxy]propoxy]butane Chemical compound CCCCOCC(C)OCC(C)OCC(C)OCCCC OHRSSDYDJRJIMN-UHFFFAOYSA-N 0.000 description 2
- SNAQINZKMQFYFV-UHFFFAOYSA-N 1-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]butane Chemical compound CCCCOCCOCCOCCOC SNAQINZKMQFYFV-UHFFFAOYSA-N 0.000 description 2
- MQGIBEAIDUOVOH-UHFFFAOYSA-N 1-[2-[2-[2-(2-butoxyethoxy)ethoxy]ethoxy]ethoxy]butane Chemical compound CCCCOCCOCCOCCOCCOCCCC MQGIBEAIDUOVOH-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 2
- KIAMPLQEZAMORJ-UHFFFAOYSA-N 1-ethoxy-2-[2-(2-ethoxyethoxy)ethoxy]ethane Chemical compound CCOCCOCCOCCOCC KIAMPLQEZAMORJ-UHFFFAOYSA-N 0.000 description 2
- ORRRIJVZQZKAKQ-UHFFFAOYSA-N 1-ethoxy-2-[2-(2-ethoxypropoxy)propoxy]propane Chemical compound CCOCC(C)OCC(C)OCC(C)OCC ORRRIJVZQZKAKQ-UHFFFAOYSA-N 0.000 description 2
- RERATEUBWLKDFE-UHFFFAOYSA-N 1-methoxy-2-[2-(2-methoxypropoxy)propoxy]propane Chemical compound COCC(C)OCC(C)OCC(C)OC RERATEUBWLKDFE-UHFFFAOYSA-N 0.000 description 2
- ROSYHLFNMZTEKZ-UHFFFAOYSA-N 1-methoxy-2-[2-[2-(2-methoxypropoxy)propoxy]propoxy]propane Chemical compound COCC(C)OCC(C)OCC(C)OCC(C)OC ROSYHLFNMZTEKZ-UHFFFAOYSA-N 0.000 description 2
- FLPPEMNGWYFRSK-UHFFFAOYSA-N 2-(2-acetyloxypropoxy)propyl acetate Chemical compound CC(=O)OCC(C)OCC(C)OC(C)=O FLPPEMNGWYFRSK-UHFFFAOYSA-N 0.000 description 2
- VXQBJTKSVGFQOL-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethyl acetate Chemical compound CCCCOCCOCCOC(C)=O VXQBJTKSVGFQOL-UHFFFAOYSA-N 0.000 description 2
- JONNRYNDZVEZFH-UHFFFAOYSA-N 2-(2-butoxypropoxy)propyl acetate Chemical compound CCCCOC(C)COC(C)COC(C)=O JONNRYNDZVEZFH-UHFFFAOYSA-N 0.000 description 2
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical compound CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 2
- CKCGJBFTCUCBAJ-UHFFFAOYSA-N 2-(2-ethoxypropoxy)propyl acetate Chemical compound CCOC(C)COC(C)COC(C)=O CKCGJBFTCUCBAJ-UHFFFAOYSA-N 0.000 description 2
- BJINVQNEBGOMCR-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethyl acetate Chemical compound COCCOCCOC(C)=O BJINVQNEBGOMCR-UHFFFAOYSA-N 0.000 description 2
- RZXAHVCTRLTLNA-UHFFFAOYSA-N 2-(2-methoxypropoxy)-1-propoxypropane Chemical compound CCCOCC(C)OCC(C)OC RZXAHVCTRLTLNA-UHFFFAOYSA-N 0.000 description 2
- DRLRGHZJOQGQEC-UHFFFAOYSA-N 2-(2-methoxypropoxy)propyl acetate Chemical compound COC(C)COC(C)COC(C)=O DRLRGHZJOQGQEC-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- OVOUKWFJRHALDD-UHFFFAOYSA-N 2-[2-(2-acetyloxyethoxy)ethoxy]ethyl acetate Chemical compound CC(=O)OCCOCCOCCOC(C)=O OVOUKWFJRHALDD-UHFFFAOYSA-N 0.000 description 2
- HFNFWZALUXHJQK-UHFFFAOYSA-N 2-[2-(2-acetyloxypropoxy)propoxy]propyl acetate Chemical compound CC(=O)OC(C)COC(C)COC(C)COC(C)=O HFNFWZALUXHJQK-UHFFFAOYSA-N 0.000 description 2
- SGQLKNKVOZVAAY-UHFFFAOYSA-N 2-[2-(2-butoxyethoxy)ethoxy]ethyl acetate Chemical compound CCCCOCCOCCOCCOC(C)=O SGQLKNKVOZVAAY-UHFFFAOYSA-N 0.000 description 2
- ZYTRLHRQWPTWNT-UHFFFAOYSA-N 2-[2-(2-butoxypropoxy)propoxy]propyl acetate Chemical compound CCCCOC(C)COC(C)COC(C)COC(C)=O ZYTRLHRQWPTWNT-UHFFFAOYSA-N 0.000 description 2
- NVSCAPMJFRYMFK-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethyl acetate Chemical compound CCOCCOCCOCCOC(C)=O NVSCAPMJFRYMFK-UHFFFAOYSA-N 0.000 description 2
- JDNLDGRWNMIHQC-UHFFFAOYSA-N 2-[2-(2-ethoxypropoxy)propoxy]propyl acetate Chemical compound CCOC(C)COC(C)COC(C)COC(C)=O JDNLDGRWNMIHQC-UHFFFAOYSA-N 0.000 description 2
- SDHQGBWMLCBNSM-UHFFFAOYSA-N 2-[2-(2-methoxyethoxy)ethoxy]ethyl acetate Chemical compound COCCOCCOCCOC(C)=O SDHQGBWMLCBNSM-UHFFFAOYSA-N 0.000 description 2
- DXYGJDUJLDXFOD-UHFFFAOYSA-N 2-[2-[2-(2-acetyloxyethoxy)ethoxy]ethoxy]ethyl acetate Chemical compound CC(=O)OCCOCCOCCOCCOC(C)=O DXYGJDUJLDXFOD-UHFFFAOYSA-N 0.000 description 2
- NTAADJGIMDADQS-UHFFFAOYSA-N 2-[2-[2-(2-acetyloxypropoxy)propoxy]propoxy]propyl acetate Chemical compound CC(=O)OCC(C)OCC(C)OCC(C)OCC(C)OC(C)=O NTAADJGIMDADQS-UHFFFAOYSA-N 0.000 description 2
- XGPAKKIIHOORKP-UHFFFAOYSA-N 2-[2-[2-(2-butoxyethoxy)ethoxy]ethoxy]ethyl acetate Chemical compound CCCCOCCOCCOCCOCCOC(C)=O XGPAKKIIHOORKP-UHFFFAOYSA-N 0.000 description 2
- UQBVDIXWZLYGOR-UHFFFAOYSA-N 2-[2-[2-(2-ethoxyethoxy)ethoxy]ethoxy]ethyl acetate Chemical compound CCOCCOCCOCCOCCOC(C)=O UQBVDIXWZLYGOR-UHFFFAOYSA-N 0.000 description 2
- OVMHYFTZTYLUHL-UHFFFAOYSA-N 2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl acetate Chemical compound COCCOCCOCCOCCOC(C)=O OVMHYFTZTYLUHL-UHFFFAOYSA-N 0.000 description 2
- PCAADGZYCGLFCM-UHFFFAOYSA-N 2-[2-[2-(2-methoxypropoxy)propoxy]propoxy]propyl acetate Chemical compound COC(C)COC(C)COC(C)COC(C)COC(C)=O PCAADGZYCGLFCM-UHFFFAOYSA-N 0.000 description 2
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 2
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 2
- HYDWALOBQJFOMS-UHFFFAOYSA-N 3,6,9,12,15-pentaoxaheptadecane Chemical compound CCOCCOCCOCCOCCOCC HYDWALOBQJFOMS-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RZTOWFMDBDPERY-UHFFFAOYSA-N Delta-Hexanolactone Chemical compound CC1CCCC(=O)O1 RZTOWFMDBDPERY-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- ZCZSIDMEHXZRLG-UHFFFAOYSA-N Heptyl acetate Chemical compound CCCCCCCOC(C)=O ZCZSIDMEHXZRLG-UHFFFAOYSA-N 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- JYVPIEJECJXXKU-UHFFFAOYSA-N [butyl(dimethyl)silyl] 2,2,2-trifluoroacetate Chemical compound CCCC[Si](C)(C)OC(=O)C(F)(F)F JYVPIEJECJXXKU-UHFFFAOYSA-N 0.000 description 2
- JDYXTZFZYGJYCU-UHFFFAOYSA-N [dimethyl(octyl)silyl] 2,2,2-trifluoroacetate Chemical compound CCCCCCCC[Si](C)(C)OC(=O)C(F)(F)F JDYXTZFZYGJYCU-UHFFFAOYSA-N 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003660 carbonate based solvent Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- UBPGILLNMDGSDS-UHFFFAOYSA-N diethylene glycol diacetate Chemical compound CC(=O)OCCOCCOC(C)=O UBPGILLNMDGSDS-UHFFFAOYSA-N 0.000 description 2
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 2
- UYAAVKFHBMJOJZ-UHFFFAOYSA-N diimidazo[1,3-b:1',3'-e]pyrazine-5,10-dione Chemical compound O=C1C2=CN=CN2C(=O)C2=CN=CN12 UYAAVKFHBMJOJZ-UHFFFAOYSA-N 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N ethylene glycol monomethyl ether acetate Natural products COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- IFYYFLINQYPWGJ-UHFFFAOYSA-N gamma-decalactone Chemical compound CCCCCCC1CCC(=O)O1 IFYYFLINQYPWGJ-UHFFFAOYSA-N 0.000 description 2
- GAEKPEKOJKCEMS-UHFFFAOYSA-N gamma-valerolactone Chemical compound CC1CCC(=O)O1 GAEKPEKOJKCEMS-UHFFFAOYSA-N 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- ZQBFAOFFOQMSGJ-UHFFFAOYSA-N hexafluorobenzene Chemical compound FC1=C(F)C(F)=C(F)C(F)=C1F ZQBFAOFFOQMSGJ-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 229910003480 inorganic solid Inorganic materials 0.000 description 2
- GJRQTCIYDGXPES-UHFFFAOYSA-N isobutyl acetate Chemical compound CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropyl acetate Chemical compound CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- YRHYCMZPEVDGFQ-UHFFFAOYSA-N methyl decanoate Chemical compound CCCCCCCCCC(=O)OC YRHYCMZPEVDGFQ-UHFFFAOYSA-N 0.000 description 2
- JGHZJRVDZXSNKQ-UHFFFAOYSA-N methyl octanoate Chemical compound CCCCCCCC(=O)OC JGHZJRVDZXSNKQ-UHFFFAOYSA-N 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- YKYONYBAUNKHLG-UHFFFAOYSA-N propyl acetate Chemical compound CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 2
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 2
- 229940116423 propylene glycol diacetate Drugs 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- GWPZHWIVXJVWCQ-UHFFFAOYSA-N silyl 2,2,2-trifluoroacetate Chemical compound FC(F)(F)C(=O)O[SiH3] GWPZHWIVXJVWCQ-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 2
- YFNKIDBQEZZDLK-UHFFFAOYSA-N triglyme Chemical compound COCCOCCOCCOC YFNKIDBQEZZDLK-UHFFFAOYSA-N 0.000 description 2
- VIYXXANHGYSBLY-UHFFFAOYSA-N trimethylsilyl 2,2,2-trifluoroacetate Chemical compound C[Si](C)(C)OC(=O)C(F)(F)F VIYXXANHGYSBLY-UHFFFAOYSA-N 0.000 description 2
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 2
- QRPLZGZHJABGRS-UHFFFAOYSA-N xi-5-Dodecanolide Chemical compound CCCCCCCC1CCCC(=O)O1 QRPLZGZHJABGRS-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- OWSKJORLRSWYGK-UHFFFAOYSA-N (3-methoxy-3-methylbutyl) propanoate Chemical compound CCC(=O)OCCC(C)(C)OC OWSKJORLRSWYGK-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- LDTMPQQAWUMPKS-OWOJBTEDSA-N (e)-1-chloro-3,3,3-trifluoroprop-1-ene Chemical compound FC(F)(F)\C=C\Cl LDTMPQQAWUMPKS-OWOJBTEDSA-N 0.000 description 1
- ZHJBJVPTRJNNIK-UPHRSURJSA-N (z)-1,2-dichloro-3,3,3-trifluoroprop-1-ene Chemical compound FC(F)(F)C(\Cl)=C\Cl ZHJBJVPTRJNNIK-UPHRSURJSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- UVWPNDVAQBNQBG-UHFFFAOYSA-N 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-icosafluorononane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F UVWPNDVAQBNQBG-UHFFFAOYSA-N 0.000 description 1
- OKIYQFLILPKULA-UHFFFAOYSA-N 1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxybutane Chemical compound COC(F)(F)C(F)(F)C(F)(F)C(F)(F)F OKIYQFLILPKULA-UHFFFAOYSA-N 0.000 description 1
- RIQRGMUSBYGDBL-UHFFFAOYSA-N 1,1,1,2,2,3,4,5,5,5-decafluoropentane Chemical compound FC(F)(F)C(F)C(F)C(F)(F)C(F)(F)F RIQRGMUSBYGDBL-UHFFFAOYSA-N 0.000 description 1
- WZLFPVPRZGTCKP-UHFFFAOYSA-N 1,1,1,3,3-pentafluorobutane Chemical compound CC(F)(F)CC(F)(F)F WZLFPVPRZGTCKP-UHFFFAOYSA-N 0.000 description 1
- RKIMETXDACNTIE-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorocyclohexane Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F RKIMETXDACNTIE-UHFFFAOYSA-N 0.000 description 1
- PWMJXZJISGDARB-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5-decafluorocyclopentane Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F PWMJXZJISGDARB-UHFFFAOYSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- VPBZZPOGZPKYKX-UHFFFAOYSA-N 1,2-diethoxypropane Chemical compound CCOCC(C)OCC VPBZZPOGZPKYKX-UHFFFAOYSA-N 0.000 description 1
- LEEANUDEDHYDTG-UHFFFAOYSA-N 1,2-dimethoxypropane Chemical compound COCC(C)OC LEEANUDEDHYDTG-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- AZLXQBNSOMJQEJ-UHFFFAOYSA-N 1,3-di(propan-2-yl)imidazolidin-2-one Chemical compound CC(C)N1CCN(C(C)C)C1=O AZLXQBNSOMJQEJ-UHFFFAOYSA-N 0.000 description 1
- NYCCIHSMVNRABA-UHFFFAOYSA-N 1,3-diethylimidazolidin-2-one Chemical compound CCN1CCN(CC)C1=O NYCCIHSMVNRABA-UHFFFAOYSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- HMCUNLUHTBHKTB-UHFFFAOYSA-N 1,4-dimethoxybutane Chemical compound COCCCCOC HMCUNLUHTBHKTB-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- QMGJMGFZLXYHCR-UHFFFAOYSA-N 1-(2-butoxypropoxy)butane Chemical compound CCCCOCC(C)OCCCC QMGJMGFZLXYHCR-UHFFFAOYSA-N 0.000 description 1
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 1
- UOWSVNMPHMJCBZ-UHFFFAOYSA-N 1-[2-(2-butoxypropoxy)propoxy]butane Chemical compound CCCCOCC(C)OCC(C)OCCCC UOWSVNMPHMJCBZ-UHFFFAOYSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- FUWDFGKRNIDKAE-UHFFFAOYSA-N 1-butoxypropan-2-yl acetate Chemical compound CCCCOCC(C)OC(C)=O FUWDFGKRNIDKAE-UHFFFAOYSA-N 0.000 description 1
- DFUYAWQUODQGFF-UHFFFAOYSA-N 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane Chemical compound CCOC(F)(F)C(F)(F)C(F)(F)C(F)(F)F DFUYAWQUODQGFF-UHFFFAOYSA-N 0.000 description 1
- SQEGLLMNIBLLNQ-UHFFFAOYSA-N 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane Chemical compound CCOC(F)(F)C(F)(C(F)(F)F)C(F)(F)F SQEGLLMNIBLLNQ-UHFFFAOYSA-N 0.000 description 1
- ZIKLJUUTSQYGQI-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxypropoxy)propane Chemical compound CCOCC(C)OCC(C)OCC ZIKLJUUTSQYGQI-UHFFFAOYSA-N 0.000 description 1
- PZHIWRCQKBBTOW-UHFFFAOYSA-N 1-ethoxybutane Chemical compound CCCCOCC PZHIWRCQKBBTOW-UHFFFAOYSA-N 0.000 description 1
- ZXHQLEQLZPJIFG-UHFFFAOYSA-N 1-ethoxyhexane Chemical compound CCCCCCOCC ZXHQLEQLZPJIFG-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- LIPRQQHINVWJCH-UHFFFAOYSA-N 1-ethoxypropan-2-yl acetate Chemical compound CCOCC(C)OC(C)=O LIPRQQHINVWJCH-UHFFFAOYSA-N 0.000 description 1
- MBDUIEKYVPVZJH-UHFFFAOYSA-N 1-ethylsulfonylethane Chemical compound CCS(=O)(=O)CC MBDUIEKYVPVZJH-UHFFFAOYSA-N 0.000 description 1
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 1
- AOPDRZXCEAKHHW-UHFFFAOYSA-N 1-pentoxypentane Chemical compound CCCCCOCCCCC AOPDRZXCEAKHHW-UHFFFAOYSA-N 0.000 description 1
- DCALJVULAGICIX-UHFFFAOYSA-N 1-propylpyrrolidin-2-one Chemical compound CCCN1CCCC1=O DCALJVULAGICIX-UHFFFAOYSA-N 0.000 description 1
- QLPZEDHKVHQPAD-UHFFFAOYSA-N 2,2,2-trifluoro-n-trimethylsilylacetamide Chemical compound C[Si](C)(C)NC(=O)C(F)(F)F QLPZEDHKVHQPAD-UHFFFAOYSA-N 0.000 description 1
- NRKYWOKHZRQRJR-UHFFFAOYSA-N 2,2,2-trifluoroacetamide Chemical compound NC(=O)C(F)(F)F NRKYWOKHZRQRJR-UHFFFAOYSA-N 0.000 description 1
- VCLJODPNBNEBKW-UHFFFAOYSA-N 2,2,4,4,6,8,8-heptamethylnonane Chemical compound CC(C)(C)CC(C)CC(C)(C)CC(C)(C)C VCLJODPNBNEBKW-UHFFFAOYSA-N 0.000 description 1
- QQLILYBIARWEIF-UHFFFAOYSA-N 2-(2-hydroxyethylsulfonyl)ethanol Chemical compound OCCS(=O)(=O)CCO QQLILYBIARWEIF-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- DJXNLVJQMJNEMN-UHFFFAOYSA-N 2-[difluoro(methoxy)methyl]-1,1,1,2,3,3,3-heptafluoropropane Chemical compound COC(F)(F)C(F)(C(F)(F)F)C(F)(F)F DJXNLVJQMJNEMN-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- CRWNQZTZTZWPOF-UHFFFAOYSA-N 2-methyl-4-phenylpyridine Chemical compound C1=NC(C)=CC(C=2C=CC=CC=2)=C1 CRWNQZTZTZWPOF-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- COAUHYBSXMIJDK-UHFFFAOYSA-N 3,3-dichloro-1,1,1,2,2-pentafluoropropane Chemical compound FC(F)(F)C(F)(F)C(Cl)Cl COAUHYBSXMIJDK-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- QMYGFTJCQFEDST-UHFFFAOYSA-N 3-methoxybutyl acetate Chemical compound COC(C)CCOC(C)=O QMYGFTJCQFEDST-UHFFFAOYSA-N 0.000 description 1
- VATRWWPJWVCZTA-UHFFFAOYSA-N 3-oxo-n-[2-(trifluoromethyl)phenyl]butanamide Chemical compound CC(=O)CC(=O)NC1=CC=CC=C1C(F)(F)F VATRWWPJWVCZTA-UHFFFAOYSA-N 0.000 description 1
- LDMRLRNXHLPZJN-UHFFFAOYSA-N 3-propoxypropan-1-ol Chemical compound CCCOCCCO LDMRLRNXHLPZJN-UHFFFAOYSA-N 0.000 description 1
- KOVAQMSVARJMPH-UHFFFAOYSA-N 4-methoxybutan-1-ol Chemical compound COCCCCO KOVAQMSVARJMPH-UHFFFAOYSA-N 0.000 description 1
- LMLBDDCTBHGHEO-UHFFFAOYSA-N 4-methoxybutyl acetate Chemical compound COCCCCOC(C)=O LMLBDDCTBHGHEO-UHFFFAOYSA-N 0.000 description 1
- PXRBWNLUQYZAAX-UHFFFAOYSA-N 6-Butyltetrahydro-2H-pyran-2-one Chemical compound CCCCC1CCCC(=O)O1 PXRBWNLUQYZAAX-UHFFFAOYSA-N 0.000 description 1
- YZRXRLLRSPQHDK-UHFFFAOYSA-N 6-Hexyltetrahydro-2H-pyran-2-one Chemical compound CCCCCCC1CCCC(=O)O1 YZRXRLLRSPQHDK-UHFFFAOYSA-N 0.000 description 1
- GHBSPIPJMLAMEP-UHFFFAOYSA-N 6-pentyloxan-2-one Chemical compound CCCCCC1CCCC(=O)O1 GHBSPIPJMLAMEP-UHFFFAOYSA-N 0.000 description 1
- 244000020998 Acacia farnesiana Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- VLSVVMPLPMNWBH-UHFFFAOYSA-N Dihydro-5-propyl-2(3H)-furanone Chemical compound CCCC1CCC(=O)O1 VLSVVMPLPMNWBH-UHFFFAOYSA-N 0.000 description 1
- AQZGPSLYZOOYQP-UHFFFAOYSA-N Diisoamyl ether Chemical compound CC(C)CCOCCC(C)C AQZGPSLYZOOYQP-UHFFFAOYSA-N 0.000 description 1
- UDSFAEKRVUSQDD-UHFFFAOYSA-N Dimethyl adipate Chemical compound COC(=O)CCCCC(=O)OC UDSFAEKRVUSQDD-UHFFFAOYSA-N 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 1
- 239000005640 Methyl decanoate Substances 0.000 description 1
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- VJFUNCKASZQOPO-UHFFFAOYSA-N N-dioctylsilyl-N-trimethylsilylmethanamine Chemical compound CCCCCCCC[SiH](N(C)[Si](C)(C)C)CCCCCCCC VJFUNCKASZQOPO-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- DIQMPQMYFZXDAX-UHFFFAOYSA-N Pentyl formate Chemical compound CCCCCOC=O DIQMPQMYFZXDAX-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 1
- OEGAMYZOUWNLEO-UHFFFAOYSA-N [butyl(dimethyl)silyl] trifluoromethanesulfonate Chemical compound CCCC[Si](C)(C)OS(=O)(=O)C(F)(F)F OEGAMYZOUWNLEO-UHFFFAOYSA-N 0.000 description 1
- QHIJPBGTYHXSSQ-UHFFFAOYSA-N [decyl(dimethyl)silyl] 2,2,2-trifluoroacetate Chemical compound CCCCCCCCCC[Si](C)(C)OC(=O)C(F)(F)F QHIJPBGTYHXSSQ-UHFFFAOYSA-N 0.000 description 1
- AQSDMBVSJLUVJX-UHFFFAOYSA-N [decyl(dimethyl)silyl] trifluoromethanesulfonate Chemical compound CCCCCCCCCC[Si](C)(C)OS(=O)(=O)C(F)(F)F AQSDMBVSJLUVJX-UHFFFAOYSA-N 0.000 description 1
- PEFNDUOLISEFNU-UHFFFAOYSA-N [dimethyl(octyl)silyl] trifluoromethanesulfonate Chemical compound CCCCCCCC[Si](C)(C)OS(=O)(=O)C(F)(F)F PEFNDUOLISEFNU-UHFFFAOYSA-N 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- KJUATNVXFLOMQN-UHFFFAOYSA-N [hexyl(dimethyl)silyl] 2,2,2-trifluoroacetate Chemical compound CCCCCC[Si](C)(C)OC(=O)C(F)(F)F KJUATNVXFLOMQN-UHFFFAOYSA-N 0.000 description 1
- HHSPZBRBLBLYJV-UHFFFAOYSA-N [hexyl(dimethyl)silyl] trifluoromethanesulfonate Chemical compound CCCCCC[Si](C)(C)OS(=O)(=O)C(F)(F)F HHSPZBRBLBLYJV-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- BEWYHVAWEKZDPP-UHFFFAOYSA-N bornane Chemical compound C1CC2(C)CCC1C2(C)C BEWYHVAWEKZDPP-UHFFFAOYSA-N 0.000 description 1
- 229930006742 bornane Natural products 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- BTMVHUNTONAYDX-UHFFFAOYSA-N butyl propionate Chemical compound CCCCOC(=O)CC BTMVHUNTONAYDX-UHFFFAOYSA-N 0.000 description 1
- FFOPEPMHKILNIT-UHFFFAOYSA-N butyric acid isopropyl ester Natural products CCCC(=O)OC(C)C FFOPEPMHKILNIT-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 239000012986 chain transfer agent Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- FYTRVXSHONWYNE-UHFFFAOYSA-N delta-octanolide Chemical compound CCCC1CCCC(=O)O1 FYTRVXSHONWYNE-UHFFFAOYSA-N 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 1
- FOTBOKBDKNTVLX-UHFFFAOYSA-N dimethylsilyl 2,2,2-trifluoroacetate Chemical compound C[SiH](C)OC(=O)C(F)(F)F FOTBOKBDKNTVLX-UHFFFAOYSA-N 0.000 description 1
- DPFCZRAGEMLFTN-UHFFFAOYSA-N dimethylsilyl trifluoromethanesulfonate Chemical compound C[SiH](C)OS(=O)(=O)C(F)(F)F DPFCZRAGEMLFTN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- FBZANXDWQAVSTQ-UHFFFAOYSA-N dodecamethylpentasiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C FBZANXDWQAVSTQ-UHFFFAOYSA-N 0.000 description 1
- 229940087203 dodecamethylpentasiloxane Drugs 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- CKSRFHWWBKRUKA-UHFFFAOYSA-N ethyl 2-ethoxyacetate Chemical compound CCOCC(=O)OCC CKSRFHWWBKRUKA-UHFFFAOYSA-N 0.000 description 1
- FJAKCEHATXBFJT-UHFFFAOYSA-N ethyl 2-oxobutanoate Chemical compound CCOC(=O)C(=O)CC FJAKCEHATXBFJT-UHFFFAOYSA-N 0.000 description 1
- BHXIWUJLHYHGSJ-UHFFFAOYSA-N ethyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OCC BHXIWUJLHYHGSJ-UHFFFAOYSA-N 0.000 description 1
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- 229940045180 ethyl perfluoroisobutyl ether Drugs 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- JBFHTYHTHYHCDJ-UHFFFAOYSA-N gamma-caprolactone Chemical compound CCC1CCC(=O)O1 JBFHTYHTHYHCDJ-UHFFFAOYSA-N 0.000 description 1
- OALYTRUKMRCXNH-QMMMGPOBSA-N gamma-nonanolactone Chemical compound CCCCC[C@H]1CCC(=O)O1 OALYTRUKMRCXNH-QMMMGPOBSA-N 0.000 description 1
- IPBFYZQJXZJBFQ-UHFFFAOYSA-N gamma-octalactone Chemical compound CCCCC1CCC(=O)O1 IPBFYZQJXZJBFQ-UHFFFAOYSA-N 0.000 description 1
- PHXATPHONSXBIL-JTQLQIEISA-N gamma-undecanolactone Chemical compound CCCCCCC[C@H]1CCC(=O)O1 PHXATPHONSXBIL-JTQLQIEISA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- YCOZIPAWZNQLMR-UHFFFAOYSA-N heptane - octane Natural products CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 229940073561 hexamethyldisiloxane Drugs 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 1
- HSDFKDZBJMDHFF-UHFFFAOYSA-N methyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OC HSDFKDZBJMDHFF-UHFFFAOYSA-N 0.000 description 1
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 1
- 229940104873 methyl perfluorobutyl ether Drugs 0.000 description 1
- 229940104872 methyl perfluoroisobutyl ether Drugs 0.000 description 1
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 229940094933 n-dodecane Drugs 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical compound C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- YVBBRRALBYAZBM-UHFFFAOYSA-N perfluorooctane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YVBBRRALBYAZBM-UHFFFAOYSA-N 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- ILPVOWZUBFRIAX-UHFFFAOYSA-N propyl 2-oxopropanoate Chemical compound CCCOC(=O)C(C)=O ILPVOWZUBFRIAX-UHFFFAOYSA-N 0.000 description 1
- HUAZGNHGCJGYNP-UHFFFAOYSA-N propyl butyrate Chemical compound CCCOC(=O)CCC HUAZGNHGCJGYNP-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
- WGPCZPLRVAWXPW-UHFFFAOYSA-N xi-Dihydro-5-octyl-2(3H)-furanone Chemical compound CCCCCCCCC1CCC(=O)O1 WGPCZPLRVAWXPW-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
- C09K3/18—Materials not provided for elsewhere for application to surfaces to minimize adherence of ice, mist or water thereto; Thawing or antifreeze materials for application to surfaces
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/02041—Cleaning
- H01L21/02057—Cleaning during device manufacture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
- C09D5/16—Antifouling paints; Underwater paints
- C09D5/1606—Antifouling paints; Underwater paints characterised by the anti-fouling agent
- C09D5/1612—Non-macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/20—Diluents or solvents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/40—Additives
- C09D7/60—Additives non-macromolecular
- C09D7/63—Additives non-macromolecular organic
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/04—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer
- H01L21/18—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic Table or AIIIBV compounds with or without impurities, e.g. doping materials
- H01L21/30—Treatment of semiconductor bodies using processes or apparatus not provided for in groups H01L21/20 - H01L21/26
- H01L21/302—Treatment of semiconductor bodies using processes or apparatus not provided for in groups H01L21/20 - H01L21/26 to change their surface-physical characteristics or shape, e.g. etching, polishing, cutting
- H01L21/306—Chemical or electrical treatment, e.g. electrolytic etching
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Physics & Mathematics (AREA)
- Computer Hardware Design (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Combustion & Propulsion (AREA)
- Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
- Cleaning Or Drying Semiconductors (AREA)
Abstract
본 발명은, 발수성 부여 효과를 더 향상시킬 수 있는 발수성 보호막 형성용 약액을 제공한다. 본 발명의 발수성 보호막 형성용 약액은,
(I)하기 일반식 [1]로 나타내어지는 아미노실란 화합물과
(II)하기 일반식 [2]로 나타내어지는 규소 화합물과
(III)비프로톤성 용제를 가지고,
(I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%이다.
[화학식 36]
[화학식 37]
The present invention provides a chemical for forming a water-repellent protective film that can further improve the water-repellent imparting effect. The chemical solution for forming a water-repellent protective film of the present invention,
(I) an aminosilane compound represented by the following general formula [1] and
(II) a silicon compound represented by the following general formula [2] and
(III) has an aprotic solvent,
The content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass.
[Formula 36]
[Formula 37]
Description
본 발명은, 기판(웨이퍼) 표면의 미세한 요철 패턴의 오목부 표면에 발수성 보호막을 형성하기 위한 발수성 보호막 형성용 약액, 및 웨이퍼의 표면 처리 방법에 관한 것이다.The present invention relates to a chemical for forming a water-repellent protective film for forming a water-repellent protective film on the surface of a concave portion of a fine uneven pattern on the surface of a substrate (wafer), and a method for surface treatment of a wafer.
네트워크나 디지털 가전용의 반도체 디바이스에 있어서, 가일층의 고성능·고기능화나 저소비 전력화가 요구되고 있다. 그 때문에 회로 패턴의 미세화가 진행되고 있고, 반도체 디바이스의 미세화에 따른 패턴의 애스펙트비가 높아지는 것에 의한 문제가 현재화(顯在化)되고 있다. 즉 세정 또는 린스 후, 기액 계면이 패턴을 통과할 때에 패턴이 붕괴되는 현상(이후 「패턴 붕괴」라고 기재하는 경우가 있음)을 야기하여, 수율이 대폭 저하하는 것이 큰 문제가 되고 있다.In semiconductor devices for networks and digital home appliances, higher performance, higher functionality, and lower power consumption are required. For this reason, circuit patterns are being miniaturized, and a problem due to an increase in the aspect ratio of the pattern due to the miniaturization of semiconductor devices is becoming more current. That is, after washing or rinsing, a phenomenon in which the pattern collapses when the gas-liquid interface passes through the pattern (hereinafter sometimes referred to as "pattern collapse") is caused, resulting in a significant decrease in the yield.
이 패턴 붕괴는, 웨이퍼 표면으로부터 세정액이나 린스액을 건조 제거할 때에 생긴다. 이것은, 패턴의 애스펙트비가 높은 부분과 낮은 부분의 사이에 있어서, 잔액(殘液) 높이의 차가 생기고, 그에 의해 패턴에 작용하는 모세관력에 차가 생기는 것이 원인이라고 알려져 있다. 이 때문에, 세정액이나 린스액을 발수성 보호막 형성용 약액으로 치환하여 패턴 표면에 발수성 보호막을 형성함으로써, 당해 패턴에 작용하는 모세관력을 작게 하면, 잔액 높이의 차이에 의한 모세관력의 차가 저감되고, 패턴 붕괴가 해소된다고 기대할 수 있다.This pattern collapse occurs when the cleaning liquid or rinse liquid is dried and removed from the wafer surface. It is known that this is caused by a difference in the height of the remaining liquid between a portion having a high aspect ratio and a portion having a low aspect ratio of the pattern, thereby causing a difference in capillary force acting on the pattern. Therefore, by forming a water-repellent protective film on the pattern surface by replacing the cleaning liquid or the rinse liquid with a chemical liquid for forming a water-repellent protective film, if the capillary force acting on the pattern is reduced, the difference in capillary force due to the difference in the height of the remaining liquid is reduced, and the pattern The collapse can be expected to be resolved.
본 출원인은, 특허문헌 1에 있어서, 표면에 미세한 요철 패턴을 가지고 당해 요철 패턴의 적어도 일부가 실리콘 원소를 포함하는 웨이퍼의 세정 시에, 당해 요철 패턴의 적어도 오목부 표면에 발수성 보호막을 형성하기 위한 약액으로서,In
하기 일반식으로 나타내어지는 산성 규소 화합물 A와 산 A를 포함하고,Including acidic silicon compound A and acid A represented by the following general formula,
당해 산 A는 트리메틸실릴트리플루오로아세테이트, 트리메틸실릴트리플루오로메탄술포네이트, 디메틸실릴트리플루오로아세테이트, 디메틸실릴트리플루오로메탄술포네이트, 부틸디메틸실릴트리플루오로아세테이트, 부틸디메틸실릴트리플루오로메탄술포네이트, 헥실디메틸실릴트리플루오로아세테이트, 헥실디메틸실릴트리플루오로메탄술포네이트, 옥틸디메틸실릴트리플루오로아세테이트, 옥틸디메틸실릴트리플루오로메탄술포네이트, 데실디메틸실릴트리플루오로아세테이트, 및, 데실디메틸실릴트리플루오로메탄술포네이트로 이루어지는 군으로부터 선택되는 적어도 1개이며,The acid A is trimethylsilyltrifluoroacetate, trimethylsilyltrifluoromethanesulfonate, dimethylsilyltrifluoroacetate, dimethylsilyltrifluoromethanesulfonate, butyldimethylsilyltrifluoroacetate, butyldimethylsilyltrifluoro Methanesulfonate, hexyldimethylsilyltrifluoroacetate, hexyldimethylsilyltrifluoromethanesulfonate, octyldimethylsilyltrifluoroacetate, octyldimethylsilyltrifluoromethanesulfonate, decyldimethylsilyltrifluoroacetate, and, It is at least one selected from the group consisting of decyldimethylsilyltrifluoromethanesulfonate,
상기 약액의 출발 원료 중의 수분의 총량이, 당해 원료의 총량에 대하여 100질량ppm 이하인 것을 특징으로 하는, 발수성 보호막 형성용 약액이나, 당해 약액을 이용한 웨이퍼의 세정 방법에 관하여 개시하고 있다.Disclosed is a chemical liquid for forming a water repellent protective film, and a wafer cleaning method using the chemical liquid, characterized in that the total amount of water in the starting material of the chemical liquid is 100 mass ppm or less with respect to the total amount of the raw material.
[화학식 1][Formula 1]
(R은, 각각 서로 독립적으로, 탄소수가 1∼18의 탄화수소기를 포함하는 1가의 유기기, 및, 탄소수가 1∼8의 플루오로알킬쇄를 포함하는 1가의 유기기로부터 선택되는 적어도 1개의 기이고, X는, 각각 서로 독립적으로, Si 원소에 결합하는 원소가 질소인 1가의 유기기이며, a는 1∼3의 정수, b는 0∼2의 정수이고, a와 b의 합계는 1∼3이다.)(R is each independently of each other, at least one group selected from a monovalent organic group containing a hydrocarbon group having 1 to 18 carbon atoms, and a monovalent organic group containing a fluoroalkyl chain having 1 to 8 carbon atoms And X is each independently a monovalent organic group in which the element bonded to the Si element is nitrogen, a is an integer of 1 to 3, b is an integer of 0 to 2, and the sum of a and b is 1 to It is 3.)
반도체 디바이스 제조에 있어서, 특히 미세하고 애스펙트비가 높은 회로 패턴화된 디바이스의 제조 수율의 향상을 목적으로 한 기판(웨이퍼)의 세정 기술에 있어서, 발수성 보호막 형성용 약액이 개발되고 있다. 특허문헌 1에 기재된 보호막 형성용 약액은, 확실히, 우수한 발수성 부여 효과를 발휘함과 함께, 약액의 출발 원료 중의 수분의 총량이 당해 원료의 총량에 대하여 100질량ppm 이하인 것에 의해 약액의 보관 안정성이 우수한 것이다. 그러나, 근래, 반도체 디바이스의 고집적화, 미소화의 경향이 높아지고, 웨이퍼 패턴의 미세화·고애스펙트비화가 진척되고 있는 점에서, 패턴 붕괴를 저감시키는 발수성 보호막 형성용 약액에는, 발수성 부여 효과의 가일층의 향상이 요망되고 있다.In semiconductor device manufacturing, in particular, in a substrate (wafer) cleaning technology for the purpose of improving the manufacturing yield of a circuit patterned device having a fine and high aspect ratio, a chemical solution for forming a water-repellent protective film is being developed. The chemical liquid for forming a protective film described in
본 발명은,The present invention,
(I)하기 일반식 [1]로 나타내어지는 아미노실란 화합물과(I) an aminosilane compound represented by the following general formula [1] and
(II)하기 일반식 [2]로 나타내어지는 규소 화합물과(II) a silicon compound represented by the following general formula [2] and
(III)비프로톤성 용제를 가지고,(III) has an aprotic solvent,
(I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액(이후, 단순히 「보호막 형성용 약액」이나 「약액」으로 기재하는 경우가 있음)이다.A chemical solution for forming a water-repellent protective film, wherein the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass (hereinafter, it may be simply described as ``a chemical solution for forming a protective film'' or a ``chemical solution'') to be.
[화학식 2][Formula 2]
[식 [1] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. a는 1∼3의 정수, b는 0∼2의 정수이고, a와 b의 합계는 1∼3이다.][In formula [1], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. a is an integer of 1 to 3, b is an integer of 0 to 2, and the sum of a and b is 1 to 3.]
[화학식 3][Formula 3]
[식 [2] 중, R2는, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. 또한, X는, 할로겐기, -OC(=O)R3, -OS(=O)2-R3, -N(S(=O)2-R3)2, -C(S(=O)2-R3)3으로 이루어지는 군으로부터 선택되는 적어도 1개의 기를 나타낸다. R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이고, c는 1∼3의 정수, d는 0∼2의 정수이며, c와 d의 합계는 1∼3이다.][In formula [2], R 2 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. In addition, X is a halogen group, -OC(=O)R 3 , -OS(=O) 2 -R 3 , -N(S(=O) 2 -R 3 ) 2 , -C(S(=O ) 2 -R 3 ) represents at least one group selected from the group consisting of 3 . R 3 is a monovalent perfluoroalkyl group having 1 to 6 carbon atoms, c is an integer of 1 to 3, d is an integer of 0 to 2, and the sum of c and d is 1 to 3.]
또한, 상기 (I)이, 하기 일반식 [3]으로 나타내어지는 화합물이면, 상기 보호막을 균질하게 형성할 수 있으므로 보다 바람직하다.Moreover, if the said (I) is a compound represented by the following general formula [3], since the said protective film can be formed homogeneously, it is more preferable.
[화학식 4][Formula 4]
[식 [3] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.][In formula [3], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
상기 약액은, (IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물을 더 함유하는 것이 약액의 조제의 용이성의 관점에서 바람직하다.It is preferable from the viewpoint of easiness of preparation of a chemical liquid that the said chemical liquid further contains a silazane compound represented by (IV) following general formula [4].
[화학식 5][Formula 5]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.][In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
또한, 상기 (I)∼(III)의 총량에 대한 (II)의 함유량은, 발수성 부여 효과의 향상의 관점에서 0.05질량% 이상이 바람직하고, 또한, 비용의 관점에서 20질량% 이하가 바람직하다.In addition, the content of (II) relative to the total amount of the above (I) to (III) is preferably 0.05% by mass or more from the viewpoint of improving the effect of imparting water repellency, and is preferably 20% by mass or less from the viewpoint of cost. .
또한, 상기 (II)가, 하기 일반식 [5]로 이루어지는 군으로부터 선택되는 적어도 1종의 화합물인 것이 발수성 부여 효과의 향상의 관점에서 바람직하다.In addition, it is preferable from the viewpoint of improving the effect of imparting water repellency that (II) is at least one compound selected from the group consisting of the following general formula [5].
[화학식 6][Formula 6]
[식 [5] 중, R2는, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이고, R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이다. 또한, g는 1∼3의 정수이다.][In formula [5], R 2 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element, and R 3 Silver is a monovalent perfluoroalkyl group having 1 to 6 carbon atoms. In addition, g is an integer of 1 to 3.]
또한 본 발명은, 웨이퍼 표면에 세정액 및 린스액으로 이루어지는 군으로부터 선택되는 적어도 1종의 액체가 보지(保持)된 상태에서, 당해 액체를, 발수성 보호막 형성용 약액으로 치환하고, 당해 약액을 웨이퍼 표면에 보지하는 발수성 보호막 형성 공정, 및, 건조 공정을 가지는 웨이퍼의 표면 처리 방법으로서,In the present invention, in a state in which at least one liquid selected from the group consisting of a cleaning liquid and a rinse liquid is held on the wafer surface, the liquid is replaced with a chemical for forming a water repellent protective film, and the chemical liquid is replaced on the wafer surface. As a surface treatment method of a wafer having a water-repellent protective film forming step and a drying step to be held on,
상기 발수성 보호막 형성용 약액은,The chemical solution for forming a water-repellent protective film,
(I)하기 일반식 [1]로 나타내어지는 아미노실란 화합물과(I) an aminosilane compound represented by the following general formula [1] and
(II)하기 일반식 [2]로 나타내어지는 규소 화합물과(II) a silicon compound represented by the following general formula [2] and
(III)비프로톤성 용제를 가지고,(III) has an aprotic solvent,
(I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 웨이퍼의 표면 처리 방법이다.It is a wafer surface treatment method wherein the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass.
[화학식 7][Formula 7]
[식 [1] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. a는 1∼3의 정수, b는 0∼2의 정수이고, a와 b의 합계는 1∼3이다.][In formula [1], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. a is an integer of 1 to 3, b is an integer of 0 to 2, and the sum of a and b is 1 to 3.]
[화학식 8][Formula 8]
[식 [2] 중, R2는, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. 또한, X는, 할로겐기, -OC(=O)R3, -OS(=O)2-R3, -N(S(=O)2-R3)2, -C(S(=O)2-R3)3으로 이루어지는 군으로부터 선택되는 적어도 1개의 기를 나타낸다. R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이고, c는 1∼3의 정수, d는 0∼2의 정수이며, c와 d의 합계는 1∼3이다.][In formula [2], R 2 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. In addition, X is a halogen group, -OC(=O)R 3 , -OS(=O) 2 -R 3 , -N(S(=O) 2 -R 3 ) 2 , -C(S(=O ) 2 -R 3 ) represents at least one group selected from the group consisting of 3 . R 3 is a monovalent perfluoroalkyl group having 1 to 6 carbon atoms, c is an integer of 1 to 3, d is an integer of 0 to 2, and the sum of c and d is 1 to 3.]
또한, 상기 (I)이, 하기 일반식 [3]으로 나타내어지는 화합물이면, 상기 보호막을 균질하게 형성할 수 있으므로 보다 바람직하다.Moreover, if the said (I) is a compound represented by the following general formula [3], since the said protective film can be formed homogeneously, it is more preferable.
[화학식 9][Formula 9]
[식 [3] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.][In formula [3], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
상기 방법에 있어서, 상기 발수성 보호막 형성용 약액이, (IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물을 더 함유하는 것이 약액의 조제의 용이성의 관점에서 바람직하다.In the above method, it is preferable from the viewpoint of ease of preparation of the chemical liquid that the chemical liquid for forming a water-repellent protective film further contains a silazane compound represented by (IV) the following general formula [4].
[화학식 10][Formula 10]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.][In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
또한 상기 방법은, 상기 발수성 보호막 형성 공정 전에,In addition, the method, before the process of forming the water repellent protective film,
(II)상기 일반식 [2]로 나타내어지는 규소 화합물과(II) a silicon compound represented by the general formula [2] and
(IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물과(IV) a silazane compound represented by the following general formula [4] and
(III)비프로톤성 용제를 가지는 원료 약액에,(III) In the raw material chemical solution having an aprotic solvent,
(II), (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 프로톤성 화합물을 접촉시킴으로써,By contacting the protic compound in a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (II), (III) and (IV),
상기 (I)∼(III)을 가지고, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액을 조제하는, 약액 조제 공정을 가지는 것이 약액의 조제의 용이성의 관점에서 바람직하다.Having a chemical solution preparation step of preparing a chemical solution for forming a water-repellent protective film in which the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass. It is preferable from the viewpoint of ease of preparation of a chemical solution.
[화학식 11][Formula 11]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.][In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
또한 상기 방법은, 상기 발수성 보호막 형성 공정 전에,In addition, the method, before the process of forming the water repellent protective film,
(II)상기 일반식 [2]로 나타내어지는 규소 화합물과(II) a silicon compound represented by the general formula [2] and
(IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물과(IV) a silazane compound represented by the following general formula [4] and
(III)비프로톤성 용제를 가지는 원료 약액에,(III) In the raw material chemical solution having an aprotic solvent,
(II), (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 프로톤성 화합물을 접촉시킴으로써,By contacting the protic compound in a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (II), (III) and (IV),
상기 (I)∼(IV)를 가지고, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액을 조제하는, 약액 조제 공정을 가지는 것이 약액의 조제의 용이성의 관점에서 바람직하다.Having the above (I) to (IV), and having a chemical solution preparation step of preparing a chemical solution for forming a water-repellent protective film in which the content of (I) is 0.02 to 0.5% by mass relative to the total amount of (I) to (III) It is preferable from the viewpoint of ease of preparation of a chemical solution.
[화학식 12][Formula 12]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.][In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
또한 상기 방법에 있어서, 상기 약액 조제 공정이, 프로톤성 화합물을 함유하는 공간 중에 상기 원료 약액을 도입하여 양자를 접촉시키는 것이면, 양자를 균일하게 접촉시키기 쉽기 때문에 바람직하다. 또한, 상기의 공간 중에 함유된 프로톤성 화합물은 액체 상태여도, 기체 상태여도 된다. 프로톤성 화합물이 기체 상태인 경우, 공간 중의 프로톤성 화합물의 농도(체적%)와 접촉시키는 시간을 관리하는 것이 바람직하다.Further, in the above method, if the chemical liquid preparation step is to bring the raw material chemical liquid into a space containing a protic compound and bring both of them into contact, it is preferable because it is easy to uniformly contact both. Further, the protic compound contained in the above space may be in a liquid state or a gaseous state. When the protonic compound is in a gaseous state, it is preferable to manage the concentration (volume %) of the protic compound in the space and the contact time.
또한 상기 방법에 있어서, 상기 프로톤성 화합물은, -OH기, 및/또는, -NH2기를 가지는 화합물인 것이 발수성 부여 효과의 향상의 관점에서 바람직하고, 물, 및/또는, 2-프로판올이면 보다 바람직하며, 특히 물이 바람직하다.Further, in the above method, the protic compound is preferably a compound having an -OH group and/or a -NH 2 group from the viewpoint of improving the effect of imparting water repellency, and more preferably water and/or 2-propanol. It is preferred, and water is particularly preferred.
또한 상기 방법은, 상기 발수성 보호막 형성 공정 전에,In addition, the method, before the process of forming the water repellent protective film,
(IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물과(IV) a silazane compound represented by the following general formula [4] and
(III)비프로톤성 용제를 가지는 원료 약액에,(III) In the raw material chemical solution having an aprotic solvent,
(III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 하기 일반식 [6]으로 나타내어지는 산성 화합물을 접촉시킴으로써,By contacting an acidic compound represented by the following general formula [6] in a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (III) and (IV),
상기 (I)∼(III)을 가지고, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액을 조제하는, 약액 조제 공정을 가지는 것이 사용하는 원료의 수를 적게 할 수 있기 때문에, 비용의 관점에서 바람직하다.Having a chemical solution preparation step of preparing a chemical solution for forming a water-repellent protective film in which the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass. Since the number of raw materials to be used can be reduced, it is preferable from the viewpoint of cost.
[화학식 13][Formula 13]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.][In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
[화학식 14][Formula 14]
[식 [6] 중, X는, 할로겐기, -OC(=O)R3, -OS(=O)2-R3, -N(S(=O)2-R3)2, -C(S(=O)2-R3)3을 나타낸다. R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이다.][In formula [6], X is a halogen group, -OC(=O)R 3 , -OS(=O) 2 -R 3 , -N(S(=O) 2 -R 3 ) 2 , -C (S(=O) 2 -R 3 ) 3 is shown. R 3 is a
또한 상기 방법은, 상기 발수성 보호막 형성 공정 전에,In addition, the method, before the process of forming the water repellent protective film,
(IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물과(IV) a silazane compound represented by the following general formula [4] and
(III)비프로톤성 용제를 가지는 원료 약액에,(III) In the raw material chemical solution having an aprotic solvent,
(III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 하기 일반식 [6]으로 나타내어지는 산성 화합물을 접촉시킴으로써,By contacting an acidic compound represented by the following general formula [6] in a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (III) and (IV),
상기 (I)∼(IV)를 가지고, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액을 조제하는, 약액 조제 공정을 가지는 것이 사용하는 원료의 수를 적게 할 수 있어, 비용의 관점에서 바람직하다.Having the above (I) to (IV), and having a chemical solution preparation step of preparing a chemical solution for forming a water-repellent protective film in which the content of (I) is 0.02 to 0.5% by mass relative to the total amount of (I) to (III) The number of raw materials to be used can be reduced, which is preferable from the viewpoint of cost.
[화학식 15][Formula 15]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.][In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
[화학식 16][Formula 16]
[식 [6] 중, X는, 할로겐기, -OC(=O)R3, -OS(=O)2-R3, -N(S(=O)2-R3)2, -C(S(=O)2-R3)3을 나타낸다. R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이다.][In formula [6], X is a halogen group, -OC(=O)R 3 , -OS(=O) 2 -R 3 , -N(S(=O) 2 -R 3 ) 2 , -C (S(=O) 2 -R 3 ) 3 is shown. R 3 is a
또한 상기 방법에 있어서, 상기 (I)∼(III)의 총량에 대한 (II)의 함유량은, 발수성 부여 효과의 향상의 관점에서 0.05질량% 이상이 바람직하고, 또한, 비용의 관점에서 20질량% 이하가 바람직하다.In the above method, the content of (II) with respect to the total amount of (I) to (III) is preferably 0.05% by mass or more from the viewpoint of improving the effect of imparting water repellency, and 20% by mass from the viewpoint of cost. The following are preferable.
또한 상기 방법에 있어서, 상기 (II)가, 하기 일반식 [5]로 이루어지는 군으로부터 선택되는 적어도 1종의 화합물이면, 발수성 부여 효과의 향상의 관점에서 바람직하다.Further, in the above method, if (II) is at least one compound selected from the group consisting of the following general formula [5], it is preferable from the viewpoint of improving the effect of imparting water repellency.
[화학식 17][Formula 17]
[식 [5] 중, R2는, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이고, R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이다. 또한 g는 1∼3의 정수이다.][In formula [5], R 2 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element, and R 3 Silver is a monovalent perfluoroalkyl group having 1 to 6 carbon atoms. In addition, g is an integer of 1 to 3.]
본 발명에 의하면, 보다 우수한 발수성 부여 효과를 발휘할 수 있는 신규한 조성의 발수성 보호막 형성용 약액, 및 당해 약액을 이용한 웨이퍼의 표면 처리 방법이 제공된다.Advantageous Effects of Invention According to the present invention, a chemical solution for forming a water-repellent protective film having a novel composition capable of exerting a more excellent water repellency imparting effect, and a method for surface treatment of a wafer using the chemical solution are provided.
도 1은, 표면 처리 양태 1의 플로우 차트이다.
도 2는, 표면 처리 양태 2의 플로우 차트이다.
도 3은, 표면 처리 양태 3의 플로우 차트이다.
도 4는, 표면 처리 양태 4의 플로우 차트이다.
도 5는, 표면 처리 양태 5의 플로우 차트이다.
도 6은, 표면 처리 양태 6의 플로우 차트이다.
도 7은, 수첨가량에 대한, 표면 처리 후의 접촉각의 플롯(비교예 1-1, 실시예 1-3, 실시예 1-2, 실시예 1-1, 비교예 1-2)이다.
도 8은, 수첨가 후의 아미노실란 화합물의 농도에 대한, 표면 처리 후의 접촉각의 플롯(비교예 1-1, 비교예 1-2, 실시예 1-3, 실시예 1-2, 실시예 1-1)이다.
도 9는, iPA 첨가량에 대한, 표면 처리 후의 접촉각의 플롯(비교예 1-1, 실시예 1-6, 실시예 1-5, 실시예 1-4, 비교예 1-3)이다.
도 10은, iPA 첨가 후의 아미노실란 화합물의 농도에 대한, 표면 처리 후의 접촉각의 플롯(비교예 1-1, 비교예 1-3, 실시예 1-6, 실시예 1-5, 실시예 1-4)이다.1 is a flow chart of
2 is a flow chart of surface treatment mode 2.
3 is a flow chart of surface treatment mode 3.
4 is a flow chart of surface treatment mode 4.
5 is a flow chart of surface treatment mode 5.
6 is a flow chart of surface treatment mode 6.
7 is a plot (Comparative Example 1-1, Example 1-3, Example 1-2, Example 1-1, Comparative Example 1-2) of the contact angle after surface treatment with respect to the amount of hydrogenation.
8 is a plot of the contact angle after surface treatment with respect to the concentration of the aminosilane compound after hydrogenation (Comparative Example 1-1, Comparative Example 1-2, Example 1-3, Example 1-2, Example 1- 1).
9 is a plot of the contact angle after surface treatment with respect to the amount of iPA added (Comparative Example 1-1, Example 1-6, Example 1-5, Example 1-4, Comparative Example 1-3).
10 is a plot of the contact angle after surface treatment with respect to the concentration of the aminosilane compound after iPA addition (Comparative Example 1-1, Comparative Example 1-3, Example 1-6, Example 1-5, Example 1- 4).
1. 발수성 보호막 형성용 약액1. Chemical liquid for forming water repellent protective film
발수성 보호막 형성용 약액은, 피처리체의 표면에 발수성 보호막(이후, 단순히 「보호막」으로 기재하는 경우가 있음)을 형성할 때에 사용된다. 피처리체의 종류는 특별히 한정되지 않는다. 피처리체로서는, 「기판(웨이퍼)」이 바람직하다. 여기서, 처리 대상이 되는 「웨이퍼」로서는, 반도체 디바이스 제작을 위해 사용되는 웨이퍼가 예시되고, 「웨이퍼의 표면」이란, 웨이퍼 자체의 표면 외에, 웨이퍼 상에 마련된 무기 패턴 및 수지 패턴의 표면, 및 패턴화되어 있지 않은 무기층 및 유기층의 표면이 예시된다.The chemical liquid for forming a water-repellent protective film is used when forming a water-repellent protective film (hereinafter, simply referred to as a "protective film") on the surface of the object to be treated. The type of object to be processed is not particularly limited. As the object to be processed, a "substrate (wafer)" is preferable. Here, as the ``wafer'' to be processed, a wafer used for manufacturing a semiconductor device is exemplified, and ``the surface of the wafer'' refers to the surface of the inorganic pattern and resin pattern provided on the wafer in addition to the surface of the wafer itself, and the pattern The surface of the inorganic layer and the organic layer which are not formed are illustrated.
웨이퍼 상에 마련된 무기 패턴으로서는, 포토레지스트법에 의해 웨이퍼에 존재하는 무기층의 표면에 에칭 마스크를 제작하고, 그 후, 에칭 처리함으로써 형성된 패턴이 예시된다. 무기층으로서는, 웨이퍼 자체 외에, 웨이퍼를 구성하는 원소의 산화막, 웨이퍼의 표면에 형성한 질화규소, 질화티탄, 텅스텐 등의 무기물의 막이나 층 등이 예시된다. 이와 같은 막이나 층으로서는, 특별히 한정되지 않지만, 반도체 디바이스의 제작 과정에 있어서 형성되는 무기물의 막이나 층 등이 예시된다.As the inorganic pattern provided on the wafer, a pattern formed by preparing an etching mask on the surface of an inorganic layer present on the wafer by a photoresist method and then performing an etching process is exemplified. Examples of the inorganic layer include, in addition to the wafer itself, oxide films of elements constituting the wafer, and films or layers of inorganic materials such as silicon nitride, titanium nitride, and tungsten formed on the surface of the wafer. Although it does not specifically limit as such a film|membrane or layer, The film|membrane, layer, etc. of inorganic materials formed in the manufacturing process of a semiconductor device are illustrated.
웨이퍼 상에 마련된 수지 패턴으로서는, 포토레지스트법에 의해 웨이퍼 상에 형성된 수지 패턴이 예시된다. 이와 같은 수지 패턴은, 예를 들면, 웨이퍼 상에 포토레지스트의 막인 유기층을 형성하고, 이 유기층에 대하여 포토마스크를 통해 노광하고, 현상함으로써 형성된다. 유기층으로서는, 웨이퍼 자체의 표면 외에, 웨이퍼의 표면에 마련된 적층막의 표면 등에 마련된 것이 예시된다. 이와 같은 유기층으로서는, 특별히 한정되지 않지만, 반도체 디바이스의 제작 과정에 있어서, 에칭 마스크를 형성하기 위해 마련된 유기물의 막이 예시된다.As a resin pattern provided on a wafer, a resin pattern formed on a wafer by a photoresist method is illustrated. Such a resin pattern is formed, for example, by forming an organic layer that is a film of a photoresist on a wafer, exposing the organic layer to light through a photomask, and developing. As the organic layer, in addition to the surface of the wafer itself, one provided on the surface of a laminated film provided on the surface of the wafer, etc. are illustrated. Although it does not specifically limit as such an organic layer, In the manufacturing process of a semiconductor device, the film of an organic material provided for forming an etching mask is illustrated.
미리 조제하여 얻은 본 발명의 약액을 스핀 코트법이나 침지법 등의 수단에 의해 웨이퍼 등의 피처리체의 표면에 도포하여, 당해 표면에 보지시킬 수 있다. 또한, 상기 약액을 증기로 하여 웨이퍼 등의 피처리체의 표면에 공급하여(이후, 「증기법」으로 기재하는 경우가 있음), 당해 표면에 보지시킬 수도 있다.The chemical solution of the present invention prepared in advance can be applied to the surface of an object to be processed such as a wafer by means such as a spin coating method or an immersion method, and can be held on the surface. In addition, the above-described chemical solution may be supplied to the surface of an object to be processed such as a wafer (hereinafter, referred to as "steam method"), and held thereon.
나아가서는, 상기의 원료 약액을 스핀 코트법이나 침지법이나 증기법 등의 수단에 의해 웨이퍼 등의 피처리체의 표면에 도포한 상태로 프로톤성 화합물을 접촉시켜, 후술하는 반응에 의해 발수성 보호막 형성용 약액을 조제하고, 이것을 피처리체의 표면에 보지시킬 수도 있다.Furthermore, the raw material chemical is applied to the surface of an object to be processed such as a wafer by means such as spin coating, immersion or steam, and the protonic compound is brought into contact with the reaction to form a water-repellent protective film. It is also possible to prepare a chemical solution and hold it on the surface of the object to be treated.
또한, 미리 프로톤성 화합물을 함유하는 공간 중에 있어서, 상기의 원료 약액을 스핀 코트법이나 침지법이나 증기법 등의 수단에 의해 웨이퍼 등의 피처리체의 표면에 도포하여, 후술하는 반응에 의해 발수성 보호막 형성용 약액을 조제하고, 이것을 피처리체의 표면에 보지시킬 수도 있다.In addition, in a space containing a protic compound in advance, the raw material chemical solution is applied to the surface of an object to be processed such as a wafer by means such as a spin coating method, an immersion method, or a vapor method, and a water-repellent protective film is carried out by a reaction described later. It is also possible to prepare a formation chemical solution and hold it on the surface of the object to be treated.
본 발명의 발수성 보호막 형성용 약액은, 적어도 (I)아미노실란 화합물과, (II)규소 화합물과, (III)비프로톤성 용제를 포함한다. 이하, 각 성분에 관하여 설명한다.The chemical liquid for forming a water-repellent protective film of the present invention contains at least an (I) aminosilane compound, (II) a silicon compound, and (III) an aprotic solvent. Hereinafter, each component is demonstrated.
[(I)아미노실란 화합물과 (II)규소 화합물][(I) Aminosilane compound and (II) silicon compound]
상기 일반식 [1]의 R1과, 상기 일반식 [2]의 R2는, 발수성의 관능기이다. 그리고, 상기 일반식 [1]의 -NH2기나 상기 일반식 [2]의 -X기가, 예를 들면 피처리체가 규소를 함유하는 웨이퍼의 경우이면 웨이퍼 표면의 실라놀기 등과 반응하고, 상기 발수성의 관능기를 가지는 부위가 웨이퍼 표면에 고정됨으로써, 당해 웨이퍼 표면에 발수성의 보호막이 형성된다. 상기 (I)과 (II)의 양방을 이용함으로써, 양자가 웨이퍼 표면과 빨리 반응하게 되고, 보다 우수한 발수성 부여 효과가 얻어진다.R 1 in the general formula [1] and R 2 in the general formula [2] are a water-repellent functional group. And, when the -NH 2 group of the general formula [1] or the -X group of the general formula [2], for example, in the case of a wafer containing silicon, reacts with a silanol group on the wafer surface, and the water repellency The portion having a functional group is fixed to the wafer surface, thereby forming a water-repellent protective film on the wafer surface. By using both of the above (I) and (II), both react quickly with the wafer surface, and a more excellent water repellency imparting effect is obtained.
상기 일반식 [1]의 R1은, 직쇄상 알킬기이면, 상기 피처리체인 웨이퍼 표면에 보호막을 형성했을 때에, 당해 표면에 보다 우수한 발수성을 부여할 수 있기 때문에 바람직하다.If R 1 in the general formula [1] is a linear alkyl group, when a protective film is formed on the surface of the wafer as the object to be processed, it is preferable because it can impart more excellent water repellency to the surface.
상기 일반식 [1]로 나타내어지는 아미노실란 화합물의 구체예로서는, 예를 들면, CH3Si(NH2)3, C2H5Si(NH2)3, C3H7Si(NH2)3, C4H9Si(NH2)3, C5H11Si(NH2)3, C6H13Si(NH2)3, C7H15Si(NH2)3, C8H17Si(NH2)3, C9H19Si(NH2)3, C10H21Si(NH2)3, C11H23Si(NH2)3, C12H25Si(NH2)3, C13H27Si(NH2)3, C14H29Si(NH2)3, C15H31Si(NH2)3, C16H33Si(NH2)3, C17H35Si(NH2)3, C18H37Si(NH2)3, (CH3)2Si(NH2)2, C2H5Si(CH3)(NH2)2, (C2H5)2Si(NH2)2, C3H7Si(CH3)(NH2)2, (C3H7)2Si(NH2)2, C4H9Si(CH3)(NH2)2, (C4H9)2Si(NH2)2, C5H11Si(CH3)(NH2)2, C6H13Si(CH3)(NH2)2, C7H15Si(CH3)(NH2)2, C8H17Si(CH3)(NH2)2, C9H19Si(CH3)(NH2)2, C10H21Si(CH3)(NH2)2, C11H23Si(CH3)(NH2)2, C12H25Si(CH3)(NH2)2, C13H27Si(CH3)(NH2)2, C14H29Si(CH3)(NH2)2, C15H31Si(CH3)(NH2)2, C16H33Si(CH3)(NH2)2, C17H35Si(CH3)(NH2)2, C18H37Si(CH3)(NH2)2, (CH3)3SiNH2, C2H5Si(CH3)2NH2, (C2H5)2Si(CH3)NH2, (C2H5)3SiNH2, C3H7Si(CH3)2NH2, (C3H7)2Si(CH3)NH2, (C3H7)3SiNH2, C4H9Si(CH3)2NH2, (C4H9)3SiNH2, C5H11Si(CH3)2NH2, C6H13Si(CH3)2NH2, C7H15Si(CH3)2NH2, C8H17Si(CH3)2NH2, C9H19Si(CH3)2NH2, C10H21Si(CH3)2NH2, C11H23Si(CH3)2NH2, C12H25Si(CH3)2NH2, C13H27Si(CH3)2NH2, C14H29Si(CH3)2NH2, C15H31Si(CH3)2NH2, C16H33Si(CH3)2NH2, C17H35Si(CH3)2NH2, C18H37Si(CH3)2NH2, (CH3)2Si(H)NH2, CH3Si(H)2NH2, (C2H5)2Si(H)NH2, C2H5Si(H)2NH2, C2H5Si(CH3)(H)NH2, (C3H7)2Si(H)NH2, C3H7Si(H)2NH2, CF3CH2CH2Si(NH2)3, C2F5CH2CH2Si(NH2)3, C3F7CH2CH2Si(NH2)3, C4F9CH2CH2Si(NH2)3, C5F11CH2CH2Si(NH2)3, C6F13CH2CH2Si(NH2)3, C7F15CH2CH2Si(NH2)3, C8F17CH2CH2Si(NH2)3, CF3CH2CH2Si(CH3)(NH2)2, C2F5CH2CH2Si(CH3)(NH2)2, C3F7CH2CH2Si(CH3)(NH2)2, C4F9CH2CH2Si(CH3)(NH2)2, C5F11CH2CH2Si(CH3)(NH2)2, C6F13CH2CH2Si(CH3)(NH2)2, C7F15CH2CH2Si(CH3)(NH2)2, C8F17CH2CH2Si(CH3)(NH2)2, CF3CH2CH2Si(CH3)2NH2, C2F5CH2CH2Si(CH3)2NH2, C3F7CH2CH2Si(CH3)2NH2, C4F9CH2CH2Si(CH3)2NH2, C5F11CH2CH2Si(CH3)2NH2, C6F13CH2CH2Si(CH3)2NH2, C7F15CH2CH2Si(CH3)2NH2, C8F17CH2CH2Si(CH3)2NH2, CF3CH2CH2Si(CH3)(H)NH2 등을 들 수 있다.As a specific example of the aminosilane compound represented by the general formula [1], for example, CH 3 Si(NH 2 ) 3 , C 2 H 5 Si(NH 2 ) 3 , C 3 H 7 Si(NH 2 ) 3 , C 4 H 9 Si(NH 2 ) 3 , C 5 H 11 Si(NH 2 ) 3 , C 6 H 13 Si(NH 2 ) 3 , C 7 H 15 Si(NH 2 ) 3 , C 8 H 17 Si (NH 2 ) 3 , C 9 H 19 Si(NH 2 ) 3 , C 10 H 21 Si(NH 2 ) 3 , C 11 H 23 Si(NH 2 ) 3 , C 12 H 25 Si(NH 2 ) 3 , C 13 H 27 Si(NH 2 ) 3 , C 14 H 29 Si(NH 2 ) 3 , C 15 H 31 Si(NH 2 ) 3 , C 16 H 33 Si(NH 2 ) 3 , C 17 H 35 Si( NH 2 ) 3 , C 18 H 37 Si(NH 2 ) 3 , (CH 3 ) 2 Si(NH 2 ) 2 , C 2 H 5 Si(CH 3 )(NH 2 ) 2 , (C 2 H 5 ) 2 Si(NH 2 ) 2 , C 3 H 7 Si(CH 3 )(NH 2 ) 2 , (C 3 H 7 ) 2 Si(NH 2 ) 2 , C 4 H 9 Si(CH 3 )(NH 2 ) 2 , (C 4 H 9 ) 2 Si(NH 2 ) 2 , C 5 H 11 Si(CH 3 )(NH 2 ) 2 , C 6 H 13 Si(CH 3 )(NH 2 ) 2 , C 7 H 15 Si (CH 3 )(NH 2 ) 2 , C 8 H 17 Si(CH 3 )(NH 2 ) 2 , C 9 H 19 Si(CH 3 )(NH 2 ) 2 , C 10 H 21 Si(CH 3 )( NH 2 ) 2 , C 11 H 23 Si(CH 3 )(NH 2 ) 2 , C 12 H 25 Si(CH 3 )(NH 2 ) 2 , C 13 H 27 Si(CH 3 )(NH 2 ) 2 , C 14 H 29 Si(CH 3 )(NH 2 ) 2 , C 15 H 31 Si(CH 3 )(NH 2 ) 2 , C 16 H 33 S i(CH 3 )(NH 2 ) 2 , C 17 H 35 Si(CH 3 )(NH 2 ) 2 , C 18 H 37 Si(CH 3 )(NH 2 ) 2 , (CH 3 ) 3 SiNH 2 , C 2 H 5 Si(CH 3 ) 2 NH 2 , (C 2 H 5 ) 2 Si(CH 3 )NH 2 , (C 2 H 5 ) 3 SiNH 2 , C 3 H 7 Si(CH 3 ) 2 NH 2 , (C 3 H 7 ) 2 Si(CH 3 )NH 2 , (C 3 H 7 ) 3 SiNH 2 , C 4 H 9 Si(CH 3 ) 2 NH 2 , (C 4 H 9 ) 3 SiNH 2 , C 5 H 11 Si(CH 3 ) 2 NH 2 , C 6 H 13 Si(CH 3 ) 2 NH 2 , C 7 H 15 Si(CH 3 ) 2 NH 2 , C 8 H 17 Si(CH 3 ) 2 NH 2 , C 9 H 19 Si(CH 3 ) 2 NH 2 , C 10 H 21 Si(CH 3 ) 2 NH 2 , C 11 H 23 Si(CH 3 ) 2 NH 2 , C 12 H 25 Si(CH 3 ) 2 NH 2 , C 13 H 27 Si(CH 3 ) 2 NH 2 , C 14 H 29 Si(CH 3 ) 2 NH 2 , C 15 H 31 Si(CH 3 ) 2 NH 2 , C 16 H 33 Si(CH 3 ) 2 NH 2 , C 17 H 35 Si(CH 3 ) 2 NH 2 , C 18 H 37 Si(CH 3 ) 2 NH 2 , (CH 3 ) 2 Si(H)NH 2 , CH 3 Si(H) 2 NH 2 , (C 2 H 5 ) 2 Si(H)NH 2 , C 2 H 5 Si(H) 2 NH 2 , C 2 H 5 Si(CH 3 )(H)NH 2 , (C 3 H 7 ) 2 Si(H)NH 2 , C 3 H 7 Si(H) 2 NH 2 , CF 3 CH 2 CH 2 Si(NH 2 ) 3 , C 2 F 5 CH 2 CH 2 Si(NH 2 ) 3 , C 3 F 7 CH 2 CH 2 Si(NH 2 ) 3 , C 4 F 9 CH 2 CH 2 Si(NH 2 ) 3 , C 5 F 11 CH 2 CH 2 Si(NH 2 ) 3 , C 6 F 13 CH 2 CH 2 Si(NH 2 ) 3 , C 7 F 15 CH 2 CH 2 Si(NH 2 ) 3 , C 8 F 17 CH 2 CH 2 Si(NH 2 ) 3 , CF 3 CH 2 CH 2 Si(CH 3 )(NH 2 ) 2 , C 2 F 5 CH 2 CH 2 Si(CH 3 )(NH 2 ) 2 , C 3 F 7 CH 2 CH 2 Si(CH 3 )(NH 2 ) 2 , C 4 F 9 CH 2 CH 2 Si(CH 3 )(NH 2 ) 2 , C 5 F 11 CH 2 CH 2 Si(CH 3 )(NH 2 ) 2 , C 6 F 13 CH 2 CH 2 Si(CH 3 )(NH 2 ) 2 , C 7 F 15 CH 2 CH 2 Si(CH 3 )(NH 2 ) 2 , C 8 F 17 CH 2 CH 2 Si(CH 3 )(NH 2 ) 2 , CF 3 CH 2 CH 2 Si(CH 3 ) 2 NH 2 , C 2 F 5 CH 2 CH 2 Si(CH 3 ) 2 NH 2 , C 3 F 7 CH 2 CH 2 Si( CH 3 ) 2 NH 2 , C 4 F 9 CH 2 CH 2 Si(CH 3 ) 2 NH 2 , C 5 F 11 CH 2 CH 2 Si(CH 3 ) 2 NH 2 , C 6 F 13 CH 2 CH 2 Si (CH 3 ) 2 NH 2 , C 7 F 15 CH 2 CH 2 Si(CH 3 ) 2 NH 2 , C 8 F 17 CH 2 CH 2 Si(CH 3 ) 2 NH 2 , CF 3 CH 2 CH 2 Si( CH 3 )(H)NH 2 and the like.
또한, 상기 일반식 [1]에 있어서 4-a-b로 나타내어지는 -NH2기의 수가 1이면, 상기 보호막을 균질하게 형성할 수 있으므로 보다 바람직하다.In addition, in the general formula [1], when the number of -NH 2 groups represented by 4-ab is 1, the protective film can be formed homogeneously, so it is more preferable.
또한, 상기 일반식 [1]에 있어서 b가 0이면, 후술의 보호막 형성 후의 세정(린스)을 행한 경우라도 발수성을 유지하기 쉽기 때문에 바람직하다.In addition, if b is 0 in the general formula [1], it is preferable because water repellency is easily maintained even when washing (rinsing) after formation of a protective film described later is performed.
또한, 상기 R1은, 2개의 -CH3기와 1개의 직쇄상 알킬기의 조합이면, 상기 보호막을 균질하게 형성할 수 있으므로 보다 바람직하다. 또한, 상기 R1은, 3개의 -CH3기인 것이 특히 바람직하다.Further, R 1 is more preferable if it is a combination of two -CH 3 groups and one linear alkyl group, since the protective film can be formed homogeneously. In addition, it is particularly preferable that R 1 is a 3 -CH 3 group.
또한, 상기 일반식 [1]로 나타내어지는 아미노실란 화합물은, 반응에 의해 얻어진 것이어도 된다.Moreover, the aminosilane compound represented by the said general formula [1] may be obtained by reaction.
상기 (I)아미노실란 화합물은, (I)∼(III)의 총량에 대하여 0.02∼0.5질량%이다. 0.02질량% 미만에서는, 발수성 부여 효과의 가일층의 향상을 달성할 수 없다. 또한, 0.5질량%를 넘으면, 아미노실란끼리가 반응하기 쉬워지기 때문에 약액의 조제가 어려워진다. 바람직하게는 0.03∼0.4질량%, 보다 바람직하게는 0.03∼0.3질량%이다.The (I) aminosilane compound is 0.02 to 0.5% by mass based on the total amount of (I) to (III). When it is less than 0.02 mass%, further improvement of the effect of imparting water repellency cannot be achieved. Moreover, when it exceeds 0.5 mass %, since aminosilanes are liable to react with each other, preparation of a chemical solution becomes difficult. It is preferably 0.03 to 0.4% by mass, more preferably 0.03 to 0.3% by mass.
또한, 상기 일반식 [2]로 나타내어지는 규소 화합물의 구체예로서는, CH3Si(OC(=O)CF3)3, C2H5Si(OC(=O)CF3)3, C3H7Si(OC(=O)CF3)3, C4H9Si(OC(=O)CF3)3, C5H11Si(OC(=O)CF3)3, C6H13Si(OC(=O)CF3)3, C7H15Si(OC(=O)CF3)3, C8H17Si(OC(=O)CF3)3, C9H19Si(OC(=O)CF3)3, C10H21Si(OC(=O)CF3)3, C11H23Si(OC(=O)CF3)3, C12H25Si(OC(=O)CF3)3, C13H27Si(OC(=O)CF3)3, C14H29Si(OC(=O)CF3)3, C15H31Si(OC(=O)CF3)3, C16H33Si(OC(=O)CF3)3, C17H35Si(OC(=O)CF3)3, C18H37Si(OC(=O)CF3)3, (CH3)2Si(OC(=O)CF3)2, C2H5Si(CH3)(OC(=O)CF3)2, (C2H5)2Si(OC(=O)CF3)2, C3H7Si(CH3)(OC(=O)CF3)2, (C3H7)2Si(OC(=O)CF3)2, C4H9Si(CH3)(OC(=O)CF3)2, (C4H9)2Si(OC(=O)CF3)2, C5H11Si(CH3)(OC(=O)CF3)2, C6H13Si(CH3)(OC(=O)CF3)2, C7H15Si(CH3)(OC(=O)CF3)2, C8H17Si(CH3)(OC(=O)CF3)2, C9H19Si(CH3)(OC(=O)CF3)2, C10H21Si(CH3)(OC(=O)CF3)2, C11H23Si(CH3)(OC(=O)CF3)2, C12H25Si(CH3)(OC(=O)CF3)2, C13H27Si(CH3)(OC(=O)CF3)2, C14H29Si(CH3)(OC(=O)CF3)2, C15H31Si(CH3)(OC(=O)CF3)2, C16H33Si(CH3)(OC(=O)CF3)2, C17H35Si(CH3)(OC(=O)CF3)2, C18H37Si(CH3)(OC(=O)CF3)2, (CH3)3SiOC(=O)CF3, C2H5Si(CH3)2OC(=O)CF3, (C2H5)2Si(CH3)OC(=O)CF3, (C2H5)3SiOC(=O)CF3, C3H7Si(CH3)2OC(=O)CF3, (C3H7)2Si(CH3)OC(=O)CF3, (C3H7)3SiOC(=O)CF3, C4H9Si(CH3)2OC(=O)CF3, (C4H9)3SiOC(=O)CF3, C5H11Si(CH3)2OC(=O)CF3, C6H13Si(CH3)2OC(=O)CF3, C7H15Si(CH3)2OC(=O)CF3, C8H17Si(CH3)2OC(=O)CF3, C9H19Si(CH3)2OC(=O)CF3, C10H21Si(CH3)2OC(=O)CF3, C11H23Si(CH3)2OC(=O)CF3, C12H25Si(CH3)2OC(=O)CF3, C13H27Si(CH3)2OC(=O)CF3, C14H29Si(CH3)2OC(=O)CF3, C15H31Si(CH3)2OC(=O)CF3, C16H33Si(CH3)2OC(=O)CF3, C17H35Si(CH3)2OC(=O)CF3, C18H37Si(CH3)2OC(=O)CF3, (CH3)2Si(H)OC(=O)CF3, CH3Si(H)2OC(=O)CF3, (C2H5)2Si(H)OC(=O)CF3, C2H5Si(H)2OC(=O)CF3, C2H5Si(CH3)(H)OC(=O)CF3, (C3H7)2Si(H)OC(=O)CF3, C3H7Si(H)2OC(=O)CF3, CF3CH2CH2Si(OC(=O)CF3)3, C2F5CH2CH2Si(OC(=O)CF3)3, C3F7CH2CH2Si(OC(=O)CF3)3, C4F9CH2CH2Si(OC(=O)CF3)3, C5F11CH2CH2Si(OC(=O)CF3)3, C6F13CH2CH2Si(OC(=O)CF3)3, C7F15CH2CH2Si(OC(=O)CF3)3, C8F17CH2CH2Si(OC(=O)CF3)3, CF3CH2CH2Si(CH3)(OC(=O)CF3)2, C2F5CH2CH2Si(CH3)(OC(=O)CF3)2, C3F7CH2CH2Si(CH3)(OC(=O)CF3)2, C4F9CH2CH2Si(CH3)(OC(=O)CF3)2, C5F11CH2CH2Si(CH3)(OC(=O)CF3)2, C6F13CH2CH2Si(CH3)(OC(=O)CF3)2, C7F15CH2CH2Si(CH3)(OC(=O)CF3)2, C8F17CH2CH2Si(CH3)(OC(=O)CF3)2, CF3CH2CH2Si(CH3)2OC(=O)CF3, C2F5CH2CH2Si(CH3)2OC(=O)CF3, C3F7CH2CH2Si(CH3)2OC(=O)CF3, C4F9CH2CH2Si(CH3)2OC(=O)CF3, C5F11CH2CH2Si(CH3)2OC(=O)CF3, C6F13CH2CH2Si(CH3)2OC(=O)CF3, C7F15CH2CH2Si(CH3)2OC(=O)CF3, C8F17CH2CH2Si(CH3)2OC(=O)CF3, CF3CH2CH2Si(CH3)(H)OC(=O)CF3 등의 트리플루오로아세톡시실란, 또는, 상기 트리플루오로아세톡시실란의 -OC(=O)CF3기를, 할로겐기, -OC(=O)CF3기 이외의 -OC(=O)R3기, -OS(=O)2-R3기, -N(S(=O)2-R3)2기, -C(S(=O)2-R3)3기(R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기)로 치환한 것 등을 들 수 있다.In addition, as a specific example of the silicon compound represented by the general formula [2], CH 3 Si(OC(=O)CF 3 ) 3 , C 2 H 5 Si(OC(=O)CF 3 ) 3 , C 3 H 7 Si(OC(=O)CF 3 ) 3 , C 4 H 9 Si(OC(=O)CF 3 ) 3 , C 5 H 11 Si(OC(=O)CF 3 ) 3 , C 6 H 13 Si (OC(=O)CF 3 ) 3 , C 7 H 15 Si(OC(=O)CF 3 ) 3 , C 8 H 17 Si(OC(=O)CF 3 ) 3 , C 9 H 19 Si(OC (=O)CF 3 ) 3 , C 10 H 21 Si(OC(=O)CF 3 ) 3 , C 11 H 23 Si(OC(=O)CF 3 ) 3 , C 12 H 25 Si(OC(= O)CF 3 ) 3 , C 13 H 27 Si(OC(=O)CF 3 ) 3 , C 14 H 29 Si(OC(=O)CF 3 ) 3 , C 15 H 31 Si(OC(=O) CF 3 ) 3 , C 16 H 33 Si(OC(=O)CF 3 ) 3 , C 17 H 35 Si(OC(=O)CF 3 ) 3 , C 18 H 37 Si(OC(=O)CF 3 ) 3 , (CH 3 ) 2 Si(OC(=O)CF 3 ) 2 , C 2 H 5 Si(CH 3 )(OC(=O)CF 3 ) 2 , (C 2 H 5 ) 2 Si(OC (=O)CF 3 ) 2 , C 3 H 7 Si(CH 3 )(OC(=O)CF 3 ) 2 , (C 3 H 7 ) 2 Si(OC(=O)CF 3 ) 2 , C 4 H 9 Si(CH 3 )(OC(=O)CF 3 ) 2 , (C 4 H 9 ) 2 Si(OC(=O)CF 3 ) 2 , C 5 H 11 Si(CH 3 )(OC(= O)CF 3 ) 2 , C 6 H 13 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 7 H 15 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 8 H 17 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 9 H 19 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 10 H 21 Si(CH 3 )(OC( =O)CF 3 ) 2 , C 11 H 23 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 12 H 25 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 13 H 27 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 14 H 29 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 15 H 31 Si(CH 3 )(OC( =O)CF 3 ) 2 , C 16 H 33 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 17 H 35 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 18 H 37 Si(CH 3 )(OC(=O)CF 3 ) 2 , (CH 3 ) 3 SiOC(=O)CF 3 , C 2 H 5 Si(CH 3 ) 2 OC(=O)CF 3 , ( C 2 H 5 ) 2 Si(CH 3 )OC(=O)CF 3 , (C 2 H 5 ) 3 SiOC(=O)CF 3 , C 3 H 7 Si(CH 3 ) 2 OC(=O)CF 3 , (C 3 H 7 ) 2 Si(CH 3 )OC(=O)CF 3 , (C 3 H 7 ) 3 SiOC(=O)CF 3 , C 4 H 9 Si(CH 3 ) 2 OC(= O)CF 3 , (C 4 H 9 ) 3 SiOC(=O)CF 3 , C 5 H 11 Si(CH 3 ) 2 OC(=O)CF 3 , C 6 H 13 Si(CH 3 ) 2 OC( =O)CF 3 , C 7 H 15 Si(CH 3 ) 2 OC(=O)CF 3 , C 8 H 17 Si(CH 3 ) 2 OC(=O)CF 3 , C 9 H 19 Si(CH 3 ) 2 OC(=O)CF 3 , C 10 H 21 Si(CH 3 ) 2 OC(=O)CF 3 , C 11 H 23 Si(CH 3 ) 2 OC(=O)CF 3 , C 12 H 25 Si(CH 3 ) 2 OC(=O)CF 3 , C 13 H 27 Si(CH 3 ) 2 OC(=O)CF 3 , C 14 H 29 Si(CH 3 ) 2 OC(=O)CF 3 , C 15 H 31 Si(CH 3 ) 2 OC(=O)CF 3 , C 16 H 33 Si(CH 3 ) 2 OC(=O)CF 3 , C 17 H 35 Si(CH 3 ) 2 OC(=O)CF 3 , C 18 H 37 Si(CH 3 ) 2 OC(=O)CF 3 , (CH 3 ) 2 Si(H)OC(=O )CF 3 , CH 3 Si(H) 2 OC(=O) CF 3 , (C 2 H 5 ) 2 Si(H)OC(=O)CF 3 , C 2 H 5 Si(H) 2 OC(= O)CF 3 , C 2 H 5 Si(CH 3 )(H)OC(=O)CF 3 , (C 3 H 7 ) 2 Si(H)OC(=O)CF 3 , C 3 H 7 Si( H) 2 OC(=O)CF 3 , CF 3 CH 2 CH 2 Si(OC(=O)CF 3 ) 3 , C 2 F 5 CH 2 CH 2 Si(OC(=O)CF 3 ) 3 , C 3 F 7 CH 2 CH 2 Si(OC(=O)CF 3 ) 3 , C 4 F 9 CH 2 CH 2 Si(OC(=O)CF 3 ) 3 , C 5 F 11 CH 2 CH 2 Si(OC (=O)CF 3 ) 3 , C 6 F 13 CH 2 CH 2 Si(OC(=O)CF 3 ) 3 , C 7 F 15 CH 2 CH 2 Si(OC(=O)CF 3 ) 3 , C 8 F 17 CH 2 CH 2 Si(OC(=O)CF 3 ) 3 , CF 3 CH 2 CH 2 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 2 F 5 CH 2 CH 2 Si (CH 3 )(OC(=O)CF 3 ) 2 , C 3 F 7 CH 2 CH 2 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 4 F 9 CH 2 CH 2 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 5 F 11 CH 2 CH 2 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 6 F 13 CH 2 CH 2 Si(CH 3 ) (OC(=O)CF 3 ) 2 , C 7 F 15 CH 2 CH 2 Si(CH 3 )(OC(=O)CF 3 ) 2 , C 8 F 17 CH 2 CH 2 Si(CH 3 )(OC (=O)CF 3 ) 2 , CF 3 CH 2 CH 2 Si(CH 3 ) 2 OC(=O)CF 3 , C 2 F 5 CH 2 C H 2 Si(CH 3 ) 2 OC(=O)CF 3 , C 3 F 7 CH 2 CH 2 Si(CH 3 ) 2 OC(=O)CF 3 , C 4 F 9 CH 2 CH 2 Si(CH 3 ) 2 OC(=O)CF 3 , C 5 F 11 CH 2 CH 2 Si(CH 3 ) 2 OC(=O)CF 3 , C 6 F 13 CH 2 CH 2 Si(CH 3 ) 2 OC(=O )CF 3 , C 7 F 15 CH 2 CH 2 Si(CH 3 ) 2 OC(=O)CF 3 , C 8 F 17 CH 2 CH 2 Si(CH 3 ) 2 OC(=O)CF 3 , CF 3 A trifluoroacetoxysilane such as CH 2 CH 2 Si(CH 3 )(H)OC(=O)CF 3 , or the -OC(=O)CF 3 group of the trifluoroacetoxysilane, a halogen group , -OC (= O) CF 3 group other than the -OC (= O) R 3 group, -OS (= O) 2 -R 3 group, -N (S (= O) 2 -R 3) 2 group, -C(S(=O) 2 -R 3 ) 3 group (R 3 is a monovalent perfluoroalkyl group having 1 to 6 carbon atoms) substituted with a group.
또한, 상기 일반식 [2]에 있어서 4-c-d로 나타내어지는 -X기의 수가 1이면, 상기 보호막을 균질하게 형성할 수 있으므로 보다 바람직하다.In addition, when the number of -X groups represented by 4-c-d in the general formula [2] is 1, since the protective film can be formed homogeneously, it is more preferable.
또한, 상기 일반식 [2]에 있어서 d가 0이면, 후술의 보호막 형성 후의 세정(린스)을 행한 경우라도 발수성을 유지하기 쉽기 때문에 바람직하다.Further, in the general formula [2], when d is 0, it is preferable because water repellency is easily maintained even when washing (rinsing) after formation of a protective film described later is performed.
또한, 상기 R2는, 2개의 -CH3기와 1개의 직쇄상 알킬기의 조합이면, 상기 보호막을 균질하게 형성할 수 있으므로 보다 바람직하다. 또한, 상기 R2는, 3개의 -CH3기인 것이 특히 바람직하다.Further, the R 2 is more preferable if it is a combination of two -CH 3 groups and one linear alkyl group, since the protective film can be formed homogeneously. In addition, it is particularly preferable that R 2 is a 3 -CH 3 group.
또한, 상기 일반식 [2]로 나타내어지는 규소 화합물은, 반응에 의해 얻어진 것이어도 된다.Moreover, the silicon compound represented by the said general formula [2] may be obtained by reaction.
또한, (I)∼(III)의 총량에 대한 (II)규소 화합물의 함유량은, 발수성 부여 효과의 향상의 관점에서 0.05질량% 이상이 바람직하고, 또한, 비용의 관점에서 20질량% 이하가 바람직하다. 더 바람직하게는 0.1∼15질량%, 보다 바람직하게는 0.2∼10질량%이다.In addition, the content of the silicon compound (II) relative to the total amount of (I) to (III) is preferably 0.05% by mass or more from the viewpoint of improving the effect of imparting water repellency, and 20% by mass or less from the viewpoint of cost. Do. It is more preferably 0.1 to 15% by mass, more preferably 0.2 to 10% by mass.
[(III)비프로톤성 용제][(III) Aprotic solvent]
본 발명의 발수성 보호막 형성용 약액은, 비프로톤성 용제를 함유한다. 비프로톤성 용제를 함유함으로써, 스핀 코트법이나 침지법이나 증기법 등에 의한 피처리체의 표면 처리를 용이하게 행할 수 있다. 또한, 약액의 보관 안정성을 확보하기 쉽다.The chemical liquid for forming a water-repellent protective film of the present invention contains an aprotic solvent. By containing the aprotic solvent, it is possible to easily perform the surface treatment of the object to be treated by a spin coating method, an immersion method, or a steam method. In addition, it is easy to ensure storage stability of the chemical solution.
상기 비프로톤성 용제로서는, 예를 들면, 탄화수소류, 에스테르류, 에테르류, 케톤류, 함할로겐 용매, 술폭시드계 용매, 술폰계 용매, 락톤계 용매, 카보네이트계 용매, 다가(多價) 알코올의 유도체 중 OH기를 갖지 않는 것, N-H기를 갖지 않는 질소 원소 함유 용매, 실리콘 용매, 테르펜계 용매 등의 유기 용매, 또는, 그들의 혼합액이 적합하게 사용된다. 이 중에서도, 탄화수소류, 에스테르류, 에테르류, 함할로겐 용매, 다가 알코올의 유도체 중 OH기를 갖지 않는 것, 또는, 그들의 혼합액을 이용하면, 피처리체의 표면에 상기 보호막을 단시간에 형성할 수 있기 때문에 보다 바람직하다.Examples of the aprotic solvent include hydrocarbons, esters, ethers, ketones, halogen-containing solvents, sulfoxide solvents, sulfone solvents, lactone solvents, carbonate solvents, and polyhydric alcohols. Among the derivatives, organic solvents such as those that do not have an OH group, a nitrogen element-containing solvent that does not have an NH group, a silicone solvent, a terpene-based solvent, or a mixture thereof are suitably used. Among them, hydrocarbons, esters, ethers, halogen-containing solvents, derivatives of polyhydric alcohols that do not have OH groups, or a mixture of them can form the protective film on the surface of the object in a short time. More preferable.
상기 탄화수소류의 예로서는, n-헥산, n-헵탄, n-옥탄, n-노난, n-데칸, n-운데칸, n-도데칸, n-테트라데칸, n-헥사데칸, n-옥타데칸, n-아이코산, 및 그들의 탄소수에 대응하는 분기상의 탄화수소(예를 들면. 이소도데칸, 이소세탄 등), 시클로헥산, 메틸시클로헥산, 데칼린, 벤젠, 톨루엔, 크실렌, (오르토-, 메타-, 또는 파라-)디에틸벤젠, 1,3,5-트리메틸벤젠 등이 있고, 상기 에스테르류의 예로서는, 아세트산 에틸, 아세트산 n-프로필, 아세트산 i-프로필, 아세트산 n-부틸, 아세트산 i-부틸, 아세트산 n-펜틸, 아세트산 i-펜틸, 아세트산 n-헥실, 아세트산 n-헵틸, 아세트산 n-옥틸, 포름산 n-펜틸, 프로피온산 n-부틸, 부티르산 에틸, 부티르산 n-프로필, 부티르산 i-프로필, 부티르산 n-부틸, n-옥탄산 메틸, 데칸산 메틸, 피루브산 메틸, 피루브산 에틸, 피루브산 n-프로필, 아세토아세트산 메틸, 아세토아세트산 에틸, 2-옥소부탄산 에틸, 아디프산 디메틸, 3-메톡시프로피온산 메틸, 3-메톡시프로피온산 에틸, 3-에톡시프로피온산 메틸, 3-에톡시프로피온산 에틸, 에톡시아세트산 에틸 등이 있고, 상기 에테르류의 예로서는, 디-n-프로필에테르, 에틸-n-부틸에테르, 디-n-부틸에테르, 에틸-n-아밀에테르, 디-n-아밀에테르, 에틸-n-헥실에테르, 디-n-헥실에테르, 디-n-옥틸에테르, 및 그들의 탄소수에 대응하는 디이소프로필에테르, 디이소아밀에테르 등의 분기상의 탄화수소기를 가지는 에테르, 디메틸에테르, 디에틸에테르, 메틸에틸에테르, 메틸시클로펜틸에테르, 디페닐에테르, 테트라히드로푸란, 디옥산 등이 있고, 상기 케톤류의 예로서는, 아세톤, 아세틸아세톤, 메틸에틸케톤, 메틸프로필케톤, 메틸부틸케톤, 시클로헥사논, 이소포론 등이 있고, 상기 함할로겐 용매의 예로서는, 퍼플루오로옥탄, 퍼플루오로노난, 퍼플루오로시클로펜탄, 퍼플루오로시클로헥산, 헥사플루오로벤젠 등의 퍼플루오로카본, 1,1,1,3,3-펜타플루오로부탄, 옥타플루오로시클로펜탄, 2,3-디하이드로데카플루오로펜탄, 제오로라 H(니폰제온제) 등의 하이드로플루오로카본, 메틸퍼플루오로이소부틸에테르, 메틸퍼플루오로부틸에테르, 에틸퍼플루오로부틸에테르, 에틸퍼플루오로이소부틸에테르, 아사히클린 AE-3000(아사히글라스제), Novec7100, Novec7200, Novec7300, Novec7600(모두 3M제) 등의 하이드로플루오로에테르, 테트라클로로메탄 등의 클로로카본, 클로로포름 등의 하이드로클로로카본, 디클로로디플루오로메탄 등의 클로로플루오로카본, 1,1-디클로로-2,2,3,3,3-펜타플루오로프로판, 1,3-디클로로-1,1,2,2,3-펜타플루오로프로판, 1-클로로-3,3,3-트리플루오로프로펜, 1,2-디클로로-3,3,3-트리플루오로프로펜 등의 하이드로클로로플루오로카본, 퍼플루오로에테르, 퍼플루오로폴리에테르 등이 있고, 상기 술폭시드계 용매의 예로서는, 디메틸술폭시드 등이 있고, 상기 술폰계 용매의 예로서는, 디메틸술폰, 디에틸술폰, 비스(2-히드록시에틸)술폰, 테트라메틸렌술폰 등이 있고, 상기 락톤계 용매의 예로서는, β-프로피오락톤, γ-부티로락톤, γ-발레로락톤, γ-헥사노락톤, γ-헵타노락톤, γ-옥타노락톤, γ-노나노락톤, γ-데카노락톤, γ-운데카노락톤, γ-도데카노락톤, δ-발레로락톤, δ-헥사노락톤, δ-옥타노락톤, δ-노나노락톤, δ-데카노락톤, δ-운데카노락톤, δ-도데카노락톤, ε-헥사노락톤 등이 있고, 상기 카보네이트계 용매의 예로서는, 디메틸카보네이트, 에틸메틸카보네이트, 디에틸카보네이트, 프로필렌카보네이트 등이 있고, 상기 다가 알코올의 유도체 중 OH기를 갖지 않는 것의 예로서는, 에틸렌글리콜디메틸에테르, 에틸렌글리콜디에틸에테르, 에틸렌글리콜디부틸에테르, 에틸렌글리콜모노메틸에테르아세테이트, 에틸렌글리콜모노에틸에테르아세테이트, 에틸렌글리콜모노부틸에테르아세테이트, 에틸렌글리콜디아세테이트, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜에틸메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜부틸메틸에테르, 디에틸렌글리콜디부틸에테르, 디에틸렌글리콜모노메틸에테르아세테이트, 디에틸렌글리콜모노에틸에테르아세테이트, 디에틸렌글리콜모노부틸에테르아세테이트, 디에틸렌글리콜디아세테이트, 트리에틸렌글리콜디메틸에테르, 트리에틸렌글리콜디에틸에테르, 트리에틸렌글리콜디부틸에테르, 트리에틸렌글리콜부틸메틸에테르, 트리에틸렌글리콜모노메틸에테르아세테이트, 트리에틸렌글리콜모노에틸에테르아세테이트, 트리에틸렌글리콜모노부틸에테르아세테이트, 트리에틸렌글리콜디아세테이트, 테트라에틸렌글리콜디메틸에테르, 테트라에틸렌글리콜디에틸에테르, 테트라에틸렌글리콜디부틸에테르, 테트라에틸렌글리콜모노메틸에테르아세테이트, 테트라에틸렌글리콜모노에틸에테르아세테이트, 테트라에틸렌글리콜모노부틸에테르아세테이트, 테트라에틸렌글리콜디아세테이트, 프로필렌글리콜디메틸에테르, 프로필렌글리콜디에틸에테르, 프로필렌글리콜디부틸에테르, 프로필렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜모노에틸에테르아세테이트, 프로필렌글리콜모노부틸에테르아세테이트, 프로필렌글리콜디아세테이트, 디프로필렌글리콜디메틸에테르, 디프로필렌글리콜메틸프로필에테르, 디프로필렌글리콜디에틸에테르, 디프로필렌글리콜디부틸에테르, 디프로필렌글리콜모노메틸에테르아세테이트, 디프로필렌글리콜모노에틸에테르아세테이트, 디프로필렌글리콜모노부틸에테르아세테이트, 디프로필렌글리콜디아세테이트, 트리프로필렌글리콜디메틸에테르, 트리프로필렌글리콜디에틸에테르, 트리프로필렌글리콜디부틸에테르, 트리프로필렌글리콜모노메틸에테르아세테이트, 트리프로필렌글리콜모노에틸에테르아세테이트, 트리프로필렌글리콜모노부틸에테르아세테이트, 트리프로필렌글리콜디아세테이트, 테트라프로필렌글리콜디메틸에테르, 테트라프로필렌글리콜모노메틸에테르아세테이트, 테트라프로필렌글리콜디아세테이트, 부틸렌글리콜디메틸에테르, 부틸렌글리콜모노메틸에테르아세테이트, 부틸렌글리콜디아세테이트, 글리세린트리아세테이트, 3-메톡시부틸아세테이트, 3-메틸-3-메톡시부틸아세테이트, 3-메틸-3-메톡시부틸프로피오네이트 등이 있고, 상기 N-H기를 갖지 않는 질소 원소 함유 용매의 예로서는, N,N-디메틸포름아미드, N,N-디메틸아세트아미드, N-메틸-2-피롤리돈, N-에틸-2-피롤리돈, N-프로필-2-피롤리돈, 1,3-디메틸-2-이미다졸리디논, 1,3-디에틸-2-이미다졸리디논, 1,3-디이소프로필-2-이미다졸리디논, 트리에틸아민, 피리딘 등이 있고, 실리콘 용매의 예로서는, 헥사메틸디실록산, 옥타메틸트리실록산, 데카메틸테트라실록산, 도데카메틸펜타실록산 등이 있고, 테르펜계 용매의 예로서는, p-멘탄, 디페닐멘탄, 리모넨, 테르피넨, 보르난, 노르보르난, 피난 등이 있다.Examples of the hydrocarbons include n-hexane, n-heptane, n-octane, n-nonane, n-decane, n-undecane, n-dodecane, n-tetradecane, n-hexadecane, n-octadecane , n-icosic acid, and branched hydrocarbons corresponding to their carbon number (e.g. isododecane, isocetane, etc.), cyclohexane, methylcyclohexane, decalin, benzene, toluene, xylene, (ortho-, meta- , Or para-)diethylbenzene, 1,3,5-trimethylbenzene, and the like, and examples of the esters include ethyl acetate, n-propyl acetate, i-propyl acetate, n-butyl acetate, i-butyl acetate, N-pentyl acetate, i-pentyl acetate, n-hexyl acetate, n-heptyl acetate, n-octyl acetate, n-pentyl formate, n-butyl propionate, ethyl butyrate, n-propyl butyrate, i-propyl butyrate, n butyric acid -Butyl, methyl n-octanoate, methyl decanoate, methyl pyruvate, ethyl pyruvate, n-propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, ethyl 2-oxobutanoate, dimethyl adipate, methyl 3-methoxypropionate , Ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, ethyl ethoxyacetate, etc. Examples of the ethers include di-n-propyl ether, ethyl-n-butyl ether, Di-n-butyl ether, ethyl-n-amyl ether, di-n-amyl ether, ethyl-n-hexyl ether, di-n-hexyl ether, di-n-octyl ether, and diiso corresponding to their carbon number Ether having a branched hydrocarbon group such as propyl ether and diisoamyl ether, dimethyl ether, diethyl ether, methyl ethyl ether, methylcyclopentyl ether, diphenyl ether, tetrahydrofuran, dioxane, etc. Examples of the ketones , Acetone, acetylacetone, methyl ethyl ketone, methyl propyl ketone, methyl butyl ketone, cyclohexanone, isophorone, and the like, and examples of the halogen-containing solvent include perfluorooctane, perfluorononane, perfluorocyclopentane , Perfluorocarbons such as perfluorocyclohexane and hexafluorobenzene, 1,1,1,3,3-pentafluorobutane, octafluorocylate Hydrofluorocarbons such as clopentane, 2,3-dihydrodecafluoropentane, Zeurora H (made by Nippon Xeon), methyl perfluoroisobutyl ether, methyl perfluorobutyl ether, ethyl perfluorobutyl ether , Hydrofluoroethers such as ethyl perfluoroisobutyl ether, AsahiClean AE-3000 (manufactured by Asahi Glass), Novec7100, Novec7200, Novec7300, Novec7600 (all manufactured by 3M), chlorocarbons such as tetrachloromethane, chloroform Chlorofluorocarbons such as hydrochlorocarbon and dichlorodifluoromethane, 1,1-dichloro-2,2,3,3,3-pentafluoropropane, 1,3-dichloro-1,1,2,2 Hydrochlorofluorocarbons such as ,3-pentafluoropropane, 1-chloro-3,3,3-trifluoropropene, 1,2-dichloro-3,3,3-trifluoropropene, purple Luoroether, perfluoropolyether, etc., and examples of the sulfoxide solvent include dimethyl sulfoxide, and examples of the sulfone solvent include dimethylsulfone, diethylsulfone, bis(2-hydroxyethyl) Sulfone, tetramethylene sulfone, and the like, and examples of the lactone-based solvent include β-propiolactone, γ-butyrolactone, γ-valerolactone, γ-hexanolactone, γ-heptanolactone, and γ-octano Lactone, γ-nonanolactone, γ-decanolactone, γ-undecanolactone, γ-dodecanolactone, δ-valerolactone, δ-hexanolactone, δ-octanolactone, δ-nonanolactone, δ-decanolactone, δ-undecanolactone, δ-dodecanolactone, ε-hexanolactone, and the like, and examples of the carbonate-based solvent include dimethyl carbonate, ethyl methyl carbonate, diethyl carbonate, and propylene carbonate. Examples of the polyhydric alcohol derivatives that do not have an OH group include ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, and ethylene glycol monobutyl ether Acetate, ethylene glycol diacetate, diethylene glycol dimethyl ether, diethylene glycol ethyl methyl ether, diethylene glycol diethyl ether, diethylene glycol butyl methyl ether, diethylene glycol Cold dibutyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, diethylene glycol diacetate, triethylene glycol dimethyl ether, triethylene glycol diethyl ether, triethylene glycol Dibutyl ether, triethylene glycol butyl methyl ether, triethylene glycol monomethyl ether acetate, triethylene glycol monoethyl ether acetate, triethylene glycol monobutyl ether acetate, triethylene glycol diacetate, tetraethylene glycol dimethyl ether, tetraethylene glycol Diethyl ether, tetraethylene glycol dibutyl ether, tetraethylene glycol monomethyl ether acetate, tetraethylene glycol monoethyl ether acetate, tetraethylene glycol monobutyl ether acetate, tetraethylene glycol diacetate, propylene glycol dimethyl ether, propylene glycol diethyl Ether, propylene glycol dibutyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, propylene glycol monobutyl ether acetate, propylene glycol diacetate, dipropylene glycol dimethyl ether, dipropylene glycol methylpropyl ether, dipropylene glycol Diethyl ether, dipropylene glycol dibutyl ether, dipropylene glycol monomethyl ether acetate, dipropylene glycol monoethyl ether acetate, dipropylene glycol monobutyl ether acetate, dipropylene glycol diacetate, tripropylene glycol dimethyl ether, tripropylene glycol Diethyl ether, tripropylene glycol dibutyl ether, tripropylene glycol monomethyl ether acetate, tripropylene glycol monoethyl ether acetate, tripropylene glycol monobutyl ether acetate, tripropylene glycol diacetate, tetrapropylene glycol dimethyl ether, tetrapropylene glycol Monomethyl ether acetate, tetrapropylene glycol diacetate, butylene glycol dimethyl ether, butylene glycol monomethyl ether acetate, butylene glycol diacetate, glycerin triacetate, 3-methoxybutyl acetate, 3-methyl-3-methoxy Examples of the nitrogen element-containing solvent that includes butyl acetate, 3-methyl-3-methoxybutyl propionate and the like and does not have an NH group include N,N-dime Tylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N-propyl-2-pyrrolidone, 1,3-dimethyl-2- Imidazolidinone, 1,3-diethyl-2-imidazolidinone, 1,3-diisopropyl-2-imidazolidinone, triethylamine, pyridine, and the like. Examples of silicone solvents include hexamethyl Disiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane, and the like, and examples of terpene-based solvents include p-mentane, diphenylmentane, limonene, terpinene, bornane, norbornane, pinan, etc. There is this.
또한, 상기 비프로톤성 용제로서 인화점이 70℃를 넘는 용매를 이용하면, 소방법 상의 안전성의 관점에서 바람직하다. 예를 들면, 카보네이트계 용매나, 다가 알코올의 유도체 중 OH기를 갖지 않는 것은, 인화점이 높은 것이 많으므로 약액의 위험성을 낮출 수 있기 때문에 바람직하다. 상기의 안전성의 관점에서, 구체적으로는 인화점이 70℃를 넘는, 프로필렌카보네이트, 에틸렌글리콜디부틸에테르, 에틸렌글리콜모노부틸에테르아세테이트, 에틸렌글리콜디아세테이트, 디에틸렌글리콜에틸메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜부틸메틸에테르, 디에틸렌글리콜디부틸에테르, 디에틸렌글리콜모노메틸에테르아세테이트, 디에틸렌글리콜모노에틸에테르아세테이트, 디에틸렌글리콜모노부틸에테르아세테이트, 디에틸렌글리콜디아세테이트, 트리에틸렌글리콜디메틸에테르, 트리에틸렌글리콜디에틸에테르, 트리에틸렌글리콜디부틸에테르, 트리에틸렌글리콜부틸메틸에테르, 트리에틸렌글리콜모노메틸에테르아세테이트, 트리에틸렌글리콜모노에틸에테르아세테이트, 트리에틸렌글리콜모노부틸에테르아세테이트, 트리에틸렌글리콜디아세테이트, 테트라에틸렌글리콜디메틸에테르, 테트라에틸렌글리콜디에틸에테르, 테트라에틸렌글리콜디부틸에테르, 테트라에틸렌글리콜모노메틸에테르아세테이트, 테트라에틸렌글리콜모노에틸에테르아세테이트, 테트라에틸렌글리콜모노부틸에테르아세테이트, 테트라에틸렌글리콜디아세테이트, 프로필렌글리콜디아세테이트, 디프로필렌글리콜메틸프로필에테르, 디프로필렌글리콜모노메틸에테르아세테이트, 디프로필렌글리콜모노에틸에테르아세테이트, 디프로필렌글리콜모노부틸에테르아세테이트, 디프로필렌글리콜디아세테이트, 트리프로필렌글리콜디메틸에테르, 트리프로필렌글리콜디에틸에테르, 트리프로필렌글리콜디부틸에테르, 트리프로필렌글리콜모노메틸에테르아세테이트, 트리프로필렌글리콜모노에틸에테르아세테이트, 트리프로필렌글리콜모노부틸에테르아세테이트, 트리프로필렌글리콜디아세테이트, 테트라프로필렌글리콜디메틸에테르, 테트라프로필렌글리콜모노메틸에테르아세테이트, 테트라프로필렌글리콜디아세테이트, 부틸렌글리콜디아세테이트, 글리세린트리아세테이트 등을 상기 용제로서 이용하는 것이 보다 바람직하다.In addition, when a solvent having a flash point exceeding 70°C is used as the aprotic solvent, it is preferable from the viewpoint of safety in the fire fighting method. For example, among carbonate-based solvents and derivatives of polyhydric alcohols, those having no OH group are preferable because many of them have a high flash point, so that the risk of a chemical solution can be reduced. From the above safety point of view, specifically, propylene carbonate, ethylene glycol dibutyl ether, ethylene glycol monobutyl ether acetate, ethylene glycol diacetate, diethylene glycol ethyl methyl ether, diethylene glycol diethyl Ether, diethylene glycol butyl methyl ether, diethylene glycol dibutyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, diethylene glycol diacetate, triethylene glycol dimethyl Ether, triethylene glycol diethyl ether, triethylene glycol dibutyl ether, triethylene glycol butyl methyl ether, triethylene glycol monomethyl ether acetate, triethylene glycol monoethyl ether acetate, triethylene glycol monobutyl ether acetate, triethylene glycol Diacetate, tetraethylene glycol dimethyl ether, tetraethylene glycol diethyl ether, tetraethylene glycol dibutyl ether, tetraethylene glycol monomethyl ether acetate, tetraethylene glycol monoethyl ether acetate, tetraethylene glycol monobutyl ether acetate, tetraethylene glycol Diacetate, Propylene glycol diacetate, Dipropylene glycol methylpropyl ether, Dipropylene glycol monomethyl ether acetate, Dipropylene glycol monoethyl ether acetate, Dipropylene glycol monobutyl ether acetate, Dipropylene glycol diacetate, Tripropylene glycol dimethyl ether , Tripropylene glycol diethyl ether, tripropylene glycol dibutyl ether, tripropylene glycol monomethyl ether acetate, tripropylene glycol monoethyl ether acetate, tripropylene glycol monobutyl ether acetate, tripropylene glycol diacetate, tetrapropylene glycol dimethyl ether , Tetrapropylene glycol monomethyl ether acetate, tetrapropylene glycol diacetate, butylene glycol diacetate, glycerin triacetate, and the like are more preferably used as the solvent.
본 발명의 발수성 보호막 형성용 약액은, 당해 약액의 안정성을 더 높이기 위해, 중합 금지제나 연쇄 이동제, 산화 방지제 등의 첨가제를 더 포함하고 있어도 된다.The chemical liquid for forming a water-repellent protective film of the present invention may further contain additives such as a polymerization inhibitor, a chain transfer agent, and an antioxidant in order to further increase the stability of the chemical liquid.
또한, 상기 약액 중의 액상(液相)에서의 광산란식 액 중 입자 검출기에 의한 파티클 측정에 있어서의 0.2㎛보다 큰 입자의 수가 당해 약액 1mL당 100개 이하인 것이 바람직하다. 상기 0.2㎛보다 큰 입자의 수가 당해 약액 1mL당 100개 초과이면, 파티클에 의해, 피처리체인 웨이퍼의 패턴 데미지를 유발할 우려가 있어 디바이스의 수율 저하 및 신뢰성의 저하를 일으키는 원인이 되기 때문에 바람직하지 않다. 또한, 0.2㎛보다 큰 입자의 수가 당해 약액 1mL당 100개 이하이면, 상기 보호막을 형성한 후의, 용매나 물에 의한 당해 웨이퍼 표면(보호막 표면)의 세정(린스)을 생략 또는 저감할 수 있기 때문에 바람직하다. 또한, 상기 0.2㎛보다 큰 입자의 수는 적을수록 바람직하지만 상기의 함유량 범위 내이면 당해 약액 1mL당 1개 이상 있어도 된다.Further, it is preferable that the number of particles larger than 0.2 µm in the measurement of particles in the light scattering liquid in the liquid phase in the chemical liquid by a particle detector is 100 or less per 1 mL of the chemical liquid. If the number of particles larger than 0.2 μm is more than 100 per 1 mL of the chemical solution, the particles may cause pattern damage to the wafer to be processed, resulting in a decrease in device yield and reliability, which is not preferable. . In addition, if the number of particles larger than 0.2 μm is 100 or less per 1 mL of the chemical solution, cleaning (rinsing) of the wafer surface (the surface of the protective film) with a solvent or water after forming the protective film can be omitted or reduced. desirable. Further, the smaller the number of particles larger than 0.2 µm is, the more preferable, but within the above content range, there may be one or more per 1 mL of the chemical solution.
또한, 본 발명에 있어서의 약액 중의 액상에서의 파티클 측정은, 레이저를 광원으로 한 광산란식 액 중 입자 측정 방식에 있어서의 시판의 측정 장치를 이용하여 측정하는 것이고, 파티클의 입경이란, PSL(폴리스티렌제 라텍스) 표준 입자 기준의 광산란 상당 직경을 의미한다.In addition, particle measurement in a liquid phase in a chemical solution in the present invention is measured using a commercially available measuring device in a particle measurement method in a light scattering liquid using a laser as a light source, and the particle diameter of the particle is PSL (polystyrene Latex) means the equivalent diameter of light scattering based on standard particles.
여기서, 상기 파티클이란, 원료에 불순물로서 포함되는 티끌, 먼지, 유기 고형물, 무기 고형물 등의 입자나, 약액의 조제 중에 오염물로서 들어가게 되는 티끌, 먼지, 유기 고형물, 무기 고형물 등의 입자이며, 최종적으로 약액 중에 용해되지 않고 입자로서 존재하는 것이 해당한다.Here, the particles are particles such as dust, dust, organic solids, inorganic solids, etc. that are included as impurities in the raw material, or particles such as dust, dust, organic solids, inorganic solids, etc. that enter as contaminants during preparation of the chemical solution, and finally This corresponds to those that do not dissolve in the chemical solution and exist as particles.
또한, 상기 약액 중의 Na, Mg, K, Ca, Mn, Fe, Cu, Li, Al, Cr, Ni, Zn 및 Ag의 각 원소(금속 불순물)의 함유량이, 당해 약액 총량에 대하여 각 0.1질량ppb 이하인 것이 바람직하다. 상기 금속 불순물 함유량이, 당해 약액 총량에 대하여 0.1질량ppb 초과이면, 디바이스의 접합 리크 전류를 증대시킬 우려가 있어 디바이스의 수율의 저하 및 신뢰성의 저하를 일으키는 원인이 되기 때문에 바람직하지 않다. 또한, 상기 금속 불순물 함유량이, 당해 약액 총량에 대하여 각 0.1질량ppb 이하이면, 피처리체인 웨이퍼 표면에 상기 보호막을 형성한 후의, 용매나 물에 의한 당해 웨이퍼 표면(보호막 표면)의 세정(린스)을 생략 또는 저감할 수 있기 때문에 바람직하다. 이 때문에, 상기 금속 불순물 함유량은 적을수록 바람직하지만, 상기의 함유량 범위 내이면 당해 약액의 총량에 대하여, 각 원소에 관하여, 0.001질량ppb 이상이어도 된다.In addition, the content of each element (metal impurity) of Na, Mg, K, Ca, Mn, Fe, Cu, Li, Al, Cr, Ni, Zn, and Ag in the chemical solution is 0.1 mass ppb each with respect to the total amount of the chemical solution. It is preferable that it is the following. If the content of the metal impurities exceeds 0.1 mass ppb with respect to the total amount of the chemical, there is a concern that the junction leakage current of the device may increase, resulting in a decrease in the yield and reliability of the device, which is not preferable. In addition, if the metal impurity content is 0.1 mass ppb or less with respect to the total amount of the chemical solution, cleaning (rinsing) the wafer surface (protective film surface) with a solvent or water after the protective film is formed on the wafer surface to be processed. It is preferable because it can be omitted or reduced. For this reason, the smaller the metal impurity content is, the more preferable it is, but within the above content range, it may be 0.001 mass ppb or more for each element with respect to the total amount of the chemical solution.
2. 웨이퍼의 표면 처리 방법2. Wafer Surface Treatment Method
본 발명의 표면 처리 방법은, 웨이퍼 표면에 세정액 및 린스액으로 이루어지는 군으로부터 선택되는 적어도 1종의 액체가 보지된 상태에서, 당해 액체를, 발수성 보호막 형성용 약액으로 치환하고, 당해 약액을 웨이퍼 표면에 보지하는 발수성 보호막 형성 공정, 및, 건조 공정을 가지고,In the surface treatment method of the present invention, while at least one liquid selected from the group consisting of a cleaning liquid and a rinse liquid is held on the wafer surface, the liquid is replaced with a chemical liquid for forming a water repellent protective film, and the chemical liquid is replaced on the wafer surface. It has a water-repellent protective film formation process to hold|maintain to, and a drying process,
상기 발수성 보호막 형성용 약액은,The chemical solution for forming a water-repellent protective film,
(I)상기 일반식 [1]로 나타내어지는 아미노실란 화합물과(I) an aminosilane compound represented by the general formula [1] and
(II)상기 일반식 [2]로 나타내어지는 규소 화합물과(II) a silicon compound represented by the general formula [2] and
(III)비프로톤성 용제를 가지고,(III) has an aprotic solvent,
(I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인 것을 특징으로 한다.It is characterized in that the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass.
(표면 처리 양태 1)(Surface treatment aspect 1)
도 1에 나타내는 바와 같이, 적어도, (I), (II), 및 (III)을 혼합하여 용액(발수성 보호막 형성용 약액)으로 하고, 당해 약액을 웨이퍼 표면에 액체 상태 또는 기체 상태로 공급하여, 당해 웨이퍼 표면에 액체 상태의 발수성 보호막 형성용 약액을 보지시킨다.As shown in Fig. 1, at least, (I), (II), and (III) are mixed to form a solution (a chemical for forming a water-repellent protective film), and the chemical is supplied to the wafer surface in a liquid state or a gas state, A liquid chemical for forming a water-repellent protective film is held on the wafer surface.
상기 약액의 공급은, 웨이퍼 표면에 세정액이나 린스액 등의 액체가 보지된 상태에서 행해지고, 당해 액체를 약액으로 치환하는 것이다. 치환 시에, 웨이퍼 표면에 보지된 상태의 세정액이나 린스액 등의 액체로서는 특별히 한정은 없지만, 2-프로판올(iPA) 등이 일반적이다.The supply of the chemical liquid is performed while a liquid such as a cleaning liquid or a rinse liquid is held on the wafer surface, and the liquid is replaced with a chemical liquid. At the time of substitution, there is no particular limitation as a liquid such as a cleaning liquid or a rinse liquid held on the wafer surface, but 2-propanol (iPA) or the like is generally used.
상기 치환에 의해, 약액을 웨이퍼 표면에 보지함으로써 웨이퍼 표면에 발수성 보호막을 형성한다. 필요에 따라 웨이퍼 표면의 상기 약액을 린스액으로 치환하여 린스 처리를 더 실시해도 된다.By the above substitution, the chemical solution is held on the wafer surface to form a water-repellent protective film on the wafer surface. If necessary, the chemical liquid on the wafer surface may be replaced with a rinse liquid to further perform a rinse treatment.
그리고, 건조에 의해 웨이퍼 표면으로부터 액체를 제거한다. 웨이퍼 표면에 발수성 보호막이 형성되어 있기 때문에, 우수한 발수성에 의해 건조 시의 패턴 붕괴를 저감할 수 있다.Then, the liquid is removed from the wafer surface by drying. Since the water-repellent protective film is formed on the wafer surface, it is possible to reduce pattern collapse during drying due to excellent water repellency.
또한, 건조에 의해 제거되는 액체로서는, 상기의 발수성 보호막 형성용 약액, 린스액, 또는 그들의 혼합액을 들 수 있다. 또한, 제거되는 액체가 린스액일 때는, 상기 약액이 린스액으로 치환되어 린스 처리가 더 실시된 경우이다. 또한, 제거되는 액체가 상기 약액과 린스액의 혼합액일 때는, 상기 약액을 린스액으로 치환하는 도중의 상태의 「혼합액」인 경우여도 되고, 미리 린스액에 약액 원료를 용해한 「혼합액」을 이용하여 상기 약액을 치환한 경우여도 된다. 후술의 표면 처리 양태 2∼6에 있어서도 마찬가지이다.In addition, examples of the liquid removed by drying include the chemical liquid for forming a water-repellent protective film, a rinse liquid, or a mixture thereof. In addition, when the liquid to be removed is a rinse liquid, the chemical liquid is replaced with a rinse liquid and a rinse treatment is further performed. In addition, when the liquid to be removed is a mixture of the chemical liquid and the rinse liquid, the liquid may be a ``mixed liquid'' in the middle of substituting the chemical liquid with the rinse liquid, and a ``mixed liquid'' in which the chemical liquid raw material is previously dissolved in the rinse liquid is used. It may be a case in which the chemical solution is substituted. The same applies to the surface treatment aspects 2 to 6 described later.
또한, 표면 처리 양태 1에 있어서, 약액의 원료인 (I)∼(III)을 혼합하는 순서는 특별히 한정되지 않지만, (III)비프로톤성 용제에 (I)이나 (II)를 혼합하는 것이 바람직하다.In addition, in the
또한 본 발명의 표면 처리 방법은, 상기 발수성 보호막 형성 공정 전에,In addition, the surface treatment method of the present invention, before the water-repellent protective film forming step,
(II)상기 일반식 [2]로 나타내어지는 규소 화합물과(II) a silicon compound represented by the general formula [2] and
(IV)상기 일반식 [4]로 나타내어지는 실라잔 화합물과(IV) a silazane compound represented by the general formula [4] and
(III)비프로톤성 용제를 가지는 원료 약액에,(III) In the raw material chemical solution having an aprotic solvent,
(II), (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 프로톤성 화합물을 접촉시킴으로써,By contacting the protic compound in a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (II), (III) and (IV),
상기 (I)∼(III)을 가지고, 또는 상기 (I)∼(IV)를 가지며, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액을 조제하는 약액 조제 공정을 더 가지고 있어도 된다.Formation of a water-repellent protective film having the above (I) to (III) or the above (I) to (IV), wherein the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5 mass% It may further have a chemical solution preparation step of preparing a solution.
원료 약액에 프로톤성 화합물을 접촉시키는 방법은, 특별히 한정되는 것이 아니고, 공지의 방법을 채용할 수 있다. 또한, 상기 접촉에 의해 발수성 보호막 형성용 약액을 조제할 때에는, 상세는 불분명하지만, 하기의 반응식처럼, 상기 일반식 [2]로 나타내어지는 규소 화합물과 프로톤성 화합물(A-H)이 반응하여 생성한 반응 생성물(X-H;산성 화합물)이, 상기 일반식 [4]로 나타내어지는 실라잔 화합물과 반응함으로써, 상기 일반식 [1]로 나타내어지는 아미노실란 화합물이 생성되고, 그 결과, 상기 (I)∼(III)을 가지고, 또는 상기 (I)∼(IV)를 가지며, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액이 얻어진다고 생각할 수 있다.The method of bringing the protonic compound into contact with the raw material chemical is not particularly limited, and a known method can be employed. In addition, when preparing the chemical solution for forming a water-repellent protective film by the above contact, the details are unclear, but the reaction produced by the reaction of the silicon compound represented by the general formula [2] and the protic compound (AH) as shown in the following reaction formula When the product (XH; acidic compound) reacts with the silazane compound represented by the general formula [4], an aminosilane compound represented by the general formula [1] is produced. As a result, the (I) to ( III), or having the above (I) to (IV), and the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass. I can.
[화학식 18][Formula 18]
이 표면 처리 방법으로서, 후술의 표면 처리 양태 2∼3을 채용할 수 있다.As this surface treatment method, surface treatment modes 2 to 3 described later can be employed.
(표면 처리 양태 2)(Surface treatment mode 2)
도 2에 나타내는 바와 같이, 적어도, (II), (III), 및 (IV)를 혼합하여 용액(원료 약액)으로 하고, 당해 원료 약액에 프로톤성 화합물을, (II), (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 접촉시켜, 발수성 보호막 형성용 약액을 조제한다. 상기 접촉에 이용하는 프로톤성 화합물은, 비프로톤성 용제로 희석된 것(상용(相溶)하지 않을 경우는 분산시킨 상태)이어도 된다. 당해 희석에 이용하는 비프로톤성 용제로서는, 본 발명의 (III)으로서 서술한 것을 들 수 있다.As shown in Fig. 2, at least, (II), (III), and (IV) are mixed to form a solution (raw chemical liquid), and a protic compound is added to the raw chemical liquid, (II), (III), ( A chemical solution for forming a water-repellent protective film is prepared by contacting at a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of IV). The protic compound used for the contact may be diluted with an aprotic solvent (in a state in which it is dispersed when not compatible). Examples of the aprotic solvent used for the dilution include those described as (III) of the present invention.
약액 조제 공정에서 이용되는 원료 약액과 프로톤성 화합물은, 액체 상태여도 되고, 기체 상태여도 된다. 예를 들면, 챔버 내의 용기 중이나 탱크 중이나 합류점 이후의 배관 중에서 액체 상태의 양자를 혼합하는 것이어도 되고, 챔버 내나 기화실 중이나 기화 후의 합류점 이후의 배관 중에서 기체 상태의 양자를 혼합하는 것이어도 되며, 챔버 내의 용기 중의 액체 상태의 원료 약액을 기체 상태의 프로톤성 화합물에 노출하여 접촉시키는 것이어도 된다. 또한, 당해 원료 약액 중에 (I)이 포함되어 있어도 된다.The raw material chemical liquid and the protonic compound used in the chemical liquid preparation step may be in a liquid state or a gaseous state. For example, a liquid state may be mixed in a container in a chamber, a tank, or a pipe after a confluence point, or a gaseous state may be mixed in a chamber, a vaporization chamber, or a pipe after a confluence point after vaporization. The liquid raw material chemical liquid in the inner container may be exposed to a gaseous protic compound to be brought into contact. Moreover, (I) may be contained in the said raw material chemical liquid.
상기 프로톤성 화합물은, -OH기, 및/또는, -NH2기를 가지는 화합물인 것이 발수성 부여 효과의 향상의 관점에서 바람직하고, -OH기를 가지는 화합물, 및/또는, NH3인 것이 특히 바람직하다. 또한, 물, 및/또는, 탄소수가 6개 이하의 알코올이 바람직하고, 특히, 물, 및/또는, 2-프로판올이면 보다 바람직하다.The protic compound is preferably a compound having an -OH group and/or a -NH 2 group from the viewpoint of improving the effect of imparting water repellency, and a compound having an -OH group, and/or NH 3 is particularly preferable. . Further, water and/or an alcohol having 6 or less carbon atoms is preferable, and particularly preferably water and/or 2-propanol.
상기 탄소수가 6개 이하인 알코올의 예로서는, 메탄올, 에탄올, 직쇄 또는 분기쇄의, 프로판올, 부탄올, 펜탄올, 헥산올뿐만 아니라, 다가 알코올이나 OH기를 가지는 다가 알코올의 유도체도 들 수 있다. 상기 다가 알코올의 예로서, 에틸렌글리콜, 디에틸렌글리콜, 디프로필렌글리콜, 트리에틸렌글리콜, 1,2-프로판디올, 1,3-프로판디올, 1,2-부탄디올, 1,3-부탄디올, 1,4-부탄디올, 글리세린 등이 있고, 상기 -OH기를 가지는 다가 알코올의 유도체의 예로서는, 에틸렌글리콜모노메틸에테르, 에틸렌글리콜모노에틸에테르, 에틸렌글리콜모노프로필에테르, 에틸렌글리콜모노부틸에테르, 프로필렌글리콜모노메틸에테르, 프로필렌글리콜모노에틸에테르, 프로필렌글리콜모노프로필에테르, 부틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르 등을 들 수 있다.Examples of the alcohol having 6 or less carbon atoms include methanol, ethanol, linear or branched chain, propanol, butanol, pentanol, and hexanol, as well as a polyhydric alcohol or a derivative of a polyhydric alcohol having an OH group. Examples of the polyhydric alcohol include ethylene glycol, diethylene glycol, dipropylene glycol, triethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 1, Examples of derivatives of polyhydric alcohols including 4-butanediol and glycerin, and having -OH groups include ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, and propylene glycol monomethyl ether , Propylene glycol monoethyl ether, propylene glycol monopropyl ether, butylene glycol monomethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, and the like.
또한, (II), (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 프로톤성 화합물을 접촉시키면, 상기 발수성 보호막 형성용 약액에 있어서, (I)∼(III)의 총량에 대한 (I)의 함유량을 0.02∼0.5질량%로 제어하기 쉽기 때문에 바람직하다. 상기의 프로톤성 화합물을 접촉시키는 비율은, 0.003∼0.2몰의 비율이 보다 바람직하고, 0.003∼0.1몰의 비율이 특히 바람직하다.In addition, when the protic compound is contacted in a proportion of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (II), (III) and (IV), the total amount of (I) to (III) in the chemical solution for forming a water repellent protective film It is preferable because the content of (I) is easily controlled to 0.02 to 0.5% by mass. The ratio of contacting the protic compound is more preferably 0.003 to 0.2 mol, particularly preferably 0.003 to 0.1 mol.
그리고, 얻어진 약액을 액체 상태 또는 기체 상태로 웨이퍼 표면에 공급하여, 당해 웨이퍼 표면에 액체 상태의 발수성 보호막 형성용 약액을 보지시킨다. 또한, 상술과 같이 반응에 의해 (I)아미노실란이 생성되기 때문에, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%의 범위로 된 상태의 약액을 웨이퍼 표면에 공급한다. 한편, 부반응 등의 약액 조성에의 영향을 무시하기 쉬우므로, 상기의 접촉으로부터 1일 이내의 약액을 웨이퍼 표면에 공급하는 것이 바람직하고, 상기의 접촉으로부터 5시간 이내의 약액을 웨이퍼 표면에 공급하는 것이 보다 바람직하며, 상기의 접촉으로부터 1시간 이내의 약액을 웨이퍼 표면에 공급하는 것이 특히 바람직하다.Then, the obtained chemical liquid is supplied to the wafer surface in a liquid state or a gaseous state, so that the liquid chemical for forming a water-repellent protective film is held on the wafer surface. In addition, since (I) aminosilane is produced by the reaction as described above, a chemical solution in a state in which the content of (I) with respect to the total amount of (I) to (III) is in the range of 0.02 to 0.5% by mass is applied to the wafer surface. To supply. On the other hand, since it is easy to ignore the influence on the composition of the chemical liquid such as side reactions, it is preferable to supply the chemical liquid within 1 day from the contact to the wafer surface, and supply the chemical liquid within 5 hours from the contact to the wafer surface. It is more preferable, and it is particularly preferable to supply the chemical solution within 1 hour from the contact to the wafer surface.
상기 약액의 공급은, 웨이퍼 표면에 세정액이나 린스액 등의 액체가 보지된 상태에서 행해지고, 당해 액체를 약액으로 치환하는 것이다. 또한, 상기의 세정액이나 린스액 등의 액체가 프로톤성 화합물인 경우는, 상기의 치환의 과정에서도 추가로 프로톤성 화합물이 접촉하게 되어, 상기 (II)와 프로톤성 화합물이 반응하고, 반응 생성물(산성 화합물)이 추가로 상기 (IV)와 반응함으로써 상기 (I)이 새롭게 생성될 가능성이 있다. 그러나, 상기의 치환에 있어서, 상기의 세정액이나 린스액 등의 액체는 발수성 보호막 형성용 약액으로 빠르게 치환되기 때문에, 상기 (II)와 프로톤성 화합물이 반응하는 영향은 거의 없다. 그 때문에, 상기의 치환 시에, 상술과 같은 (I)이 새롭게 생성되는 영향은 무시할 수 있는 정도이다. 치환 시에, 웨이퍼 표면에 보지된 상태의 세정액이나 린스액 등의 액체로서는 특별히 한정은 없지만, 2-프로판올(iPA) 등이 일반적이다.The supply of the chemical liquid is performed while a liquid such as a cleaning liquid or a rinse liquid is held on the wafer surface, and the liquid is replaced with a chemical liquid. In addition, when the liquid such as the washing liquid or the rinse liquid is a protic compound, the protic compound is further brought into contact in the process of the substitution as described above, and the (II) and the protic compound react, and the reaction product ( There is a possibility that the (I) is newly formed by further reacting the acidic compound) with the (IV). However, in the above substitution, since the liquid such as the washing liquid or the rinse liquid is rapidly substituted with the chemical liquid for forming a water-repellent protective film, the reaction between the (II) and the protic compound has little effect. Therefore, at the time of the above substitution, the effect of newly generated (I) as described above is negligible. At the time of substitution, there is no particular limitation as a liquid such as a cleaning liquid or a rinse liquid held on the wafer surface, but 2-propanol (iPA) or the like is generally used.
상기 치환에 의해, 약액을 웨이퍼 표면에 보지함으로써 웨이퍼 표면에 발수성 보호막을 형성한다. 필요에 따라 웨이퍼 표면의 상기 약액을 린스액으로 치환하여 린스 처리를 더 실시해도 된다.By the above substitution, the chemical solution is held on the wafer surface to form a water-repellent protective film on the wafer surface. If necessary, the chemical liquid on the wafer surface may be replaced with a rinse liquid to further perform a rinse treatment.
그리고, 건조에 의해 웨이퍼 표면으로부터 액체를 제거한다. 웨이퍼 표면에 발수성 보호막이 형성되어 있기 때문에, 우수한 발수성에 의해 건조 시의 패턴 붕괴를 저감할 수 있다. 또한, 건조에 의해 제거되는 액체로서는, 상기의 발수성 보호막 형성용 약액, 린스액, 또는 그들의 혼합액을 들 수 있다.Then, the liquid is removed from the wafer surface by drying. Since the water-repellent protective film is formed on the wafer surface, it is possible to reduce pattern collapse during drying due to excellent water repellency. In addition, examples of the liquid removed by drying include the chemical liquid for forming a water-repellent protective film, a rinse liquid, or a mixture thereof.
(표면 처리 양태 3)(Surface treatment mode 3)
도 3에 나타내는 바와 같이, 적어도, (II), (III), 및 (IV)를 혼합하여 용액(원료 약액)으로 하고, 당해 원료 약액을 액체 상태 또는 기체 상태로 웨이퍼 표면에 공급하여, 당해 웨이퍼 표면에 액체 상태의 원료 약액을 보지시킨다.As shown in Fig. 3, at least, (II), (III), and (IV) are mixed to form a solution (raw chemical liquid), and the raw chemical liquid is supplied to the wafer surface in a liquid state or a gaseous state, and the wafer The liquid raw material chemical solution is held on the surface.
상기 원료 약액의 공급은, 웨이퍼 표면에 세정액이나 린스액 등의 액체가 보지된 상태에서 행해지고, 당해 액체를 원료 약액으로 치환하는 것이다. 또한, 상기의 세정액이나 린스액 등의 액체가 물이나 알코올 등의 프로톤성 화합물인 경우는, 상기의 치환의 과정에서 상기 (II)와 프로톤성 화합물이 반응하고, 반응 생성물(산성 화합물)이 추가로 상기 (IV)와 반응함으로써 상기 (I)이 생성될 가능성이 있다. 그러나, 상기의 치환에 있어서, 상기의 세정액이나 린스액 등의 액체는 원료 약액으로 빠르게 치환되기 때문에, 상기 (II)와 프로톤성 화합물이 반응하는 영향은 거의 없다. 그 때문에, 상기의 치환 시에, 상술과 같은 (I)이 새롭게 생성되는 영향은 무시할 수 있는 정도이다. 치환 시에, 웨이퍼 표면에 보지된 상태의 세정액이나 린스액 등의 액체로서는 특별히 한정은 없지만, 2-프로판올(iPA) 등이 일반적이다.The supply of the chemical raw material is performed while a liquid such as a cleaning liquid or a rinse liquid is held on the wafer surface, and the liquid is replaced with the chemical raw material. In addition, when the liquid such as the washing liquid or the rinse liquid is a protic compound such as water or alcohol, the (II) and the protic compound react in the process of the above substitution, and the reaction product (acid compound) is added. There is a possibility that (I) is produced by reacting with (IV) above. However, in the above substitution, since the liquid such as the washing solution or the rinse solution is rapidly substituted with the raw material chemical solution, there is little effect of the reaction of the (II) and the protic compound. Therefore, at the time of the above substitution, the effect of newly generated (I) as described above is negligible. At the time of substitution, there is no particular limitation as a liquid such as a cleaning liquid or a rinse liquid held on the wafer surface, but 2-propanol (iPA) or the like is generally used.
다음에, 당해 원료 약액에 프로톤성 화합물을, (II), (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 접촉시켜, 웨이퍼 표면에 있어서 발수성 보호막 형성용 약액을 조제한다. 또한, 상술과 같이 반응에 의해 (I)아미노실란이 생성되기 때문에, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%의 범위가 되도록 웨이퍼 표면에 약액을 보지한다.Next, a protic compound is brought into contact with the raw material chemical solution at a ratio of 0.001 to 0.3 moles per 1 kg of the total amount of (II), (III), and (IV) to prepare a chemical solution for forming a water-repellent protective film on the wafer surface. . In addition, since (I) aminosilane is produced by the reaction as described above, the chemical solution is held on the wafer surface so that the content of (I) with respect to the total amount of (I) to (III) is in the range of 0.02 to 0.5% by mass. do.
상기 접촉에 이용하는 프로톤성 화합물은, 비프로톤성 용제로 희석된 것(상용되지 않을 경우는 분산시킨 상태)이어도 된다. 당해 희석에 이용하는 비프로톤성 용제로서는, 본 발명의 (III)으로서 서술한 것을 들 수 있다. 약액 조제 공정에서 이용되는 프로톤성 화합물은, 액체 상태여도 되고, 기체 상태여도 된다. 예를 들면, 챔버 내에서 웨이퍼 표면에 보지된 액체 상태의 원료 약액에 액체 상태의 프로톤성 화합물을 첨가하는 것이어도 되고, 챔버 내에서 웨이퍼 표면에 보지된 액체 상태의 원료 약액을 기체 상태의 프로톤성 화합물에 노출시켜 접촉시키는 것이어도 된다. 후자의 경우, 예를 들면 챔버 내를 소정의 농도의 프로톤성 화합물의 증기 분위기로 해 두어 원료 약액의 공급을 행하는 것이어도 된다.The protic compound used for the above contact may be diluted with an aprotic solvent (in a disperse state when not compatible). Examples of the aprotic solvent used for the dilution include those described as (III) of the present invention. The protic compound used in the chemical solution preparation step may be in a liquid state or a gaseous state. For example, a liquid protonic compound may be added to the liquid raw material chemical liquid held on the wafer surface in the chamber, or the liquid raw material chemical liquid held on the wafer surface in the chamber may be gaseous. It may be exposed to the compound and brought into contact. In the latter case, for example, a raw material chemical solution may be supplied by placing the inside of the chamber in a vapor atmosphere of a protonic compound having a predetermined concentration.
또한, 원료 약액과 기체 상태의 프로톤성 화합물을 접촉시킬 경우, 웨이퍼 표면에 용액 상태의 원료 약액을 펼쳐, 기체 상태의 프로톤성 화합물과 접촉시키면, 접촉 면적을 크게 할 수 있어, 단시간에 프로톤성 화합물을 도입할 수 있으므로 바람직하다. 이 때, 공간 중의 기체 상태의 프로톤성 화합물의 농도는, 0.05∼5체적%가 바람직하고, 0.1∼2체적%가 더 바람직하다. 또한, 접촉 시간은, 0.1∼600초가 바람직하고, 2∼180초가 더 바람직하다. 웨이퍼 표면에 원료 약액을 펼치는 방법은 적절히 공지의 방법을 사용할 수 있고, 특히 스핀 코트법이 바람직하다.In addition, when the raw material chemical liquid and the gaseous protic compound are brought into contact, the contact area can be increased by spreading the liquid raw material chemical liquid on the wafer surface and in contact with the gaseous protic compound, and thus the protic compound in a short time. It is preferable because it can introduce. At this time, the concentration of the gaseous protic compound in the space is preferably 0.05 to 5% by volume, and more preferably 0.1 to 2% by volume. In addition, 0.1 to 600 seconds are preferable and, as for the contact time, 2 to 180 seconds are more preferable. As a method of spreading the raw material chemical solution on the wafer surface, a known method can be appropriately used, and a spin coating method is particularly preferable.
상술과 같이 조제된 약액을 웨이퍼 표면에 보지함으로써 웨이퍼 표면에 발수성 보호막을 형성한다. 필요에 따라 웨이퍼 표면의 상기 약액을 린스액으로 치환하여 린스 처리를 더 실시해도 된다.A water-repellent protective film is formed on the wafer surface by holding the chemical solution prepared as described above on the wafer surface. If necessary, the chemical liquid on the wafer surface may be replaced with a rinse liquid to further perform a rinse treatment.
그리고, 건조에 의해 웨이퍼 표면으로부터 액체를 제거한다. 웨이퍼 표면에 발수성 보호막이 형성되어 있기 때문에, 우수한 발수성에 의해 건조 시의 패턴 붕괴를 저감할 수 있다. 또한, 건조에 의해 제거되는 액체로서는, 상기의 발수성 보호막 형성용 약액, 린스액, 또는 그들의 혼합액을 들 수 있다.Then, the liquid is removed from the wafer surface by drying. Since the water-repellent protective film is formed on the wafer surface, it is possible to reduce pattern collapse during drying due to excellent water repellency. In addition, examples of the liquid removed by drying include the chemical liquid for forming a water-repellent protective film, a rinse liquid, or a mixture thereof.
또한 본 발명의 표면 처리 방법은, 상기 발수성 보호막 형성 공정 전에,In addition, the surface treatment method of the present invention, before the water-repellent protective film forming step,
(IV)상기 일반식 [4]로 나타내어지는 실라잔 화합물과(IV) a silazane compound represented by the general formula [4] and
(III)비프로톤성 용제를 가지는 원료 약액에,(III) In the raw material chemical solution having an aprotic solvent,
(III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로, 상기 일반식 [6]으로 나타내어지는 산성 화합물을 접촉시킴으로써,By contacting the acidic compound represented by the general formula [6] in a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (III) and (IV),
상기 (I)∼(III)을 가지고, 또는 상기 (I)∼(IV)를 가지며,Having the above (I) to (III), or having the above (I) to (IV),
(I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액을 조제하는 약액 조제 공정을 가지고 있어도 된다.You may have a chemical liquid preparation step of preparing a chemical liquid for forming a water-repellent protective film in which the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass.
원료 약액에 산성 화합물을 접촉시키는 방법은, 특별히 한정되는 것이 아니고, 공지의 방법을 채용할 수 있다. 또한, 상기 접촉에 의해 발수성 보호막 형성용 약액을 조제할 때에는, 상세는 불분명하지만, 하기의 반응식처럼, 상기 일반식 [4]로 나타내어지는 실라잔 화합물과 상기 일반식 [6]으로 나타내어지는 산성 화합물이 반응함으로써, 상기 일반식 [1]로 나타내어지는 아미노실란 화합물과 상기 일반식 [2]로 나타내어지는 규소 화합물이 생성되고, 그 결과, 상기 (I)∼(III)을 가지고, 또는 상기 (I)∼(IV)를 가지며, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액이 얻어진다고 생각할 수 있다.The method of bringing the acidic compound into contact with the raw material chemical is not particularly limited, and a known method can be employed. In addition, when preparing the chemical liquid for forming a water-repellent protective film by contacting, the details are unclear, but the silazane compound represented by the general formula [4] and the acidic compound represented by the general formula [6], as in the following reaction formula By this reaction, an aminosilane compound represented by the general formula [1] and a silicon compound represented by the general formula [2] are produced, and as a result, having the above (I) to (III), or the above (I ) To (IV), and the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass, it is considered that a chemical for forming a water-repellent protective film can be obtained.
[화학식 19][Formula 19]
또한, (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 산성 화합물을 접촉시키면, 상기 발수성 보호막 형성용 약액에 있어서, (I)∼(III)의 총량에 대한 (I)의 함유량을 0.02∼0.5질량%로 제어하기 쉽기 때문에 바람직하다. 상기의 산성 화합물을 접촉시키는 비율은, 0.003∼0.2몰의 비율이 보다 바람직하고, 0.003∼0.1몰의 비율이 특히 바람직하다.In addition, when the acidic compound is contacted in a proportion of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (III) and (IV), (I) relative to the total amount of (I) to (III) in the chemical solution for forming a water-repellent protective film It is preferable because it is easy to control the content of 0.02 to 0.5% by mass. The ratio of contacting the acidic compound is more preferably 0.003 to 0.2 mole, particularly preferably 0.003 to 0.1 mole.
이 표면 처리 방법으로서, 후술의 표면 처리 양태 4∼5를 채용할 수 있다.As this surface treatment method, surface treatment modes 4 to 5 described later can be employed.
(표면 처리 양태 4)(Surface treatment mode 4)
도 4에 나타내는 바와 같이, 적어도, (III) 및 (IV)를 혼합하여 용액(원료 약액)으로 하고, 당해 원료 약액에 상기 일반식 [6]으로 나타내어지는 산성 화합물을 (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 접촉시켜, 발수성 보호막 형성용 약액을 조제한다. 상기 접촉에 이용하는 산성 화합물은, 비프로톤성 용제로 희석된 것(상용되지 않을 경우는 분산시킨 상태)이어도 된다. 당해 희석에 이용하는 비프로톤성 용제로서는, 본 발명의 (III)으로서 서술한 것을 들 수 있다.As shown in Fig. 4, at least, (III) and (IV) are mixed to form a solution (raw chemical liquid), and the acidic compound represented by the general formula [6] is added to the raw chemical liquid (III), (IV). A chemical solution for forming a water-repellent protective film is prepared by contacting at a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of. The acidic compound used for the contact may be diluted with an aprotic solvent (if not in common use, in a dispersed state). Examples of the aprotic solvent used for the dilution include those described as (III) of the present invention.
약액 조제 공정에서 이용되는 원료 약액과 산성 화합물은, 액체 상태여도 되고, 기체 상태여도 된다. 예를 들면, 챔버 내의 용기 중이나 탱크 중이나 합류점 이후의 배관 중에서 액체 상태의 양자를 혼합하는 것이어도 되고, 챔버 내나 기화실 중이나 기화 후의 합류점 이후의 배관 중에서 기체 상태의 양자를 혼합하는 것이어도 되며, 챔버 내의 용기 중의 액체 상태의 원료 약액을 기체 상태의 산성 화합물에 노출시켜 접촉시키는 것이어도 된다.The raw material chemical liquid and the acidic compound used in the chemical liquid preparation step may be in a liquid state or a gaseous state. For example, a liquid state may be mixed in a container in a chamber, a tank, or a pipe after a confluence point, or a gaseous state may be mixed in a chamber, a vaporization chamber, or a pipe after a confluence point after vaporization. The liquid raw material chemical liquid in the inner container may be exposed to a gaseous acidic compound to be brought into contact.
그리고, 얻어진 약액을 액체 상태 또는 기체 상태로 웨이퍼 표면에 공급하여, 당해 웨이퍼 표면에 액체 상태의 발수성 보호막 형성용 약액을 보지시킨다. 또한, 상술과 같이 반응에 의해 (I)아미노실란이 생성되기 때문에, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%의 범위로 된 상태의 약액을 웨이퍼 표면에 공급한다. 한편, 부반응 등의 약액 조성에의 영향을 무시하기 쉬우므로, 상기의 접촉으로부터 1일 이내의 약액을 웨이퍼 표면에 공급하는 것이 바람직하고, 상기의 접촉으로부터 5시간 이내의 약액을 웨이퍼 표면에 공급하는 것이 보다 바람직하며, 상기의 접촉으로부터 1시간 이내의 약액을 웨이퍼 표면에 공급하는 것이 특히 바람직하다.Then, the obtained chemical liquid is supplied to the wafer surface in a liquid state or a gaseous state, so that the liquid chemical for forming a water-repellent protective film is held on the wafer surface. In addition, since (I) aminosilane is produced by the reaction as described above, a chemical solution in a state in which the content of (I) with respect to the total amount of (I) to (III) is in the range of 0.02 to 0.5% by mass is applied to the wafer surface. To supply. On the other hand, since it is easy to ignore the influence on the composition of the chemical liquid such as side reactions, it is preferable to supply the chemical liquid within 1 day from the contact to the wafer surface, and supply the chemical liquid within 5 hours from the contact to the wafer surface. It is more preferable, and it is particularly preferable to supply the chemical solution within 1 hour from the contact to the wafer surface.
상기 약액의 공급은, 웨이퍼 표면에 세정액이나 린스액 등의 액체가 보지된 상태에서 행해지고, 당해 액체를 약액으로 치환하는 것이다. 치환 시에, 웨이퍼 표면에 보지된 상태의 세정액이나 린스액 등의 액체로서는 특별히 한정은 없지만, 2-프로판올(iPA) 등이 일반적이다.The supply of the chemical liquid is performed while a liquid such as a cleaning liquid or a rinse liquid is held on the wafer surface, and the liquid is replaced with a chemical liquid. At the time of substitution, there is no particular limitation as a liquid such as a cleaning liquid or a rinse liquid held on the wafer surface, but 2-propanol (iPA) or the like is generally used.
상기 치환에 의해, 약액을 웨이퍼 표면에 보지함으로써 웨이퍼 표면에 발수성 보호막을 형성한다. 필요에 따라 웨이퍼 표면의 상기 약액을 린스액으로 치환하여 린스 처리를 더 실시해도 된다.By the above substitution, the chemical solution is held on the wafer surface to form a water-repellent protective film on the wafer surface. If necessary, the chemical liquid on the wafer surface may be replaced with a rinse liquid to further perform a rinse treatment.
그리고, 건조에 의해 웨이퍼 표면으로부터 액체를 제거한다. 웨이퍼 표면에 발수성 보호막이 형성되어 있기 때문에, 우수한 발수성에 의해 건조 시의 패턴 붕괴를 저감할 수 있다. 또한, 건조에 의해 제거되는 액체로서는, 상기의 발수성 보호막 형성용 약액, 린스액, 또는 그들의 혼합액을 들 수 있다.Then, the liquid is removed from the wafer surface by drying. Since the water-repellent protective film is formed on the wafer surface, it is possible to reduce pattern collapse during drying due to excellent water repellency. In addition, examples of the liquid removed by drying include the chemical liquid for forming a water-repellent protective film, a rinse liquid, or a mixture thereof.
(표면 처리 양태 5)(Surface treatment mode 5)
도 5에 나타내는 바와 같이, 적어도, (III) 및 (IV)를 혼합하여 용액(원료 약액)으로 하고, 당해 원료 약액을 액체 상태 또는 기체 상태로 웨이퍼 표면에 공급하여, 당해 웨이퍼 표면에 액체 상태의 원료 약액을 보지시킨다.As shown in Fig. 5, at least, (III) and (IV) are mixed to form a solution (raw chemical liquid), and the raw chemical liquid is supplied to the wafer surface in a liquid state or a gaseous state, so that the wafer surface is in a liquid state. Hold the raw chemical liquid.
상기 원료 약액의 공급은, 웨이퍼 표면에 세정액이나 린스액 등의 액체가 보지된 상태에서 행해지고, 당해 액체를 원료 약액으로 치환하는 것이다. 치환 시에, 웨이퍼 표면에 보지된 상태의 세정액이나 린스액 등의 액체로서는 특별히 한정은 없지만, 2-프로판올(iPA) 등이 일반적이다.The supply of the chemical raw material is performed while a liquid such as a cleaning liquid or a rinse liquid is held on the wafer surface, and the liquid is replaced with the chemical raw material. At the time of substitution, there is no particular limitation as a liquid such as a cleaning liquid or a rinse liquid held on the wafer surface, but 2-propanol (iPA) or the like is generally used.
다음에, 당해 원료 약액에 산성 화합물을 (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 접촉시켜, 웨이퍼 표면에 있어서 발수성 보호막 형성용 약액을 조제한다. 또한, 상술과 같이 반응에 의해 (I)아미노실란이 생성되기 때문에, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%의 범위가 되도록 웨이퍼 표면에 약액을 보지한다.Next, an acidic compound is brought into contact with the raw material chemical at a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (III) and (IV) to prepare a chemical for forming a water-repellent protective film on the wafer surface. In addition, since (I) aminosilane is produced by the reaction as described above, the chemical solution is held on the wafer surface so that the content of (I) with respect to the total amount of (I) to (III) is in the range of 0.02 to 0.5% by mass. do.
상기 접촉에 이용하는 산성 화합물은, 비프로톤성 용제로 희석된 것(상용되지 않을 경우는 분산시킨 상태)이어도 된다. 당해 희석에 이용하는 비프로톤성 용제로서는, 본 발명의 (III)으로서 서술한 것을 들 수 있다. 약액 조제 공정에서 이용되는 산성 화합물은, 액체 상태여도 되고, 기체 상태여도 된다. 예를 들면, 챔버 내에서 웨이퍼 표면에 보지된 액체 상태의 원료 약액에 액체 상태의 산성 화합물을 첨가하는 것이어도 되고, 챔버 내에서 웨이퍼 표면에 보지된 액체 상태의 원료 약액을 기체 상태의 산성 화합물에 노출시켜 접촉시키는 것이어도 된다. 후자의 경우, 예를 들면 챔버 내를 소정의 농도의 산성 화합물의 증기 분위기로 해 두어 원료 약액의 공급을 행하는 것이어도 된다.The acidic compound used for the contact may be diluted with an aprotic solvent (if not in common use, in a dispersed state). Examples of the aprotic solvent used for the dilution include those described as (III) of the present invention. The acidic compound used in the chemical solution preparation step may be in a liquid state or a gaseous state. For example, a liquid acidic compound may be added to the liquid raw material chemical liquid held on the wafer surface in the chamber, or the liquid raw material chemical liquid held on the wafer surface in the chamber may be added to the gaseous acidic compound. It may be exposed to contact. In the latter case, for example, a raw material chemical solution may be supplied by placing the inside of the chamber in a vapor atmosphere of an acidic compound having a predetermined concentration.
또한, 원료 약액과 기체 상태의 산성 화합물을 접촉시킬 경우, 웨이퍼 표면에 용액 상태의 원료 약액을 펼쳐, 기체 상태의 산성 화합물과 접촉시키면, 접촉 면적을 크게 할 수 있어, 단시간에 산성 화합물을 도입할 수 있으므로 바람직하다. 이 때, 공간 중의 기체 상태의 산성 화합물의 농도는, 0.05∼5체적%가 바람직하고, 0.1∼2체적%가 더 바람직하다. 또한, 접촉 시간은, 0.01∼600초가 바람직하고, 0.1∼180초가 더 바람직하다. 웨이퍼 표면에 원료 약액을 펼치는 방법은 적절히 공지의 방법을 사용할 수 있고, 특히 스핀 코트법이 바람직하다.In addition, when the raw material chemical liquid and the gaseous acidic compound are brought into contact, the contact area can be increased by spreading the liquid raw material chemical liquid on the wafer surface and in contact with the gaseous acidic compound. It is desirable because it can. At this time, the concentration of the gaseous acidic compound in the space is preferably 0.05 to 5% by volume, and more preferably 0.1 to 2% by volume. Further, the contact time is preferably 0.01 to 600 seconds, more preferably 0.1 to 180 seconds. As a method of spreading the raw material chemical solution on the wafer surface, a known method can be appropriately used, and a spin coating method is particularly preferable.
상술과 같이 조제된 약액을 웨이퍼 표면에 보지함으로써 웨이퍼 표면에 발수성 보호막을 형성한다. 필요에 따라 웨이퍼 표면의 상기 약액을 린스액으로 치환하여 린스 처리를 더 실시해도 된다.A water-repellent protective film is formed on the wafer surface by holding the chemical solution prepared as described above on the wafer surface. If necessary, the chemical liquid on the wafer surface may be replaced with a rinse liquid to further perform a rinse treatment.
그리고, 건조에 의해 웨이퍼 표면으로부터 액체를 제거한다. 웨이퍼 표면에 발수성 보호막이 형성되어 있기 때문에, 우수한 발수성에 의해 건조 시의 패턴 붕괴를 저감할 수 있다. 또한, 건조에 의해 제거되는 액체로서는, 상기의 발수성 보호막 형성용 약액, 린스액, 또는 그들의 혼합액을 들 수 있다.Then, the liquid is removed from the wafer surface by drying. Since the water-repellent protective film is formed on the wafer surface, it is possible to reduce pattern collapse during drying due to excellent water repellency. In addition, examples of the liquid removed by drying include the chemical liquid for forming a water-repellent protective film, a rinse liquid, or a mixture thereof.
또한, 표면 처리 방법으로서, 후술의 표면 처리 양태 6을 채용해도 된다.Further, as the surface treatment method, a surface treatment mode 6 described later may be employed.
(표면 처리 양태 6)(Surface treatment mode 6)
예를 들면 암모니아 성분을 가지는 SC-1로의 전처리를 실시하면, 웨이퍼 표면에 암모니아 성분에 유래하는 NH2기를 포함하는 성분(프로톤성 화합물)이 분자 레벨로 잔류하기 쉬운 경향이 있다. 상기 NH2기를 포함하는 성분(프로톤성 화합물)이 분자 레벨로 소정량 잔류한 웨이퍼 표면에 대하여, 도 6에 나타내는 바와 같이, 적어도, (II), (III), 및 (IV)를 혼합하여 얻은 용액(원료 약액)을 액체 상태 또는 기체 상태로 공급하여, 상기 SC-1이나 SC-1 처리 후에 치환한 세정액 등을, 액체 상태의 원료 약액으로 치환한다. 그리고, 당해 원료 약액과 상기 분자 레벨로 소정량 잔류한 NH2기를 포함하는 성분(프로톤성 화합물)을 접촉시켜, 웨이퍼 표면에 있어서 본 발명에 기재된 발수성 보호막 형성용 약액을 조제하고, 당해 약액을 웨이퍼 표면에 보지하는, 발수성 보호막 형성 공정, 및, 건조 공정을 가진다.For example, when pretreatment with SC-1 having an ammonia component is performed, a component (protic compound) containing an NH 2 group derived from an ammonia component tends to remain on the wafer surface at a molecular level. With respect to the wafer surface in which the component (protic compound) containing the NH 2 group remained in a predetermined amount at the molecular level, as shown in FIG. 6, at least, obtained by mixing (II), (III), and (IV) A solution (chemical raw material) is supplied in a liquid state or a gaseous state, and the cleaning liquid or the like substituted after the SC-1 or SC-1 treatment is replaced with a liquid raw material chemical. Then, the raw material chemical is brought into contact with a component (protic compound) containing an NH 2 group remaining in a predetermined amount at the molecular level to prepare the chemical liquid for forming a water repellent protective film according to the present invention on the wafer surface, and the chemical liquid is applied to the wafer. It has a water-repellent protective film formation process and a drying process held on the surface.
반응의 발열을 억제하기 쉽다는 관점에서, 표면 처리 양태 3이 바람직하다.Surface treatment mode 3 is preferred from the viewpoint of being easy to suppress the exotherm of the reaction.
상기 일반식 [4]로 나타내어지는 실라잔 화합물의 구체예로서는, 예를 들면, [(CH3)3Si]2NH, [(CH3)2Si(H)]2NH, [CH3Si(H)2]2NH, [C2H5Si(CH3)2]2NH, [(C2H5)2Si(CH3)]2NH, [(C2H5)3Si]2NH, [C3H7Si(CH3)2]2NH, [(C3H7)2Si(CH3)]2NH, [(C3H7)3Si]2NH, [C4H9Si(CH3)2]2NH, [C5H11Si(CH3)2]2NH, [C6H13Si(CH3)2]2NH, [C7H15Si(CH3)2]2NH, [C8H17Si(CH3)2]2NH, [C9H19Si(CH3)2]2NH, [C10H21Si(CH3)2]2NH, [C11H23Si(CH3)2]2NH, [C12H25Si(CH3)2]2NH, [C13H27Si(CH3)2]2NH, [C14H29Si(CH3)2]2NH, [C15H31Si(CH3)2]2NH, [C16H33Si(CH3)2]2NH, [C17H35Si(CH3)2]2NH, [C18H37Si(CH3)2]2NH, [(C2H5)2Si(H)]2NH, [C2H5Si(H)2]2NH, [C2H5Si(CH3)(H)]2NH, [(C3H7)2Si(H)]2NH, [C3H7Si(H)2]2NH, [CF3CH2CH2Si(CH3)2]2NH, [C2F5CH2CH2Si(CH3)2]2NH, [C3F7CH2CH2Si(CH3)2]2NH, [C4F9CH2CH2Si(CH3)2]2NH, [C5F11CH2CH2Si(CH3)2]2NH, [C6F13CH2CH2Si(CH3)2]2NH, [C7F15CH2CH2Si(CH3)2]2NH, [C8F17CH2CH2Si(CH3)2]2NH, [CF3CH2CH2Si(CH3)(H)]2NH 등을 들 수 있고, 그 중에서도 특히, [(CH3)3Si]2NH, [C2H5Si(CH3)2]2NH, [C3H7Si(CH3)2]2NH, [C4H9Si(CH3)2]2NH, [CF3CH2CH2Si(CH3)2]2NH가 바람직하며, 특히 [(CH3)3Si]2NH가 바람직하다.As a specific example of the silazane compound represented by the general formula [4], for example, [(CH 3 ) 3 Si] 2 NH, [(CH 3 ) 2 Si(H)] 2 NH, [CH 3 Si( H) 2 ] 2 NH, [C 2 H 5 Si(CH 3 ) 2 ] 2 NH, [(C 2 H 5 ) 2 Si(CH 3 )] 2 NH, [(C 2 H 5 ) 3 Si] 2 NH, [C 3 H 7 Si(CH 3 ) 2 ] 2 NH, [(C 3 H 7 ) 2 Si(CH 3 )] 2 NH, [(C 3 H 7 ) 3 Si] 2 NH, [C 4 H 9 Si(CH 3 ) 2 ] 2 NH, [C 5 H 11 Si(CH 3 ) 2 ] 2 NH, [C 6 H 13 Si(CH 3 ) 2 ] 2 NH, [C 7 H 15 Si(CH 3 ) 2 ] 2 NH, [C 8 H 17 Si(CH 3 ) 2 ] 2 NH, [C 9 H 19 Si(CH 3 ) 2 ] 2 NH, [C 10 H 21 Si(CH 3 ) 2 ] 2 NH, [C 11 H 23 Si(CH 3 ) 2 ] 2 NH, [C 12 H 25 Si(CH 3 ) 2 ] 2 NH, [C 13 H 27 Si(CH 3 ) 2 ] 2 NH, [C 14 H 29 Si(CH 3 ) 2 ] 2 NH, [C 15 H 31 Si(CH 3 ) 2 ] 2 NH, [C 16 H 33 Si(CH 3 ) 2 ] 2 NH, [C 17 H 35 Si(CH 3 ) 2 ] 2 NH, [C 18 H 37 Si(CH 3 ) 2 ] 2 NH, [(C 2 H 5 ) 2 Si(H)] 2 NH, [C 2 H 5 Si(H) 2 ] 2 NH, [C 2 H 5 Si(CH 3 )(H)] 2 NH, [(C 3 H 7 ) 2 Si(H)] 2 NH, [C 3 H 7 Si(H) 2 ] 2 NH, [ CF 3 CH 2 CH 2 Si(CH 3 ) 2 ] 2 NH, [C 2 F 5 CH 2 CH 2 Si(CH 3 ) 2 ] 2 NH, [C 3 F 7 CH 2 CH 2 Si(CH 3 ) 2 ] 2 NH, [C 4 F 9 CH 2 CH 2 Si(CH 3 ) 2 ] 2 NH, [C 5 F 11 CH 2 CH 2 Si(CH 3 ) 2 ] 2 NH, [C 6 F 13 CH 2 CH 2 Si(CH 3 ) 2 ] 2 NH, [ C 7 F 15 CH 2 CH 2 Si(CH 3 ) 2 ] 2 NH, [C 8 F 17 CH 2 CH 2 Si(CH 3 ) 2 ] 2 NH, [CF 3 CH 2 CH 2 Si(CH 3 )( H)] 2 NH and the like, among others, [(CH 3 ) 3 Si] 2 NH, [C 2 H 5 Si(CH 3 ) 2 ] 2 NH, [C 3 H 7 Si(CH 3 ) 2 ] 2 NH, [C 4 H 9 Si(CH 3 ) 2 ] 2 NH, [CF 3 CH 2 CH 2 Si(CH 3 ) 2 ] 2 NH is preferred, especially [(CH 3 ) 3 Si] 2 NH is preferred.
상기 일반식 [6]으로 나타내어지는 산성 화합물의 구체예로서는, 예를 들면, HCl, HBr, HI, CF3COOH, C2F5COOH, C3F7COOH, C4F9COOH, C5F11COOH, C6F13COOH, CF3S(=O)2OH, C2F5S(=O)2OH, C3F7S(=O)2OH, C4F9S(=O)2OH, C5F11S(=O)2OH, C6F13S(=O)2OH, {CF3S(=O)2}2NH, {C2F5S(=O)2}2NH, {C3F7S(=O)2}2NH, {C4F9S(=O)2}2NH, {C5F11S(=O)2}2NH, {C6F13S(=O)2}2NH, {CF3S(=O)2}3CH, {C2F5S(=O)2}3CH, {C3F7S(=O)2}3CH, {C4F9S(=O)2}3CH, {C5F11S(=O)2}3CH, {C6F13S(=O)2}3CH 등을 들 수 있고, 그 중에서도 특히, CF3COOH, C2F5COOH, C3F7COOH, C4F9COOH가 바람직하며, 특히 CF3COOH가 바람직하다.Specific examples of the acidic compound represented by the general formula [6] include, for example, HCl, HBr, HI, CF 3 COOH, C 2 F 5 COOH, C 3 F 7 COOH, C 4 F 9 COOH, C 5 F 11 COOH, C 6 F 13 COOH, CF 3 S(=O) 2 OH, C 2 F 5 S(=O) 2 OH, C 3 F 7 S(=O) 2 OH, C 4 F 9 S(= O) 2 OH, C 5 F 11 S(=O) 2 OH, C 6 F 13 S(=O) 2 OH, {CF 3 S(=O) 2 } 2 NH, {C 2 F 5 S(= O) 2 } 2 NH, {C 3 F 7 S(=O) 2 } 2 NH, {C 4 F 9 S(=O) 2 } 2 NH, {C 5 F 11 S(=O) 2 } 2 NH, {C 6 F 13 S(=O) 2 } 2 NH, {CF 3 S(=O) 2 } 3 CH, {C 2 F 5 S(=O) 2 } 3 CH, {C 3 F 7 S(=O) 2 } 3 CH, {C 4 F 9 S(=O) 2 } 3 CH, {C 5 F 11 S(=O) 2 } 3 CH, {C 6 F 13 S(=O) 2 } 3 CH and the like are mentioned. Among them, CF 3 COOH, C 2 F 5 COOH, C 3 F 7 COOH, and C 4 F 9 COOH are preferable, and CF 3 COOH is particularly preferable.
[실시예][Example]
이하, 본 발명의 실시 형태를 보다 구체적으로 개시한 실시예를 나타낸다. 또한, 본 발명은 이러한 실시예에만 한정되는 것은 아니다.Hereinafter, examples in which the embodiments of the present invention are more specifically disclosed are shown. In addition, the present invention is not limited only to these examples.
웨이퍼의 표면을 요철 패턴을 가지는 면으로 하는 것, 요철 패턴의 적어도 오목부에 보지된 세정액을 다른 세정액으로 치환하는 것은, 다른 문헌 등에서 여러 가지 검토가 이루어져, 이미 확립된 기술이므로, 본 발명에서는, 발수성 보호막 형성용 약액으로 웨이퍼를 표면 처리했을 때의 발수성 부여 효과에 관하여 평가를 행했다. 또한, 실시예에 있어서, 접촉각을 평가할 때에 웨이퍼 표면에 접촉시키는 액체로서는, 수계 세정액의 대표적인 것인 물을 이용했다.Making the surface of the wafer a surface having an uneven pattern, and replacing the cleaning liquid held in at least the concave portion of the uneven pattern with another cleaning liquid is a technique that has been previously established by various studies in other documents, etc., in the present invention, The effect of imparting water repellency when the wafer was surface-treated with the chemical liquid for forming a water-repellent protective film was evaluated. In addition, in Examples, as the liquid to be brought into contact with the wafer surface when evaluating the contact angle, water, which is a typical water-based cleaning solution, was used.
단, 표면에 요철 패턴을 가지는 웨이퍼의 경우, 당해 요철 패턴 표면에 형성된 발수성 보호막 자체의 접촉각을 정확하게 평가할 수 없다.However, in the case of a wafer having an uneven pattern on the surface, the contact angle of the water-repellent protective film itself formed on the surface of the uneven pattern cannot be accurately evaluated.
수적의 접촉각의 평가는, JIS R3257 「기판 유리 표면의 젖음성 시험 방법」에도 있는 바와 같이, 샘플(기재(基材)) 표면에 수 ㎕의 수적을 적하하여, 수적과 기재 표면이 이루는 각도의 측정에 의해 이루어진다. 그러나, 패턴을 가지는 웨이퍼의 경우, 접촉각이 매우 커진다. 이것은, Wenzel 효과나 Cassie 효과가 생기기 때문으로, 접촉각이 기재의 표면 형상(러프니스)에 영향을 받아, 외관상의 수적의 접촉각이 증대하기 때문이다.As for the evaluation of the contact angle of the water droplets, as in JIS R3257 ``Method of testing the wettability of the substrate glass surface,'' several µl of water droplets were dropped on the surface of the sample (substrate), and the angle between the water droplet and the substrate surface was measured. Made by However, in the case of a wafer having a pattern, the contact angle becomes very large. This is because the Wenzel effect or the Cassie effect occurs, and the contact angle is affected by the surface shape (roughness) of the substrate, and the contact angle of the water droplets in appearance increases.
그래서, 본 실시예에서는 상기 약액을 표면이 평활한 웨이퍼에 제공하여, 웨이퍼 표면에 보호막을 형성하고, 당해 보호막을 표면에 요철 패턴이 형성된 웨이퍼의 표면에 형성된 보호막으로 간주하여, 여러 가지 평가를 행했다. 또한, 본 실시예에서는, 표면이 평활한 웨이퍼로서, 표면이 평활한 실리콘 웨이퍼 상에 SiO2층을 가지는 「SiO2막을 가지는 웨이퍼」를 이용했다.Therefore, in this embodiment, the chemical solution was provided to a wafer having a smooth surface, a protective film was formed on the wafer surface, and the protective film was regarded as a protective film formed on the surface of the wafer having an uneven pattern formed on the surface, and various evaluations were performed. . In addition, in this example, as a wafer having a smooth surface, a "wafer having a SiO 2 film" having a SiO 2 layer on a silicon wafer having a smooth surface was used.
상세를 하기에 서술한다. 이하에서는, 평가 방법, 발수성 보호막 형성용 약액이나 원료 약액의 조제, 발수성 보호막 형성용 약액을 이용한 웨이퍼의 표면 처리 방법, 및 평가 결과를 기재한다.Details are described below. Hereinafter, an evaluation method, a preparation of a chemical liquid for forming a water-repellent protective film or a raw material chemical liquid, a method of surface treatment of a wafer using a chemical liquid for forming a water-repellent protective film, and an evaluation result are described.
〔평가 방법〕 웨이퍼 표면에 형성된 보호막의 접촉각 평가(발수성 부여 효과의 평가)[Evaluation method] Evaluation of the contact angle of the protective film formed on the wafer surface (evaluation of the effect of imparting water repellency)
보호막이 형성된 웨이퍼 표면 상에 순수 약 2㎕를 두고, 수적과 웨이퍼 표면이 이루는 각(접촉각)을 접촉각계(교와계면과학제:CA-X형)로 측정하여, 80° 이상을 합격으로 했다.Approximately 2 µl of pure water was placed on the wafer surface on which the protective film was formed, and the angle (contact angle) formed by the water droplet and the wafer surface was measured with a contact angle meter (Kyowa Interfacial Science Co., Ltd.: CA-X type), and 80° or more was determined as a pass .
[실시예 1-1][Example 1-1]
(1-1) 발수성 보호막 형성용 약액의 조제(1-1) Preparation of a chemical solution for forming a water-repellent protective film
(II)규소 화합물인 트리메틸실릴트리플루오로아세테이트〔TMS-TFA:(CH3)3Si-OC(=O)CF3〕:15g, (IV)실라잔 화합물인 헥사메틸디실라잔〔HMDS:(CH3)3Si-NH-Si(CH3)3〕:70g, (III)비프로톤성 용제인 프로필렌글리콜모노메틸에테르아세테이트(PGMEA):915g을 혼합하여 용액 상태의 원료 약액을 얻었다. 다음에, 프로톤성 화합물인 물:3.6g을 원료 약액에 첨가함으로써, TMS-TFA, HMDS, PGMEA의 총량 1kg에 대하여 0.2몰의 프로톤성 화합물(액체 상태의 물)을 원료 약액에 접촉시켜, 발수성 보호막 형성용 약액을 조제했다.(II) Trimethylsilyltrifluoroacetate (TMS-TFA:(CH 3 ) 3 Si-OC(=O)CF 3 ) as a silicon compound: 15 g, (IV) hexamethyldisilazane as a silazane compound [HMDS: (CH 3 ) 3 Si-NH-Si(CH 3 ) 3 ]: 70 g, (III) propylene glycol monomethyl ether acetate (PGMEA): 915 g, which is an aprotic solvent, was mixed to obtain a raw material chemical solution in a solution state. Next, by adding 3.6 g of water as a protic compound to the raw material chemical solution, 0.2 mol of the protic compound (liquid water) per 1 kg of the total amount of TMS-TFA, HMDS, and PGMEA is brought into contact with the raw material chemical solution. A chemical solution for forming a protective film was prepared.
(1-2) 실리콘 웨이퍼의 세정(1-2) cleaning of silicon wafers
평활한 열산화막을 가지는 실리콘 웨이퍼(표면에 두께 1㎛의 열산화막층을 가지는 Si 웨이퍼)를 1질량%의 불산 수용액에 실온에서 10분 침지하고, 순수에 실온에서 1분, 2-프로판올(iPA)에 실온에서 1분 침지했다.A silicon wafer having a smooth thermal oxide film (Si wafer having a thermal oxide layer having a thickness of 1 μm on the surface) was immersed in 1% by mass aqueous hydrofluoric acid solution at room temperature for 10 minutes, and then in pure water for 1 minute at room temperature, 2-propanol (iPA ) At room temperature for 1 minute.
(1-3) 실리콘 웨이퍼 표면에의 보호막 형성용 약액에 의한 표면 처리(1-3) Surface treatment with chemical solution for forming protective film on the surface of silicon wafer
상기 세정 후의 실리콘 웨이퍼를, 상기 「(1-1) 발수성 보호막 형성용 약액의 조제」에서 조제한 발수성 보호막 형성용 약액에 25℃에서 30초 침지하고, iPA에 실온에서 30초 침지했다. 마지막으로, 실리콘 웨이퍼를 iPA로부터 취출하고, 에어를 분사하여, 표면의 iPA를 제거하여 건조시켰다.The cleaned silicon wafer was immersed in the chemical solution for forming a water-repellent protective film prepared in "(1-1) Preparation of a chemical liquid for forming a water-repellent protective film" at 25°C for 30 seconds, and immersed in iPA for 30 seconds at room temperature. Finally, the silicon wafer was taken out from the iPA, air was blown, and the iPA on the surface was removed and dried.
본 실시예는, 표면 처리 양태 2의 방법으로 표면 처리한 것이 된다. 얻어진 웨이퍼를 평가한 바, 표 1에 나타내는 바와 같이, 표면 처리 전의 초기 접촉각이 10° 미만이었던 것이, 표면 처리 후의 접촉각은 90°가 되어, 우수한 발수성 부여 효과를 나타냈다.In this example, the surface treatment was performed by the method of surface treatment mode 2. When the obtained wafer was evaluated, as shown in Table 1, when the initial contact angle before the surface treatment was less than 10°, the contact angle after the surface treatment was 90°, showing an excellent effect of imparting water repellency.
[표 1][Table 1]
[실시예 1-2∼1-23][Examples 1-2 to 1-23]
실시예 1-1에서 이용한 프로톤성 화합물의 종류나 접촉 방법이나 접촉량, 및, 아미노실란 화합물이나 규소 화합물이나 실라잔 화합물의 종류나 함유량을 변경한 것 이외에는 실시예 1-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 1에 나타낸다.The surface of the wafer as in Example 1-1 except for changing the type, contact method, or contact amount of the protic compound used in Example 1-1, and the type or content of the aminosilane compound, silicon compound, or silazane compound. The process was performed, and the evaluation was further performed. Table 1 shows the results.
또한, 표 중에서, 「iPA」는 2-프로판올을 의미하고, 「MeOH」는 메탄올을 의미하며, 「EtOH」는 에탄올을 의미하고, 「nBuOH」는 1-부탄올을 의미하며, 「PGME」는 프로필렌글리콜모노메틸에테르를 의미하고, 「TFAcA」는 트리플루오로아세트아미드를 의미한다.In addition, in the table, "iPA" refers to 2-propanol, "MeOH" refers to methanol, "EtOH" refers to ethanol, "nBuOH" refers to 1-butanol, and "PGME" refers to propylene. It means glycol monomethyl ether, and "TFAcA" means trifluoroacetamide.
또한, 실시예 1-18에 있어서는, 먼저, 실라잔 화합물인 디부틸테트라메틸디실라잔〔DBTMDS:C4H9(CH3)2Si-NH-Si(CH3)2C4H9〕:86g, 비프로톤성 용제인 PGMEA:900g, 트리플루오로아세트산 무수물:14g을 혼합하여, 후술의 반응에 의해 용액 상태의 원료 약액을 얻었다. 트리플루오로아세트산 무수물은, DBTMDS와 바로 반응하여, 부틸디메틸실릴트리플루오로아세테이트〔BDMS-TFA:C4H9(CH3)2Si-OC(=O)CF3〕와 부틸디메틸실릴트리플루오로아세트아미드〔BDS-TFAcA:C4H9(CH3)2Si-NH-C(=O)CF3〕로 변화한다. 즉, 본 실시예의 원료 약액은, 규소 화합물이나 실라잔 화합물의 종류가 상이함과 함께, 그 밖의 규소 화합물로서 BDS-TFAcA를 함유하는 것으로 되어 있다.In addition, in Example 1-18, first, dibutyltetramethyldisilazane (DBTMDS:C 4 H 9 (CH 3 ) 2 Si-NH-Si(CH 3 ) 2 C 4 H 9 ) which is a silazane compound. :86g, PGMEA:900g which is an aprotic solvent, and trifluoroacetic anhydride:14g were mixed, and the raw material chemical liquid in a solution state was obtained by the reaction mentioned later. Trifluoroacetic anhydride reacts directly with DBTMDS, and butyldimethylsilyltrifluoroacetate [BDMS-TFA:C 4 H 9 (CH 3 ) 2 Si-OC (=O) CF 3 ] and butyldimethylsilyl trifluoro Roacetamide [BDS-TFAcA:C 4 H 9 (CH 3 ) 2 Si-NH-C(=O)CF 3 ]. That is, the raw material chemical solution of the present example differs in the type of the silicon compound and the silazane compound, and contains BDS-TFAcA as another silicon compound.
다음에, 프로톤성 화합물인 물:0.9g을 원료 약액에 첨가함으로써, BDMS-TFA, DBTMDS, PGMEA의 총량 1kg에 대하여 0.05몰의 프로톤성 화합물(액체 상태의 물)을 원료 약액에 접촉시켜, 발수성 보호막 형성용 약액을 조제했다.Next, by adding 0.9 g of water, which is a protic compound, to the raw material chemical, 0.05 mol of the protic compound (liquid water) per 1 kg of the total amount of BDMS-TFA, DBTMDS, and PGMEA is brought into contact with the raw material chemical, A chemical solution for forming a protective film was prepared.
또한, 실시예 1-19에 있어서는, 먼저, 실라잔 화합물인 디옥틸테트라메틸디실라잔〔DOTMDS:C8H17(CH3)2Si-NH-Si(CH3)2C8H17〕:89g, 비프로톤성 용제인 PGMEA:900g, 트리플루오로아세트산 무수물:11g을 혼합하여, 후술의 반응에 의해 용액 상태의 원료 약액을 얻었다. 트리플루오로아세트산 무수물은, DOTMDS와 바로 반응하여, 옥틸디메틸실릴트리플루오로아세테이트〔ODMS-TFA:C8H17(CH3)2Si-OC(=O)CF3〕와 옥틸디메틸실릴트리플루오로아세트아미드〔ODS-TFAcA:C8H17(CH3)2Si-NH-C(=O)CF3〕로 변화한다. 즉, 본 실시예의 원료 약액은, 규소 화합물이나 실라잔 화합물의 종류가 상이함과 함께, 그 밖의 규소 화합물로서 ODS-TFAcA를 함유하는 것으로 되어 있다.In addition, in Example 1-19, first, dioctyltetramethyldisilazane (DOTMDS:C 8 H 17 (CH 3 ) 2 Si-NH-Si(CH 3 ) 2 C 8 H 17 ) which is a silazane compound. : 89 g, PGMEA as an aprotic solvent: 900 g, and trifluoroacetic anhydride: 11 g were mixed, and a raw material chemical solution in a solution state was obtained by a reaction described below. Trifluoroacetic anhydride reacts directly with DOTMDS, and octyldimethylsilyltrifluoroacetate [ODMS-TFA:C 8 H 17 (CH 3 ) 2 Si-OC (=O) CF 3 ] and octyldimethylsilyl trifluoro Roacetamide [ODS-TFAcA:C 8 H 17 (CH 3 ) 2 Si-NH-C(=O)CF 3 ]. That is, the raw material chemical solution of the present example differs in the type of the silicon compound and the silazane compound, and contains ODS-TFAcA as another silicon compound.
다음에, 프로톤성 화합물인 물:0.9g을 원료 약액에 첨가함으로써, ODMS-TFA, DOTMDS, PGMEA의 총량 1kg에 대하여 0.05몰의 프로톤성 화합물(액체 상태의 물)을 원료 약액에 접촉시켜, 발수성 보호막 형성용 약액을 조제했다.Next, by adding 0.9 g of water as a protic compound to the raw material chemical solution, 0.05 mol of the protic compound (liquid water) per 1 kg of the total amount of ODMS-TFA, DOTMDS, and PGMEA is brought into contact with the raw material chemical solution. A chemical solution for forming a protective film was prepared.
또한, 실시예 1-22에 있어서는, 먼저, 실라잔 화합물인 HMDS:83g, 비프로톤성 용제인 PGMEA:900g, 트리플루오로아세트산 무수물:17g을 혼합하여, 후술의 반응에 의해 용액 상태의 원료 약액을 얻었다. 트리플루오로아세트산 무수물은, HMDS와 바로 반응하여, TMS-TFA와 트리메틸실릴트리플루오로아세트아미드〔TMS-TFAcA:(CH3)3Si-NH-C(=O)CF3〕로 변화한다. 즉, 본 실시예의 원료 약액은, 규소 화합물이나 실라잔 화합물 이외의 그 밖의 규소 화합물로서 TMS-TFAcA를 함유하는 것으로 되어 있다.In addition, in Example 1-22, first, a silazane compound HMDS: 83 g, an aprotic solvent PGMEA: 900 g, trifluoroacetic anhydride: 17 g were mixed, and a raw material chemical solution in a solution state by a reaction described below. Got it. Trifluoroacetic anhydride reacts directly with HMDS to change to TMS-TFA and trimethylsilyltrifluoroacetamide [TMS-TFAcA:(CH 3 ) 3 Si-NH-C(=O)CF 3 ]. That is, the raw material chemical solution of this example contains TMS-TFAcA as other silicon compounds other than the silicon compound and silazane compound.
또한, 실시예 1-20, 1-21, 1-23에서는, 프로톤성 화합물 농도가 (II), (III), (IV)의 총량 1kg에 대하여 0.001몰 미만의 비율이 되도록 미리 컨트롤된 공간 내에 원료 약액을 재치하고, 당해 공간에 기체 상태의 프로톤성 화합물을 소정량 도입하여, 양자를 접촉시킴으로써 발수성 보호막 형성용 약액을 조제했다.In addition, in Examples 1-20, 1-21, and 1-23, the concentration of the protonic compound is in a space controlled in advance so that the ratio of the total amount of (II), (III), and (IV) is less than 0.001 mole per 1 kg. A raw material chemical solution was placed, a predetermined amount of a gaseous protonic compound was introduced into the space, and the chemical solution for forming a water-repellent protective film was prepared by bringing both of them into contact.
어느 실시예에 있어서도, 표면 처리 전의 초기 접촉각이 10° 미만이었던 것이, 표면 처리 후에 접촉각은 80° 이상이 되어, 우수한 발수성 부여 효과를 나타냈다.In any of the Examples, the initial contact angle before the surface treatment was less than 10°, and the contact angle after the surface treatment was 80° or more, thereby exhibiting an excellent water repellency imparting effect.
[비교예 1-1∼1-3][Comparative Examples 1-1 to 1-3]
실시예 1-1에서 이용한 프로톤성 화합물의 종류나 접촉량을 변경한 것 이외에는 실시예 1-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 1에 나타낸다. 모두 표면 처리 후의 접촉각이 80° 미만이 되어, 발수성 부여 효과는 실시예보다 뒤떨어지는 것이었다.The wafer was surface-treated in the same manner as in Example 1-1, except that the type and contact amount of the protic compound used in Example 1-1 was changed, and further evaluated. Table 1 shows the results. In both cases, the contact angle after the surface treatment was less than 80°, and the effect of imparting water repellency was inferior to that of the examples.
실시예 1-1∼1-3, 비교예 1-1, 1-2의 결과로부터, 프로톤성 화합물(액체 상태의 물)의 접촉량에 대한 표면 처리 후의 접촉각의 플롯을 도 7에, (I)∼(III)의 총량 중의 (I)아미노실란 화합물(TMS-NH2)의 함유량에 대한 표면 처리 후의 접촉각의 플롯을 도 8에, 각각 나타낸다.From the results of Examples 1-1 to 1-3 and Comparative Examples 1-1 and 1-2, a plot of the contact angle after surface treatment with respect to the contact amount of the protic compound (liquid water) is shown in FIG. A plot of the contact angle after surface treatment with respect to the content of the (I) aminosilane compound (TMS-NH 2 ) in the total amount of) to (III) is shown in Fig. 8, respectively.
도 7, 8로부터, 프로톤성 화합물(액체 상태의 물)을 접촉시키지 않는 비교예 1-1이나, 당해 접촉량이 너무 많은 비교예 1-2에서는, (I)∼(III)의 총량 중의 (I)아미노실란 화합물(TMS-NH2)의 함유량이 모두 너무 적기((I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%의 범위로부터 벗어남) 때문에, 표면 처리 후의 접촉각은 80° 미만이었다.From Figs. 7 and 8, in Comparative Example 1-1 in which the protic compound (liquid water) is not brought into contact, and in Comparative Example 1-2 with too much contact amount, (I) in the total amount of (I) to (III) ) Since the content of all aminosilane compounds (TMS-NH 2 ) is too small (the content of (I) relative to the total amount of (I) to (III) is out of the range of 0.02 to 0.5 mass%), the contact angle after surface treatment Was less than 80°.
이에 비하여, 프로톤성 화합물(액체 상태의 물)을 접촉시킴으로써, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인 발수성 보호막 형성용 약액을 이용한 실시예 1-1∼1-3은, 모두 표면 처리 후의 접촉각이 80°를 넘어, 보다 우수한 발수성 부여 효과를 나타냈다.In contrast, Example 1 using a chemical solution for forming a water-repellent protective film having a content of (I) of 0.02 to 0.5% by mass relative to the total amount of (I) to (III) by contacting a protic compound (liquid water). In all of 1 to 1-3, the contact angle after surface treatment exceeded 80 degrees, and showed the effect of providing more excellent water repellency.
또한, 프로톤성 화합물의 종류를 바꾼 경우도 마찬가지의 경향이 확인되었다.In addition, the same tendency was confirmed even when the type of the protic compound was changed.
실시예 1-4∼1-6, 비교예 1-1, 1-3의 결과로부터, 프로톤성 화합물(액체 상태의 iPA)의 접촉량에 대한 표면 처리 후의 접촉각의 플롯을 도 9에, (I)∼(III)의 총량 중의 (I)아미노실란 화합물(TMS-NH2)의 함유량에 대한 표면 처리 후의 접촉각의 플롯을 도 10에, 각각 나타낸다.From the results of Examples 1-4 to 1-6 and Comparative Examples 1-1 and 1-3, a plot of the contact angle after surface treatment with respect to the contact amount of the protic compound (iPA in a liquid state) is shown in Fig. 9, (I A plot of the contact angle after surface treatment with respect to the content of the (I) aminosilane compound (TMS-NH 2 ) in the total amount of) to (III) is shown in Fig. 10, respectively.
도 9, 10으로부터, 프로톤성 화합물(액체 상태의 iPA)을 접촉시키지 않는 비교예 1-1이나, 당해 접촉량이 너무 많은 비교예 1-3에서는, (I)∼(III)의 총량 중의 (I)아미노실란 화합물(TMS-NH2)의 함유량이 모두 너무 적기((I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%의 범위로부터 벗어남) 때문에, 표면 처리 후의 접촉각은 80° 미만이었다.9 and 10, in Comparative Example 1-1 in which the protic compound (iPA in liquid state) was not brought into contact, and Comparative Example 1-3 in which the contact amount was too large, (I) in the total amount of (I) to (III) ) Since the content of all aminosilane compounds (TMS-NH 2 ) is too small (the content of (I) relative to the total amount of (I) to (III) is out of the range of 0.02 to 0.5 mass%), the contact angle after surface treatment Was less than 80°.
이에 비하여, 프로톤성 화합물(액체 상태의 iPA)을 접촉시킴으로써, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인 발수성 보호막 형성용 약액을 이용한 실시예 1-4∼1-6은, 모두 표면 처리 후의 접촉각이 80°를 넘어, 보다 우수한 발수성 부여 효과를 나타냈다.In contrast, Example 1 using a chemical for forming a water-repellent protective film having a content of (I) of 0.02 to 0.5% by mass relative to the total amount of (I) to (III) by contacting a protic compound (iPA in a liquid state). In all of 4 to 1-6, the contact angle after surface treatment exceeded 80 degrees, and showed a more excellent water repellency imparting effect.
[실시예 2-1][Example 2-1]
(2-1) 원료 약액의 조제(2-1) Preparation of raw material chemical solution
(II)규소 화합물인 TMS-TFA:15g, (IV)실라잔 화합물인 HMDS:70g, (III)비프로톤성 용제인 PGMEA:915g을 혼합하여 용액 상태의 원료 약액을 얻었다.(II) TMS-TFA as a silicon compound: 15 g, (IV) HMDS as a silazane compound: 70 g, and (III) PGMEA: 915 g as an aprotic solvent were mixed to obtain a raw material chemical solution in a solution state.
(2-2) 발수성 보호막 형성용 약액의 조제와 실리콘 웨이퍼 표면에의 보호막 형성용 약액에 의한 표면 처리(2-2) Preparation of a chemical liquid for forming a water-repellent protective film and surface treatment with a chemical liquid for forming a protective film on the surface of a silicon wafer
실시예 1-1과 마찬가지의 방법으로 세정한 실리콘 웨이퍼를, 상기 「(2-1) 원료 약액의 조제」에서 조제한 원료 약액에 침지하고, 이어서 프로톤성 화합물인 액체 상태의 물:3.6g을 당해 원료 약액에 첨가함으로써, TMS-TFA, HMDS, PGMEA의 총량 1kg에 대하여 0.2몰의 프로톤성 화합물(액체 상태의 물)을 원료 약액에 접촉시켜, 발수성 보호막 형성용 약액을 조제했다. 당해 발수성 보호막 형성용 약액에 30초 침지 후에 실리콘 웨이퍼를 취출하고, iPA에 실온에서 30초 침지 후, 실리콘 웨이퍼를 iPA로부터 취출하고, 에어를 분사하여, 표면의 iPA를 제거하여 건조시켰다.The silicon wafer cleaned in the same manner as in Example 1-1 was immersed in the raw material chemical solution prepared in the above "(2-1) Preparation of the raw material chemical solution", and then liquid water as a protic compound: 3.6 g was obtained. By adding to the raw material chemical, 0.2 mol of a protic compound (liquid water) was brought into contact with the raw material chemical with respect to 1 kg of the total amount of TMS-TFA, HMDS, and PGMEA to prepare a chemical for forming a water-repellent protective film. After immersion in the water-repellent protective film-forming chemical solution for 30 seconds, the silicon wafer was taken out and immersed in iPA for 30 seconds at room temperature, then the silicon wafer was taken out from the iPA, air was sprayed, and the iPA on the surface was removed and dried.
본 실시예는, 표면 처리 양태 3의 방법으로 표면 처리한 것이 된다. 얻어진 웨이퍼를 평가한 바, 표 2에 나타내는 바와 같이, 표면 처리 전의 초기 접촉각이 10° 미만이었던 것이, 표면 처리 후의 접촉각은 90°가 되어, 우수한 발수성 부여 효과를 나타냈다.In this example, the surface treatment was performed by the method of surface treatment mode 3. When the obtained wafer was evaluated, as shown in Table 2, when the initial contact angle before the surface treatment was less than 10°, the contact angle after the surface treatment was 90°, showing an excellent effect of imparting water repellency.
[표 2][Table 2]
[실시예 2-2∼2-16][Examples 2-2 to 2-16]
실시예 2-1에서 이용한 프로톤성 화합물의 종류나 접촉 방법이나 접촉량, 및, 아미노실란 화합물이나 규소 화합물이나 실라잔 화합물의 종류나 함유량을 변경한 것 이외에는 실시예 2-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 2에 나타낸다.The surface of the wafer as in Example 2-1, except that the type, contact method, and contact amount of the protic compound used in Example 2-1, and the type or content of the aminosilane compound, silicon compound, or silazane compound were changed. The process was performed, and the evaluation was further performed. The results are shown in Table 2.
또한, 실시예 2-13, 2-14, 2-16에서는, 실시예 1-1과 마찬가지의 방법으로 세정한 실리콘 웨이퍼를, 미리 소정량의 기체 상태의 프로톤성 화합물이 도입된 공간 내에 재치하고, 당해 실리콘 웨이퍼 표면(SiO2막측 표면)에 원료 약액을 액 담음함으로써, 원료 약액과 프로톤성 화합물을 접촉시켜 발수성 보호막 형성용 약액을 조제했다.In addition, in Examples 2-13, 2-14, and 2-16, the silicon wafer cleaned in the same manner as in Example 1-1 was placed in a space into which a predetermined amount of a gaseous protic compound was introduced. , By immersing the raw material chemical liquid on the silicon wafer surface (SiO 2 film side surface), the raw material chemical liquid and the protonic compound were brought into contact to prepare a chemical liquid for forming a water-repellent protective film.
어느 실시예에 있어서도, 표면 처리 전의 초기 접촉각이 10° 미만이었던 것이, 표면 처리 후에 접촉각은 80°이상이 되어, 우수한 발수성 부여 효과를 나타냈다.In any of the Examples, the initial contact angle before the surface treatment was less than 10°, and the contact angle after the surface treatment was 80° or more, thereby exhibiting an excellent water repellency imparting effect.
[비교예 2-1∼2-3][Comparative Examples 2-1 to 2-3]
실시예 2-1에서 이용한 프로톤성 화합물의 종류나 접촉량을 변경한 것 이외에는 실시예 2-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 2에 나타낸다. 모두 표면 처리 후의 접촉각이 80° 미만이 되어, 발수성 부여 효과는 실시예보다 뒤떨어지는 것이었다.The wafer was surface-treated in the same manner as in Example 2-1, except that the type and contact amount of the protic compound used in Example 2-1 were changed, and further evaluated. The results are shown in Table 2. In both cases, the contact angle after the surface treatment was less than 80°, and the effect of imparting water repellency was inferior to that of the examples.
[실시예 3-1][Example 3-1]
(IV)실라잔 화합물인 HMDS:71g, (III)비프로톤성 용제인 PGMEA:929g을 혼합하여 용액 상태의 원료 약액을 얻었다. 다음에, 산성 화합물인 트리플루오로아세트산〔TFA:CF3COOH〕:22.8g을 원료 약액에 첨가함으로써, HMDS, PGMEA의 총량 1kg에 대하여 0.2몰의 산성 화합물(액체 상태의 TFA)을 원료 약액에 접촉시켜, 발수성 보호막 형성용 약액을 조제했다. 그 이외는, 실시예 1-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 3에 나타낸다.(IV) HMDS as a silazane compound: 71 g and (III) PGMEA: 929 g as an aprotic solvent were mixed to obtain a raw material chemical solution in a solution state. Next, by adding 22.8 g of the acidic compound trifluoroacetic acid [TFA:CF 3 COOH]: to the raw material chemical, 0.2 mol of the acidic compound (liquid TFA) per 1 kg of the total amount of HMDS and PGMEA is added to the raw material chemical. It was brought into contact to prepare a chemical liquid for forming a water-repellent protective film. Other than that, surface treatment of the wafer was performed in the same manner as in Example 1-1, and the evaluation was further performed. Table 3 shows the results.
본 실시예는, 표면 처리 양태 4의 방법으로 표면 처리한 것이 된다. 얻어진 웨이퍼를 평가한 바, 표 3에 나타내는 바와 같이, 표면 처리 전의 초기 접촉각이 10° 미만이었던 것이, 표면 처리 후의 접촉각은 90°가 되어, 우수한 발수성 부여 효과를 나타냈다.In this example, the surface treatment was performed by the method of surface treatment mode 4. When the obtained wafer was evaluated, as shown in Table 3, when the initial contact angle before the surface treatment was less than 10°, the contact angle after the surface treatment was 90°, and an excellent water repellency imparting effect was exhibited.
[표 3][Table 3]
[실시예 3-2∼3-6][Examples 3-2 to 3-6]
실시예 3-1에서 이용한 산성 화합물의 종류나 접촉량, 및, 아미노실란 화합물이나 규소 화합물이나 실라잔 화합물의 종류나 함유량을 변경한 것 이외에는 실시예 3-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 3에 나타낸다.The wafer was surface-treated in the same manner as in Example 3-1, except that the type and contact amount of the acidic compound used in Example 3-1, and the type or content of the aminosilane compound, silicon compound, or silazane compound were changed, Further, the evaluation was made. Table 3 shows the results.
또한, 표 중에서, 「TFMSA」는 트리플루오로메탄술폰산〔CF3SO3H〕을 의미하고, 「TMS-TFMSA」는 트리메틸실릴트리플루오로메탄술포네이트〔(CH3)3Si-OS(=O)2CF3〕를 의미한다.In addition, in the table, "TFMSA" refers to trifluoromethanesulfonic acid [CF 3 SO 3 H], and "TMS-TFMSA" refers to trimethylsilyltrifluoromethanesulfonate [(CH 3 ) 3 Si-OS (= O) means 2 CF 3 ].
어느 실시예에 있어서도, 표면 처리 전의 초기 접촉각이 10° 미만이었던 것이, 표면 처리 후에 접촉각은 80°이상이 되어, 우수한 발수성 부여 효과를 나타냈다.In any of the Examples, the initial contact angle before the surface treatment was less than 10°, and the contact angle after the surface treatment was 80° or more, thereby exhibiting an excellent water repellency imparting effect.
[비교예 3-1, 3-2][Comparative Examples 3-1, 3-2]
실시예 3-1에서 이용한 산성 화합물의 접촉량을 변경한 것 이외에는 실시예 3-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 3에 나타낸다. 모두 표면 처리 후의 접촉각이 80° 미만이 되어, 발수성 부여 효과는 실시예보다 뒤떨어지는 것이었다.The wafer was surface-treated in the same manner as in Example 3-1, except that the contact amount of the acidic compound used in Example 3-1 was changed, and the evaluation was further performed. Table 3 shows the results. In both cases, the contact angle after the surface treatment was less than 80°, and the effect of imparting water repellency was inferior to that of the examples.
[실시예 4-1][Example 4-1]
(4-1) 원료 약액의 조제(4-1) Preparation of raw material chemical solution
(IV)실라잔 화합물인 HMDS:71g, (III)비프로톤성 용제인 PGMEA:929g을 혼합하여 용액 상태의 원료 약액을 얻었다.(IV) HMDS as a silazane compound: 71 g and (III) PGMEA: 929 g as an aprotic solvent were mixed to obtain a raw material chemical solution in a solution state.
(4-2) 발수성 보호막 형성용 약액의 조제와 실리콘 웨이퍼 표면에의 보호막 형성용 약액에 의한 표면 처리(4-2) Preparation of a chemical liquid for forming a water-repellent protective film and surface treatment with a chemical liquid for forming a protective film on the surface of a silicon wafer
실시예 1-1과 마찬가지의 방법으로 세정한 실리콘 웨이퍼를, 상기 「(4-1) 원료 약액의 조제」에서 조제한 원료 약액에 침지하고, 이어서 산성 화합물인 액체 상태의 TFA:22.8g을 당해 원료 약액에 첨가함으로써, HMDS, PGMEA의 총량 1kg에 대하여 0.2몰의 산성 화합물(액체 상태의 TFA)을 원료 약액에 접촉시켜, 발수성 보호막 형성용 약액을 조제했다. 당해 발수성 보호막 형성용 약액에 30초 침지 후에 실리콘 웨이퍼를 취출하고, iPA에 실온에서 30초 침지 후, 실리콘 웨이퍼를 iPA로부터 취출하고, 에어를 분사하여, 표면의 iPA를 제거하여 건조시켰다.The silicon wafer cleaned in the same manner as in Example 1-1 was immersed in the raw material chemical solution prepared in the above "(4-1) Preparation of the raw material chemical solution", and then, 22.8 g of TFA in a liquid state as an acidic compound was added to the raw material. By adding to the chemical solution, 0.2 mol of an acidic compound (liquid TFA) per 1 kg of the total amount of HMDS and PGMEA was brought into contact with the raw material chemical to prepare a chemical for forming a water-repellent protective film. After immersion in the water-repellent protective film-forming chemical solution for 30 seconds, the silicon wafer was taken out and immersed in iPA for 30 seconds at room temperature, then the silicon wafer was taken out from the iPA, air was sprayed, and the iPA on the surface was removed and dried.
본 실시예는, 표면 처리 양태 5의 방법으로 표면 처리한 것이 된다. 얻어진 웨이퍼를 평가한 바, 표 4에 나타내는 바와 같이, 표면 처리 전의 초기 접촉각이 10° 미만이었던 것이, 표면 처리 후의 접촉각은 90°가 되어, 우수한 발수성 부여 효과를 나타냈다.In this example, the surface treatment was performed by the method of the surface treatment aspect 5. When the obtained wafer was evaluated, as shown in Table 4, when the initial contact angle before the surface treatment was less than 10°, the contact angle after the surface treatment was 90°, showing an excellent effect of imparting water repellency.
[표 4][Table 4]
[실시예 4-2∼4-6][Examples 4-2 to 4-6]
실시예 4-1에서 이용한 산성 화합물의 종류나 접촉량, 및, 아미노실란 화합물이나 규소 화합물이나 실라잔 화합물의 종류나 함유량을 변경한 것 이외에는 실시예 4-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 4에 나타낸다.The wafer was surface-treated in the same manner as in Example 4-1, except that the type and contact amount of the acidic compound used in Example 4-1, and the type or content of the aminosilane compound, silicon compound, or silazane compound were changed, Further, the evaluation was made. The results are shown in Table 4.
어느 실시예에 있어서도, 표면 처리 전의 초기 접촉각이 10° 미만이었던 것이, 표면 처리 후에 접촉각은 80°이상이 되어, 우수한 발수성 부여 효과를 나타냈다.In any of the Examples, the initial contact angle before the surface treatment was less than 10°, and the contact angle after the surface treatment was 80° or more, thereby exhibiting an excellent water repellency imparting effect.
[비교예 4-1, 4-2][Comparative Examples 4-1, 4-2]
실시예 4-1에서 이용한 산성 화합물의 접촉량을 변경한 것 이외에는 실시예 4-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 4에 나타낸다. 모두 표면 처리 후의 접촉각이 80° 미만이 되어, 발수성 부여 효과는 실시예보다 뒤떨어지는 것이었다.Except having changed the contact amount of the acidic compound used in Example 4-1, the surface treatment of a wafer was performed like Example 4-1, and the evaluation was performed further. The results are shown in Table 4. In both cases, the contact angle after the surface treatment was less than 80°, and the effect of imparting water repellency was inferior to that of the examples.
이상과 같이, 상이한 표면 처리 양태라도, 본 발명에 관련된 발수성 보호막 형성용 약액, 및, 본 발명에 관련된 웨이퍼의 표면 처리 방법을 채용함으로써, 발수성 부여 효과를 종래에 비해 더 향상시킬 수 있다.As described above, even in different surface treatment modes, the effect of imparting water repellency can be further improved compared to the prior art by employing the chemical liquid for forming a water-repellent protective film according to the present invention and the wafer surface treatment method according to the present invention.
[실시예 1-1a][Example 1-1a]
「발수성 보호막 형성용 약액의 조제」에 있어서, 프로톤성 화합물인 물을 비프로톤성 용제인 PGMEA에 희석한 상태로(상용되지 않을 경우는 분산시킨 상태로), 원료 약액에 첨가하는 것 이외에는, 실시예 1-1과 마찬가지의 조작을 행하여, 마찬가지의 평가를 행했다. 또한, 물의 첨가량은, TMS-TFA, HMDS, 원료 약액에 포함되는 PGMEA, 및 희석에 이용하는 PGMEA의 총량 1kg에 대하여 0.2몰이 되도록 했다. 결과를 표 5에 나타낸다. 또한, 희석에 이용한 PGMEA의 양과 원료 약액에 포함되는 PGMEA의 양을 동량이 되도록 했다.In ``Preparation of a chemical liquid for forming a water repellent protective film'', except that water, which is a protic compound, is diluted in PGMEA, which is an aprotic solvent (if not commonly used, in a dispersed state), except for adding it to the raw material chemical liquid. The same operation as in Example 1-1 was performed, and the same evaluation was performed. In addition, the amount of water added was 0.2 mol with respect to 1 kg of the total amount of TMS-TFA, HMDS, PGMEA contained in the raw material chemical solution, and PGMEA used for dilution. Table 5 shows the results. In addition, the amount of PGMEA used for dilution and the amount of PGMEA contained in the raw material chemical were made the same amount.
[표 5][Table 5]
[실시예 1-2a∼1-22a, 비교예 1-2a∼1-3a][Examples 1-2a to 1-22a, Comparative Examples 1-2a to 1-3a]
실시예 1-1a에서 이용한 프로톤성 화합물의 종류나 접촉 방법이나 접촉량, 및, 아미노실란 화합물이나 규소 화합물이나 실라잔 화합물의 종류나 함유량을 변경한 것 이외에는 실시예 1-1a와 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 또한, 실시예 1-20a, 1-21a에 관해서는, 기체 상태의 프로톤성 화합물을 기체 상태의 비프로톤성 용제에 희석하여 원료 약액에 접촉시켰다. 결과를 표 5에 나타낸다.The surface of the wafer as in Example 1-1a except for changing the type, contact method, and contact amount of the protic compound used in Example 1-1a, and the type or content of the aminosilane compound, silicon compound, or silazane compound. The process was performed, and the evaluation was further performed. In addition, in Examples 1-20a and 1-21a, a protic compound in a gaseous state was diluted in a gaseous aprotic solvent and brought into contact with a raw material chemical. Table 5 shows the results.
또한, 프로톤성 화합물을 접촉시키지 않는 비교예에 관해서는, 비교예 1-1의 결과를 기재했다.In addition, the results of Comparative Example 1-1 were described for Comparative Examples in which the protic compound was not brought into contact.
[실시예 2-1a][Example 2-1a]
「발수성 보호막 형성용 약액의 조제와 실리콘 웨이퍼 표면에의 보호막 형성용 약액에 의한 표면 처리」에 있어서, 프로톤성 화합물인 물을 비프로톤성 용제인 PGMEA에 희석한 상태로(상용되지 않을 경우는 분산시킨 상태로), 원료 약액에 첨가하는 것 이외에는, 실시예 2-1과 마찬가지의 조작을 행하여, 마찬가지의 평가를 행했다. 또한, 물의 첨가량은, TMS-TFA, HMDS, 원료 약액에 포함되는 PGMEA, 및 희석에 이용하는 PGMEA의 총량 1kg에 대하여 0.2몰이 되도록 했다. 결과를 표 6에 나타낸다. 또한, 희석에 이용한 PGMEA의 양과 원료 약액에 포함되는 PGMEA의 양을 동량이 되도록 했다.In ``Preparation of a chemical liquid for forming a water repellent protective film and surface treatment with a chemical liquid for forming a protective film on the surface of a silicon wafer'', water as a protic compound is diluted in PGMEA as an aprotic solvent (dispersion if not commonly used). In the same state), except for adding to the raw material chemical liquid, the same operation as in Example 2-1 was performed, and the same evaluation was performed. In addition, the amount of water added was 0.2 mol with respect to 1 kg of the total amount of TMS-TFA, HMDS, PGMEA contained in the raw material chemical solution, and PGMEA used for dilution. Table 6 shows the results. In addition, the amount of PGMEA used for dilution and the amount of PGMEA contained in the raw material chemical were made to be the same amount.
[표 6][Table 6]
[실시예 2-2a∼2-15a, 비교예 2-2a∼2-3a][Examples 2-2a to 2-15a, Comparative Examples 2-2a to 2-3a]
실시예 2-1a에서 이용한 프로톤성 화합물의 종류나 접촉 방법이나 접촉량, 및, 아미노실란 화합물이나 규소 화합물이나 실라잔 화합물의 종류나 함유량을 변경한 것 이외에는 실시예 2-1a와 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 또한, 실시예 2-13a, 2-14a에 관해서는, 기체 상태의 프로톤성 화합물을 기체 상태의 비프로톤성 용제에 희석하여 원료 약액에 접촉시켰다. 결과를 표 6에 나타낸다.The surface of the wafer as in Example 2-1a except that the type, contact method, and contact amount of the protic compound used in Example 2-1a, and the type or content of the aminosilane compound, silicon compound, or silazane compound were changed. The process was performed, and the evaluation was further performed. In addition, in Examples 2-13a and 2-14a, the protic compound in the gaseous state was diluted with an aprotic solvent in the gaseous state to contact the raw material chemical solution. Table 6 shows the results.
또한, 프로톤성 화합물을 접촉시키지 않는 비교예에 관해서는, 비교예 2-1의 결과를 기재했다.In addition, the results of Comparative Example 2-1 were described with respect to Comparative Examples in which the protic compound was not brought into contact.
[실시예 3-1a][Example 3-1a]
「발수성 보호막 형성용 약액의 조제」에 있어서, 산성 화합물인 TFA를 비프로톤성 용제인 PGMEA에 희석한 상태로(상용되지 않을 경우는 분산시킨 상태로), 원료 약액에 첨가하는 것 이외에는, 실시예 3-1과 마찬가지의 조작을 행하여, 마찬가지의 평가를 행했다. 또한, TFA의 첨가량은, HMDS, 원료 약액에 포함되는 PGMEA, 및 희석에 이용하는 PGMEA의 총량 1kg에 대하여 0.2몰이 되도록 했다. 결과를 표 7에 나타낸다. 또한, 희석에 이용한 PGMEA의 양과 원료 약액에 포함되는 PGMEA의 양을 동량이 되도록 했다.In the ``Preparation of a chemical liquid for forming a water-repellent protective film'', examples except that TFA, an acidic compound, is diluted in PGMEA, an aprotic solvent (if not commonly used, dispersed), and added to the raw material chemical liquid. The same operation as in 3-1 was performed, and the same evaluation was performed. In addition, the amount of TFA added was 0.2 mol with respect to 1 kg of the total amount of HMDS, PGMEA contained in the raw material chemical solution, and PGMEA used for dilution. Table 7 shows the results. In addition, the amount of PGMEA used for dilution and the amount of PGMEA contained in the raw material chemical were made the same amount.
[표 7][Table 7]
[실시예 3-2a∼3-6a, 비교예 3-2a][Examples 3-2a to 3-6a, Comparative Example 3-2a]
실시예 3-1a에서 이용한 산성 화합물의 종류나 접촉량, 및, 아미노실란 화합물이나 규소 화합물이나 실라잔 화합물의 종류나 함유량을 변경한 것 이외에는 실시예 3-1a와 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 7에 나타낸다.Wafer surface treatment was performed in the same manner as in Example 3-1a except that the type and contact amount of the acidic compound used in Example 3-1a, and the type or content of the aminosilane compound, silicon compound, or silazane compound were changed, Further, the evaluation was made. Table 7 shows the results.
또한, 산성 화합물을 접촉시키지 않는 비교예에 관해서는, 비교예 3-1의 결과를 기재했다.In addition, the results of Comparative Example 3-1 were described with respect to Comparative Examples in which the acidic compound was not brought into contact.
[실시예 4-1a][Example 4-1a]
「발수성 보호막 형성용 약액의 조제와 실리콘 웨이퍼 표면에의 보호막 형성용 약액에 의한 표면 처리」에 있어서, 산성 화합물인 TFA를 비프로톤성 용제인 PGMEA에 희석한 상태로(상용되지 않을 경우는 분산시킨 상태로), 원료 약액에 첨가하는 것 이외에는, 실시예 4-1과 마찬가지의 조작을 행하여, 마찬가지의 평가를 행했다. 또한, TFA의 첨가량은, HMDS, 원료 약액에 포함되는 PGMEA, 및 희석에 이용하는 PGMEA의 총량 1kg에 대하여 0.2몰이 되도록 했다. 결과를 표 8에 나타낸다. 또한, 희석에 이용한 PGMEA의 양과 원료 약액에 포함되는 PGMEA의 양을 동량이 되도록 했다.In ``Preparation of a chemical for forming a water-repellent protective film and surface treatment with a chemical for forming a protective film on the surface of a silicon wafer'', TFA, an acidic compound, is diluted in PGMEA, an aprotic solvent (if not used, it is dispersed. In the state), except for adding to the raw material chemical liquid, the same operation as in Example 4-1 was performed, and the same evaluation was performed. In addition, the amount of TFA added was 0.2 mol with respect to 1 kg of the total amount of HMDS, PGMEA contained in the raw material chemical solution, and PGMEA used for dilution. The results are shown in Table 8. In addition, the amount of PGMEA used for dilution and the amount of PGMEA contained in the raw material chemical were made to be the same amount.
[표 8][Table 8]
[실시예 4-2a∼4-6a, 비교예 4-2a][Examples 4-2a to 4-6a, Comparative Example 4-2a]
실시예 4-1a에서 이용한 산성 화합물의 종류나 접촉량, 및, 아미노실란 화합물이나 규소 화합물이나 실라잔 화합물의 종류나 함유량을 변경한 것 이외에는 실시예 4-1a와 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 8에 나타낸다.Wafer surface treatment was performed in the same manner as in Example 4-1a except that the type and contact amount of the acidic compound used in Example 4-1a, and the type or content of the aminosilane compound, silicon compound, or silazane compound were changed, Further, the evaluation was made. The results are shown in Table 8.
또한, 산성 화합물을 접촉시키지 않는 비교예에 관해서는, 비교예 4-1의 결과를 기재했다.In addition, the result of Comparative Example 4-1 was described about the comparative example in which the acidic compound was not brought into contact.
[실시예 5-1][Example 5-1]
「발수성 보호막 형성용 약액의 조제」에 있어서, 프로톤성 화합물을 NH3으로 하고, 비프로톤성 용제인 디옥산에 희석한 상태로, 원료 약액에 첨가하는 것 이외에는, 실시예 1-2와 마찬가지의 조작을 행하여, 마찬가지의 평가를 행했다. 또한, NH3의 첨가량은, TMS-TFA, HMDS, 원료 약액에 포함되는 PGMEA, 및 희석에 이용하는 디옥산의 총량 1kg에 대하여 0.05몰이 되도록 했다. 결과를 표 9에 나타낸다. 또한, 원료 약액에 첨가할 때의 NH3/디옥산 용액의 농도는 0.4몰/리터로 했다.In ``Preparation of a chemical liquid for forming a water-repellent protective film'', the same as in Example 1-2 except that the protic compound is NH 3 and diluted in dioxane as an aprotic solvent, and added to the raw material chemical liquid. Operation was performed and the same evaluation was performed. In addition, the amount of NH 3 added was 0.05 mol with respect to 1 kg of the total amount of TMS-TFA, HMDS, PGMEA contained in the raw material chemical solution, and dioxane used for dilution. The results are shown in Table 9. In addition, the concentration of the NH 3 /dioxane solution when added to the raw material chemical solution was set to 0.4 mol/liter.
[표 9][Table 9]
[실시예 5-2][Example 5-2]
실시예 5-1에서 희석에 이용한 비프로톤성 용제의 종류를 테트라히드로푸란〔THF〕으로 변경한 것 이외에는 실시예 5-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 9에 나타낸다.The wafer was surface-treated in the same manner as in Example 5-1, except that the type of the aprotic solvent used for dilution in Example 5-1 was changed to tetrahydrofuran [THF], and further evaluated. The results are shown in Table 9.
또한, 프로톤성 화합물을 접촉시키지 않는 비교예에 관해서는, 비교예 1-1의 결과를 기재했다.In addition, the results of Comparative Example 1-1 were described for Comparative Examples in which the protic compound was not brought into contact.
[실시예 6-1][Example 6-1]
「발수성 보호막 형성용 약액의 조제와 실리콘 웨이퍼 표면에의 보호막 형성용 약액에 의한 표면 처리」에 있어서, 프로톤성 화합물을 NH3으로 하고, 비프로톤성 용제인 디옥산에 희석한 상태로, 원료 약액에 첨가하는 것 이외에는, 실시예 2-2와 마찬가지의 조작을 행하여, 마찬가지의 평가를 행했다. 또한, NH3의 첨가량은, TMS-TFA, HMDS, 원료 약액에 포함되는 PGMEA, 및 희석에 이용하는 디옥산의 총량 1kg에 대하여 0.05몰이 되도록 했다. 결과를 표 10에 나타낸다. 또한, 원료 약액에 첨가할 때의 NH3/디옥산 용액의 농도는 0.4몰/리터로 했다.In ``Preparation of a chemical for forming a water-repellent protective film and surface treatment with a chemical for forming a protective film on the surface of a silicon wafer'', a raw material chemical solution in a state in which the protonic compound is NH 3 and diluted in dioxane as an aprotic solvent. Except for adding to, the same operation as in Example 2-2 was performed, and the same evaluation was performed. In addition, the amount of NH 3 added was 0.05 mol with respect to 1 kg of the total amount of TMS-TFA, HMDS, PGMEA contained in the raw material chemical solution, and dioxane used for dilution. Table 10 shows the results. In addition, the concentration of the NH 3 /dioxane solution when added to the raw material chemical solution was set to 0.4 mol/liter.
[표 10][Table 10]
[실시예 6-2][Example 6-2]
실시예 6-1에서 희석에 이용한 비프로톤성 용제의 종류를 테트라히드로푸란〔THF〕으로 변경한 것 이외에는 실시예 6-1과 마찬가지로 웨이퍼의 표면 처리를 행하고, 추가로 그 평가를 행했다. 결과를 표 10에 나타낸다.The wafer was surface-treated in the same manner as in Example 6-1, except that the type of the aprotic solvent used for dilution in Example 6-1 was changed to tetrahydrofuran [THF], and further evaluated. Table 10 shows the results.
또한, 프로톤성 화합물을 접촉시키지 않는 비교예에 관해서는, 비교예 2-1의 결과를 기재했다.In addition, the results of Comparative Example 2-1 were described with respect to Comparative Examples in which the protic compound was not brought into contact.
이상과 같이, 원료 약액에 첨가하는 프로톤성 화합물이나 산성 화합물이 비프로톤성 용제에 희석된 상태(상용되지 않을 경우는 분산시킨 상태)라도, 마찬가지로, 발수성 부여 효과를 종래에 비해 더 향상시킬 수 있다.As described above, even in a state in which the protic compound or acidic compound added to the raw material chemical solution is diluted in an aprotic solvent (if not commonly used, it is dispersed), the effect of imparting water repellency can be further improved compared to the conventional one. .
Claims (19)
(II)하기 일반식 [2]로 나타내어지는 규소 화합물과
(III)비프로톤성 용제를 가지고,
(I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액.
[화학식 20]
[식 [1] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. a는 1∼3의 정수, b는 0∼2의 정수이고, a와 b의 합계는 1∼3이다.]
[화학식 21]
[식 [2] 중, R2는, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. 또한, X는, 할로겐기, -OC(=O)R3, -OS(=O)2-R3, -N(S(=O)2-R3)2, -C(S(=O)2-R3)3으로 이루어지는 군으로부터 선택되는 적어도 1개의 기를 나타낸다. R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이고, c는 1∼3의 정수, d는 0∼2의 정수이며, c와 d의 합계는 1∼3이다.](I) an aminosilane compound represented by the following general formula [1] and
(II) a silicon compound represented by the following general formula [2] and
(III) has an aprotic solvent,
A chemical liquid for forming a water-repellent protective film, wherein the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass.
[Formula 20]
[In formula [1], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. a is an integer of 1 to 3, b is an integer of 0 to 2, and the sum of a and b is 1 to 3.]
[Formula 21]
[In formula [2], R 2 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. In addition, X is a halogen group, -OC(=O)R 3 , -OS(=O) 2 -R 3 , -N(S(=O) 2 -R 3 ) 2 , -C(S(=O ) 2 -R 3 ) represents at least one group selected from the group consisting of 3 . R 3 is a monovalent perfluoroalkyl group having 1 to 6 carbon atoms, c is an integer of 1 to 3, d is an integer of 0 to 2, and the sum of c and d is 1 to 3.]
상기 (I)이, 하기 일반식 [3]으로 나타내어지는 화합물인, 발수성 보호막 형성용 약액.
[화학식 22]
[식 [3] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.]The method of claim 1,
The chemical liquid for forming a water-repellent protective film, wherein (I) is a compound represented by the following general formula [3].
[Formula 22]
[In formula [3], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
(IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물을 더 함유하는, 발수성 보호막 형성용 약액.
[화학식 23]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.]The method according to claim 1 or 2,
(IV) A chemical for forming a water-repellent protective film further containing a silazane compound represented by the following general formula [4].
[Formula 23]
[In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
상기 (I)∼(III)의 총량에 대한 (II)의 함유량이 0.05∼20질량%인, 발수성 보호막 형성용 약액.The method according to any one of claims 1 to 3,
The chemical liquid for forming a water-repellent protective film, wherein the content of (II) relative to the total amount of the above (I) to (III) is 0.05 to 20% by mass.
상기 (II)가, 하기 일반식 [5]로 이루어지는 군으로부터 선택되는 적어도 1종의 화합물인, 발수성 보호막 형성용 약액.
[화학식 24]
[식 [5] 중, R2는, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이고, R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이다. 또한, g는 1∼3의 정수이다.]The method according to any one of claims 1 to 4,
The chemical liquid for forming a water-repellent protective film, wherein (II) is at least one compound selected from the group consisting of the following general formula [5].
[Formula 24]
[In formula [5], R 2 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element, and R 3 Silver is a monovalent perfluoroalkyl group having 1 to 6 carbon atoms. In addition, g is an integer of 1 to 3.]
상기 발수성 보호막 형성용 약액은,
(I)하기 일반식 [1]로 나타내어지는 아미노실란 화합물과
(II)하기 일반식 [2]로 나타내어지는 규소 화합물과
(III)비프로톤성 용제를 가지고,
(I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 웨이퍼의 표면 처리 방법.
[화학식 25]
[식 [1] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. a는 1∼3의 정수, b는 0∼2의 정수이고, a와 b의 합계는 1∼3이다.]
[화학식 26]
[식 [2] 중, R2는, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. 또한 X는, 할로겐기, -OC(=O)R3, -OS(=O)2-R3, -N(S(=O)2-R3)2, -C(S(=O)2-R3)3으로 이루어지는 군으로부터 선택되는 적어도 1개의 기를 나타낸다. R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이고, c는 1∼3의 정수, d는 0∼2의 정수이며, c와 d의 합계는 1∼3이다.]A water-repellent protective film forming step in which at least one liquid selected from the group consisting of a cleaning liquid and a rinse liquid is held on the wafer surface, the liquid is replaced with a chemical for forming a water-repellent protective film, and the chemical is held on the wafer surface, and , As a method for surface treatment of a wafer having a drying process,
The chemical solution for forming a water-repellent protective film,
(I) an aminosilane compound represented by the following general formula [1] and
(II) a silicon compound represented by the following general formula [2] and
(III) has an aprotic solvent,
A method for surface treatment of a wafer, wherein the content of (I) relative to the total amount of (I) to (III) is 0.02 to 0.5% by mass.
[Formula 25]
[In formula [1], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. a is an integer of 1 to 3, b is an integer of 0 to 2, and the sum of a and b is 1 to 3.]
[Formula 26]
[In formula [2], R 2 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. In addition, X is a halogen group, -OC(=O)R 3 , -OS(=O) 2 -R 3 , -N(S(=O) 2 -R 3 ) 2 , -C(S(=O) 2 -R 3 ) represents at least one group selected from the group consisting of 3 . R 3 is a monovalent perfluoroalkyl group having 1 to 6 carbon atoms, c is an integer of 1 to 3, d is an integer of 0 to 2, and the sum of c and d is 1 to 3.]
상기 (I)이, 하기 일반식 [3]으로 나타내어지는 화합물인, 웨이퍼의 표면 처리 방법.
[화학식 27]
[식 [3] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.]The method of claim 6,
The surface treatment method of a wafer, wherein (I) is a compound represented by the following general formula [3].
[Formula 27]
[In formula [3], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
상기 발수성 보호막 형성용 약액이, (IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물을 더 함유하는, 웨이퍼의 표면 처리 방법.
[화학식 28]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.]The method according to claim 6 or 7,
The method for surface treatment of a wafer, wherein the chemical liquid for forming a water-repellent protective film further contains (IV) a silazane compound represented by the following general formula [4].
[Formula 28]
[In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
상기 발수성 보호막 형성 공정 전에,
(II)상기 일반식 [2]로 나타내어지는 규소 화합물과
(IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물과
(III)비프로톤성 용제를 가지는 원료 약액에,
(II), (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 프로톤성 화합물을 접촉시킴으로써,
상기 (I)∼(III)을 가지고, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액을 조제하는, 약액 조제 공정을 가지는, 웨이퍼의 표면 처리 방법.
[화학식 29]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.]The method according to any one of claims 6 to 8,
Before the process of forming the water repellent protective film,
(II) a silicon compound represented by the general formula [2] and
(IV) a silazane compound represented by the following general formula [4] and
(III) In the raw material chemical solution having an aprotic solvent,
By contacting the protic compound in a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (II), (III) and (IV),
Having the above (I) to (III), and having a chemical solution preparation step of preparing a chemical solution for forming a water-repellent protective film, wherein the content of (I) is 0.02 to 0.5% by mass relative to the total amount of (I) to (III), Wafer surface treatment method.
[Chemical Formula 29]
[In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
상기 발수성 보호막 형성 공정 전에,
(II)상기 일반식 [2]로 나타내어지는 규소 화합물과
(IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물과
(III)비프로톤성 용제를 가지는 원료 약액에,
(II), (III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 프로톤성 화합물을 접촉시킴으로써,
상기 (I)∼(IV)를 가지고, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액을 조제하는, 약액 조제 공정을 가지는, 웨이퍼의 표면 처리 방법.
[화학식 30]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.]The method of claim 8,
Before the process of forming the water repellent protective film,
(II) a silicon compound represented by the general formula [2] and
(IV) a silazane compound represented by the following general formula [4] and
(III) In the raw material chemical solution having an aprotic solvent,
By contacting the protic compound in a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (II), (III) and (IV),
Having the above (I) to (IV) and having a chemical solution preparation step of preparing a chemical solution for forming a water-repellent protective film, wherein the content of (I) is 0.02 to 0.5% by mass relative to the total amount of (I) to (III), Wafer surface treatment method.
[Formula 30]
[In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
상기 약액 조제 공정이, 프로톤성 화합물을 함유하는 공간 중에 상기 원료 약액을 도입하여 양자를 접촉시키는 것인, 웨이퍼의 표면 처리 방법.The method of claim 9 or 10,
The method for surface treatment of a wafer, wherein the chemical solution preparation step is to introduce the raw material chemical solution into a space containing a protic compound and bring both of them into contact.
상기 프로톤성 화합물이 기체 상태인, 웨이퍼의 표면 처리 방법.The method according to any one of claims 9 to 11,
The method for surface treatment of a wafer, wherein the protic compound is in a gaseous state.
상기 프로톤성 화합물이 액체 상태인, 웨이퍼의 표면 처리 방법.The method according to any one of claims 9 to 11,
The method for surface treatment of a wafer, wherein the protic compound is in a liquid state.
상기 프로톤성 화합물이, -OH기, 및/또는, -NH2기를 가지는 화합물인, 웨이퍼의 표면 처리 방법.The method according to any one of claims 9 to 13,
The method for surface treatment of a wafer, wherein the protic compound is a compound having an -OH group and/or a -NH 2 group.
상기 프로톤성 화합물이 물, 및/또는, 2-프로판올인, 웨이퍼의 표면 처리 방법.The method according to any one of claims 9 to 14,
The method for surface treatment of a wafer, wherein the protic compound is water and/or 2-propanol.
상기 발수성 보호막 형성 공정 전에,
(IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물과
(III)비프로톤성 용제를 가지는 원료 약액에,
(III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 하기 일반식 [6]으로 나타내어지는 산성 화합물을 접촉시킴으로써,
상기 (I)∼(III)을 가지고, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액을 조제하는, 약액 조제 공정을 가지는, 웨이퍼의 표면 처리 방법.
[화학식 31]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.]
[화학식 32]
[식 [6] 중, X는, 할로겐기, -OC(=O)R3, -OS(=O)2-R3, -N(S(=O)2-R3)2, -C(S(=O)2-R3)3을 나타낸다. R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이다.]The method according to any one of claims 6 to 8,
Before the process of forming the water repellent protective film,
(IV) a silazane compound represented by the following general formula [4] and
(III) In the raw material chemical solution having an aprotic solvent,
By contacting an acidic compound represented by the following general formula [6] in a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (III) and (IV),
Having the above (I) to (III), and having a chemical solution preparation step of preparing a chemical solution for forming a water-repellent protective film, wherein the content of (I) is 0.02 to 0.5% by mass relative to the total amount of (I) to (III), Wafer surface treatment method.
[Formula 31]
[In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
[Formula 32]
[In formula [6], X is a halogen group, -OC(=O)R 3 , -OS(=O) 2 -R 3 , -N(S(=O) 2 -R 3 ) 2 , -C (S(=O) 2 -R 3 ) 3 is shown. R 3 is a C 1 to C 6 monovalent perfluoroalkyl group.]
상기 발수성 보호막 형성 공정 전에,
(IV)하기 일반식 [4]로 나타내어지는 실라잔 화합물과
(III)비프로톤성 용제를 가지는 원료 약액에,
(III), (IV)의 총량 1kg에 대하여 0.001∼0.3몰의 비율로 하기 일반식 [6]으로 나타내어지는 산성 화합물을 접촉시킴으로써,
상기 (I)∼(IV)를 가지고, (I)∼(III)의 총량에 대한 (I)의 함유량이 0.02∼0.5질량%인, 발수성 보호막 형성용 약액을 조제하는, 약액 조제 공정을 가지는, 웨이퍼의 표면 처리 방법.
[화학식 33]
[식 [4] 중, R1은, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이다. e는 1∼3의 정수, f는 0∼2의 정수이고, e와 f의 합계는 3이다.]
[화학식 34]
[식 [6] 중, X는, 할로겐기, -OC(=O)R3, -OS(=O)2-R3, -N(S(=O)2-R3)2, -C(S(=O)2-R3)3을 나타낸다. R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이다.]The method of claim 8,
Before the process of forming the water repellent protective film,
(IV) a silazane compound represented by the following general formula [4] and
(III) In the raw material chemical solution having an aprotic solvent,
By contacting an acidic compound represented by the following general formula [6] in a ratio of 0.001 to 0.3 mol with respect to 1 kg of the total amount of (III) and (IV),
Having the above (I) to (IV) and having a chemical solution preparation step of preparing a chemical solution for forming a water-repellent protective film, wherein the content of (I) is 0.02 to 0.5% by mass relative to the total amount of (I) to (III), Wafer surface treatment method.
[Formula 33]
[In formula [4], R 1 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element. e is an integer of 1 to 3, f is an integer of 0 to 2, and the sum of e and f is 3.]
[Formula 34]
[In formula [6], X is a halogen group, -OC(=O)R 3 , -OS(=O) 2 -R 3 , -N(S(=O) 2 -R 3 ) 2 , -C (S(=O) 2 -R 3 ) 3 is shown. R 3 is a monovalent perfluoroalkyl group having 1 to 6 carbon atoms.]
상기 (I)∼(III)의 총량에 대한 (II)의 함유량이 0.05∼20질량%인, 웨이퍼의 표면 처리 방법.The method according to any one of claims 6 to 17,
The method for surface treatment of a wafer, wherein the content of (II) relative to the total amount of the (I) to (III) is 0.05 to 20% by mass.
상기 (II)가, 하기 일반식 [5]로 이루어지는 군으로부터 선택되는 적어도 1종의 화합물인, 웨이퍼의 표면 처리 방법.
[화학식 35]
[식 [5] 중, R2는, 각각 서로 독립적으로, 일부 또는 전부의 수소 원소가 불소 원소로 치환되어 있어도 되는 탄소수가 1 내지 18의 1가의 탄화수소기를 포함하는 1가의 유기기이고, R3은, 탄소수가 1 내지 6의 1가의 퍼플루오로알킬기이다. 또한, g는 1∼3의 정수이다.]The method according to any one of claims 6 to 18,
The method for surface treatment of a wafer, wherein (II) is at least one compound selected from the group consisting of the following general formula [5].
[Formula 35]
[In formula [5], R 2 is each independently a monovalent organic group containing a monovalent hydrocarbon group having 1 to 18 carbon atoms in which some or all of the hydrogen elements may be substituted with a fluorine element, and R 3 Silver is a monovalent perfluoroalkyl group having 1 to 6 carbon atoms. In addition, g is an integer of 1 to 3.]
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018003977 | 2018-01-15 | ||
JPJP-P-2018-003977 | 2018-01-15 | ||
JP2018231703A JP7277700B2 (en) | 2018-01-15 | 2018-12-11 | Chemical solution for forming water-repellent protective film and method for surface treatment of wafer |
JPJP-P-2018-231703 | 2018-12-11 | ||
PCT/JP2018/047754 WO2019138870A1 (en) | 2018-01-15 | 2018-12-26 | Chemical agent for forming water repellent protective film and surface treatment method for wafers |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200108887A true KR20200108887A (en) | 2020-09-21 |
KR102465276B1 KR102465276B1 (en) | 2022-11-10 |
Family
ID=67398155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020207023680A KR102465276B1 (en) | 2018-01-15 | 2018-12-26 | Chemical solution for forming water-repellent protective film and surface treatment method of wafer |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP7277700B2 (en) |
KR (1) | KR102465276B1 (en) |
CN (1) | CN111630633B (en) |
SG (1) | SG11202005846XA (en) |
TW (1) | TWI707030B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115110094A (en) * | 2021-03-18 | 2022-09-27 | 江苏筑磊电子科技有限公司 | Method for treating metal surface of dipropylene glycol after fire |
WO2023199824A1 (en) * | 2022-04-11 | 2023-10-19 | セントラル硝子株式会社 | Surface treatment composition and method for producing wafer |
WO2024070526A1 (en) * | 2022-09-30 | 2024-04-04 | 富士フイルム株式会社 | Chemical solution, method for producing modified substrate, and method for producing layered body |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5821844B2 (en) | 1975-04-03 | 1983-05-04 | 日本電気株式会社 | micro hatadan filter |
JP2012015335A (en) * | 2010-06-30 | 2012-01-19 | Central Glass Co Ltd | Chemical for forming protective film, and cleaning method of wafer surface |
JP2013104954A (en) * | 2011-11-11 | 2013-05-30 | Central Glass Co Ltd | Wafer surface treatment method and surface treatment liquid |
KR101363441B1 (en) * | 2010-06-07 | 2014-02-21 | 샌트랄 글래스 컴퍼니 리미티드 | Chemical solution for formation of protective film, process for preparing thereof and process for cleaning using the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6824879B2 (en) * | 1999-06-10 | 2004-11-30 | Honeywell International Inc. | Spin-on-glass anti-reflective coatings for photolithography |
US9228120B2 (en) * | 2010-06-07 | 2016-01-05 | Central Glass Company, Limited | Liquid chemical for forming protecting film |
WO2012002200A1 (en) * | 2010-06-30 | 2012-01-05 | セントラル硝子株式会社 | Wafer cleaning method |
JP2013118347A (en) | 2010-12-28 | 2013-06-13 | Central Glass Co Ltd | Cleaning method of wafer |
JP2017168828A (en) * | 2016-03-15 | 2017-09-21 | セントラル硝子株式会社 | Chemical solution for water-repellent protection film formation |
-
2018
- 2018-12-11 JP JP2018231703A patent/JP7277700B2/en active Active
- 2018-12-26 KR KR1020207023680A patent/KR102465276B1/en active IP Right Grant
- 2018-12-26 SG SG11202005846XA patent/SG11202005846XA/en unknown
- 2018-12-26 CN CN201880086426.XA patent/CN111630633B/en active Active
-
2019
- 2019-01-11 TW TW108101088A patent/TWI707030B/en active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5821844B2 (en) | 1975-04-03 | 1983-05-04 | 日本電気株式会社 | micro hatadan filter |
KR101363441B1 (en) * | 2010-06-07 | 2014-02-21 | 샌트랄 글래스 컴퍼니 리미티드 | Chemical solution for formation of protective film, process for preparing thereof and process for cleaning using the same |
JP2012015335A (en) * | 2010-06-30 | 2012-01-19 | Central Glass Co Ltd | Chemical for forming protective film, and cleaning method of wafer surface |
JP2013104954A (en) * | 2011-11-11 | 2013-05-30 | Central Glass Co Ltd | Wafer surface treatment method and surface treatment liquid |
Also Published As
Publication number | Publication date |
---|---|
TWI707030B (en) | 2020-10-11 |
JP2019123860A (en) | 2019-07-25 |
CN111630633B (en) | 2023-09-19 |
SG11202005846XA (en) | 2020-07-29 |
CN111630633A (en) | 2020-09-04 |
JP7277700B2 (en) | 2023-05-19 |
TW201932575A (en) | 2019-08-16 |
KR102465276B1 (en) | 2022-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101361203B1 (en) | Cleaning agent for silicon wafer, water-repellent cleaning liquid and cleaning method for surface of silicon wafer | |
KR101363441B1 (en) | Chemical solution for formation of protective film, process for preparing thereof and process for cleaning using the same | |
US9748092B2 (en) | Liquid chemical for forming protecting film | |
US8828144B2 (en) | Process for cleaning wafers | |
TWI601810B (en) | Preparation of a protective film-forming solution | |
SG190068A1 (en) | Process for cleaning wafers | |
JP5482192B2 (en) | Silicon wafer cleaning agent | |
JP5446848B2 (en) | Silicon wafer cleaning agent | |
KR102465276B1 (en) | Chemical solution for forming water-repellent protective film and surface treatment method of wafer | |
KR101425543B1 (en) | Chemical solution for forming water-repellent protective film and method for cleaning of wafer using the same | |
US20120164818A1 (en) | Process for Cleaning Wafers | |
KR102509450B1 (en) | Manufacturing method of surface treatment agent and surface treatment body | |
WO2019138870A1 (en) | Chemical agent for forming water repellent protective film and surface treatment method for wafers | |
KR20210092297A (en) | Bevel treatment agent composition and manufacturing method of wafer | |
TW201937296A (en) | Chemical solution for forming water-repellent protective film, method for preparing same, and method for manufacturing surface-treated body | |
TWI484023B (en) | Water-borne protective film-forming liquid, water-repellent protective film-forming liquid pack and wafer cleaning method | |
WO2010084826A1 (en) | Silicon wafer cleaning agent | |
KR20220024836A (en) | Surface treatment agent and method for producing surface treatment body | |
JP5712670B2 (en) | Water repellent protective film forming chemical |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |